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With the burgeoning interest for understanding the nature, an 
interdisciplinary overlay substantiates a better achievement. This can be 
evidenced by the strongly overlaid biomimetic supramolecular chemistry and 
biochemistry.  
Studying the crystal engineering of the metal-amino acid Schiff bases 
is the first focus of the study. We chose to investigate the architecturally rich 
arginine, histidine, tyrosine and tryptophan. The arginine Schiff bases were 
reported structurally by XRD for the first time. Their guanidinium side chains 
may offer potential application as thrombin inhibitor. Tyrosine and tryptophan 
Schiff bases exhibit a series of bilayer-mimicking solid-state structures, stem 
from the distinctive H-bonding and aromatic stacking interactions. Moreover, 
the feasibility of these aromatic amino acids (including histidine) to form 
metal aggregates, coordination polymer and MOF has been proven. Potential 
applications such as magneto compounds and host-guest reaction are also 
discussed.  
While the crystal engineering of small molecules is presented, the next 
focus of the study emphasizes on the metalloprotein design. Of particular 
interest is to tune the redox potential of cupredoxin T1 azurin (Az), by 
manipulating the interaction beyond primary coordination sphere. Careful 
introduction of hydrophobicity around histidine ligands by M44F/G116F 
mutation raises the potential by ~50 mV. Combining this mutation with a 
reported triple mutant, N47S/F114N/M121L gives a nearly 1V variant, which 
maybe a viable redox agent for oxidation process. Finally, a direct comparison 
of such secondary effect between T1 Az and CuA Az was attempted. 
 xi 
 
Interestingly, similar mutation on CuA Az (N47S and E114P) exerts only half 
of the changes that seen on T1 Az, implying the spread-out effect in the 
binuclear CuA Az. 
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WT. (b) The unexpected orientation of Phe13 side chain 
results in a more solvent-exposed His117. The overlaid 
protein surface of M13F/G116F and WT Az is shown in 




The mutation site of the T1 Az site. The copper-binding 
ligands are depicted in stick model; the residues that involved 




UV-vis spectra of 5Mut. Spectrum was obtained at 25°C in 




Different orientation of dx2-y2 orbital lobes of copper with 
cysteine thiolate ligand will affect the intensity of two 




(a) The EPR samples of 5Mut in different buffer. (b) The EPR 




CV of 5Mut on glassy carbon electrode in 50 mM NH4OAc 




Crystal structure of 4Mut contains two copper atoms in a 
molecule, with the special copper atom ligated to His83. (b) 
N47S and F114N rearrange the H-bonding in the active site 
(left). The hydrophobicity introduced by M44F and G116F 





The diamond core geometry of dinuclear copper site of CuA 
Az. The mutation sites, Asn47 and Glu114 are shown as well 
(PDB ID 1CC3). 
209 





UV-vis spectra of CuA Az, N47S and E114P mutants. 210 
Figure 
5.18 
X-band EPR spectrum of CuA Az, N47S and E114P mutants 
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1.1 Crystal Engineering of Small Molecules 
Since the concept of ‗supramolecular chemistry‘ was introduced by J.-
M. Lehn in 1978, the field has grown dramatically over decades.
1,2
 In contrast 
to the traditional chemistry in making and breaking covalent bonds, 
supramolecular chemistry employs non-covalent interactions in maintaining 
the structures and directing the fundamental functions to the system.  
Crystal engineering is one of the key directions in supramolecular 
chemistry. It has been defined by Desiraju in 1989 as ―the understanding of 
intermolecular interactions in the context of crystal packing and in the 
utilisation of such understanding in the design of new solids with desired 
physical and chemical properties‖.3 Over the years, crystal engineering has 
provided not only deeper insights in understanding the natural systems, but 
also resourceful ideas in developing functional devices, e.g. drug delivery, 
biomimetic functions and sensing.
4-8
  
To design a crystal with desired property, a good control of topological 
is a fundamental necessity.
9
 To achieve this, two non-covalent interactions are 
of critical importance, namely hydrogen bonding
10,11
 and π-π interaction.12 A 
hydrogen bond (H-bond) is defined as electrostatic attraction between a 
hydrogen donor, A–H and an acceptor B (A and B are generally 
electronegative atoms, such as N, O or halides).
13
 In comparison, π-π 
interaction has been referred as stacking of aromatic groups separated by ca. 
3.3-3.8 Å.
14
 Both of these interactions are significantly weaker than a typical 
covalent bond (200-400 kJ mol
-1
), with the former being ca. 1-80 kJ mol
-1
 and 




 In spite of this, they play a decisive role in driving 




the supramolecular assemblies and crystal packing. Particularly, H-bond has 
been regarded as ―an indispensable tool for designing molecular aggregates‖, 
due to its highly directional property.
10 
Such interactions will be discussed 
shortly in the following chapters. 
It should be stressed that the concept of crystal engineering 
encompasses intermolecular assembly ranging from small molecules to 
proteins. Thus, the crystal engineering is so highly interdisciplinary, covering 
the fields of organic, inorganic, biology, materials, etc. This thesis comprises 
of two parts, Part I and Part II, which will focus on small molecules and 
proteins respectively. Studies on proteins will only be highlighted from 
Chapter 4 onwards. 
1.1.1 Self-Assembly in Biological Systems 
One of the ultimate goals of supramolecular chemistry is to achieve the 
efficiency of natural systems by emulating them structurally and functionally. 
Thus,
 
we must first learn the lessons from the nature, which has exquisitely 
demonstrated the self-assemblies in a precise and amazing way.
16-20
    
Self-assembly is a central concept to supramolecular chemistry and has 
been defined as a process in which „programmed‟ molecular subunits 
spontaneously form complex supramolecular frameworks through mutual 
recognition. Understandably, this recognition event is again based on non-
covalent interaction, including electrostatic interaction, H-bond, van der Waals 
forces, π-π interaction and repulsive steric interaction, which may act either 
independently or cooperatively to adopt the supramolecular assembly.
21,22
 A 
few examples of self-assembling systems found in the nature including DNA 




double helix, assembly of lipid bilayer, tobacco mosaic virus (TMV) and 
secondary R-helix structure of proteins.
22 
Here only the DNA double helix and 
lipid membrane will be presented in detail to demonstrate the principles 
clearly. 
The DNA double helix is an amazing paradigm of self-assembly in 
nature. It is formed via complementary and specific interactions between two 
polynucleotide strands.
22
 There are four bases paired up by H-bond 
interactions: adenine (A)─thymine (T) and guanine (G)─cytosine (C) (Figure 
1.1). Despite the H-bonds between the base pair are weak, the built up of the 
forces is strong enough to held the strands in a helical structure. In addition, 
the thermodynamics of helix formation is also aided by the base stacking, with 








































Figure 1.1 Complementary H-bond between (a) thymine and adenine; (b) 
cytosine and guanine. 
 
The self-assembly of amphiphiles in forming lipid is another 
illustrative example. Amphiphiles are molecules containing both hydrophilic 
and hydrophobic regions. Driven by energetically unfavorable interaction with 
the aqueous environment, the hydrophobic tails of amphiphiles tend to 
assemble in the core while the hydrophilic parts face the outside of the 






 This hydrophobic effect results in various forms of bilayers with 
minimum energy organizations, e.g. bilayer sheets, micelles, vesicles or 
liposomes.
24,25 
Since the fluid mosaic model was postulated by Singer and 
Nicholson in 1972 (Figure 1.2), other functions of lipids have been unraveled 
progressively.
26
 The lipid plays a key role as a cell separator to ensure the 





 and drug delivery.
29,30
 Owing to its intriguing structure, the 
lipid has been commercially used for drug delivery. In this case, the liposome 
is an established delivery agent that enabling the labile drug being 
encapsulated within the vesicles and released to the target site. 
 
 
Figure 1.2 The fluid mosaic model proposed by Singer and Nicholson.
26
 The 
lipid bilayers are two dimensional fluids and the membrane proteins are partially 
embedded in the matrix. 
 
Based on the above review, it is clear that understanding the self-
assembly in the natural systems can help researchers harness the principle and 
translate it into real application. Of particular interest is to make use of the 
natural building blocks (e.g. nucleotide and amino acid) which more closely 
approximates these systems.    




1.1.2 Synthetic Supramolecular Assemblies Using Amino Acids – the 
Building Blocks of Life 
Amino acids are the most important building blocks of protein found 
ubiquitously in the biological systems. They are excellent chelating agents that 
can coordinate to metal via the amino and carboxylato groups, forming stable 
five-membered chelate rings.
31
 When the side chain contains a functional 
group, it presumably provides an additional metal binding site or generates 
weak interactions with other groups, forming a variety of assembled 
structures.
32,33
 More importantly, the amino acid possess natural stereogenic 
center, making it of prime importance to induce chirality for further 
application.
34
 Thus, a myriad of efforts have been directed at using the rich 
architectural amino acids in the realm of synthetic supramolecular systems.  
A simple system in this frame will be the metal-amino acid complexes, 
which establishes fundamental insights into the metal-ligand interaction in 
metalloprotein and metalloenzymes. A very recent example given by Saunders 
et al. has provided structural information of amino acid complexed with lead, 
which is a heavy metal that causes adverse health effects.
35 
Also, Yamauchi et 





. This indicates the advantages of chiral amino 
acid in constructing interesting supramolecular system.
36 
More works of 
Yamauchi‘s group will be discussed in the following section. 
In spite of the importance as reviewed above, the exploration of amino 
acid crystal engineering is limited by the scarcity of natively available 
candidates (20 amino acids). Furthermore, the tendency of amino acids 




coordinate to metal via the amino and carboxylato groups often leads to the 
formation low, even zero-dimensional complexes. This is especially common 
for simple amino acids without functional side chains.
37
 Hence, some studies 
focus on the incorporation of co-ligands or chemically modification of the 
amino acids in the construction of supramolecular structures. For example, 
Hong‘s group has showed the construction of three-dimensional (3D) helical 
array and 3D porous framework, by incorporating coligand 4,4‘-bipyridine 
(4,4‘-bpy) with copper-D, L-alanine and D, L-phenylalanine respectively.38 
Also, Khatua et al. have showed the self-assembly of copper-lysine Schiff 
bases which generated a 3D H-bond network via interaction of lysine side 
chain with carboxylate groups.
39
 It is interesting to observe the formation of 
octanuclear water clusters and water chains and their interaction with these 
networks.
 
As such, amino acid-derived supramolecular system has variable areal 
extent for significant exploitation. Particularly, amino acids bearing functional 
side chains have potency to generate higher dimensional interaction network. 
The next section will highlight some reviews on a few selected amino acids of 
interest in this study, followed by a synthetic derivative, viz. the amino acid 
Schiff base.  
1.1.2.1 Arginine and Its Guanidinium Moiety 
Let us consider arginine first. A salient feature of arginine amongst the 
20 amino acids is its guanidinium moiety which plays a functional and 
structural role in a range of biological activities. Owing to its high pKa value 
(~12.5), the guanidinium group always retains its protonation state over a wide 




range of pH media. Consequently, it is particularly amenable to both 
electrostatic and H-bond interactions with various anionic substrates.
35,40
 
Numerous examples found in nature clearly elucidate the significant 







superoxide (eg. superoxide dismutase, SOD),
45
 etc. Louis and coworkers have 
proven the primary role of Arg87 in stabilizing dimers of mature HIV-1 
protease (PR), by forming a salt bridge with Asp29. The mutation to Lys87 
has significantly increased the dimer dissociation, and subsequently reduced 
the catalytic activity.
46
 In a separate study, Chad et al. have identified Arg280 
and Arg174 as two key residues in the catalytic activities of UDP-
galactopyranose mutase (UGM), an enzyme that mediates the cell wall 
biosynthesis in microbacteria. It was shown that the substitution of either 
arginine residues resulted in a completely loss of enzyme activity.
47
 Another 
study from Santolini‘s group demonstrated that guanidinium moiety of 
arginine is crucial in determining the stability of heme in nitric-oxide synthase 
(NOS), as well as controlling the proton transfer event.
48
 
Given the biological importance of arginine and its guanidinium 
moiety, innumerable efforts have been directed in designing guanidinium-
based drugs and artificial receptors over the decades.
40,49-50
 The first receptor 
for phosphate anion was reported by Lehn and co-workers in 1978, which 
opened up a new avenue in the development of macrocyclic guanidinium-
based receptors.
1
 In the ensuing studies, receptor design was focused on the 
incorporation of guanidinium into a bicyclic system. This scaffold is beneficial 
as it improves the solubility in apolar solvent. Furthermore, the restricted 




conformation of guanidinium may enhance its interaction with anions. This is 
because the NH protons are constrained in a syn position, allowing a more 
complement DD-AA H-bonding as shown in Figure 1.3.
40,49
  In line of drug 
development, thrombin inhibitors which typically contain a benzamidine or 
arginine moiety is widely studied. This moiety is important to establish crucial 
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Figure 1.3  (a) Examples of bicyclic guanidinium receptors with DD-AA and 





Crystallographic results revealed that the guanidinium moiety could 
orientate the substrate via two parallel H-bonds, ultimately elaborating the 
non-covalent network (Figure 1.3).
40
 Utilizing this peculiar binding capability, 
Mak et.al. have constructed a series of fused-rosette layers using guanidinium 






 The different combination of these small 
molecules exhibited interesting sinusoidal, planar and wavy rosette motifs.
55
  





structures. The two arginines are coordinated to the Cu(II) atom in 
cis- and trans- configurations, leading to helical and layer patterns 
respectively (Scheme 1.1). The configuration highly depends on the ability of 
X
2-
 to form chelating H-bond with the coordinated amino groups. Thus, bulky 
anions will generally induce trans- configurations due to steric effect, 
subsequently forming the layer structures. Also, it should be noted as well that 
helices with different handedness can be appropriately influenced by the 
chirality of amino acid used.
36,58  
 
















= isophthalate; dpc = dicarboxylic acid).
58 




The above-mentioned works clearly indicate that arginine offers a 
good candidate to design fascinating supramolecular system, owing to its 
structural feature, as well as its ability to form ion-pairing and H-bonding. 
1.1.2.2 Aromatic Amino Acids – Tryptophan, Tyrosine and Histidine 
While arginine is a potential candidate to induce interesting H-bond 
interaction, tryptophan, tyrosine and histidine are among the aromatic amino 
acids that potentially form aromatic stacking (Section 1.1) – a weak yet vital 
interaction widely found in the protein-ligand system.
59
  
Bearing the largest aromatic indole ring, tryptophan is crucial in 
creating a hydrophobic environment in the biological system, such as in the 
avidin-biotin and streptavidin-biotin interaction.
60
 In studying tryptophan-
derived synthetic assembly, Subramanian and co-workers have illustrated the 
helical strands made of [Cu(L-trp)(bpy)](ClO4) and [Cu(L-
trp)(phen)](ClO4)·3H2O (L-trp = L-tryptophan; bpy = bipyridyl; phen = 
phenanthroline).
61
 Considerable π-π stacking was observed between the indole 
ring of tryptophan and the coligand (bipy and phen), as well as aryl-metal-
chelate. This aromatic interaction is proposed to assist the folding of the 
helical structures. 
Likewise, tyrosine containing a phenol side chain is capable of 
exhibiting aromatic stacking. Its additional hydroxyl group serves to embellish 
the reactions, including H-bonding, phosphorylation, metal binding, etc.
33
 
Both tyrosine and tryptophan are also widely involved as transient 
intermediates in the redox active co-factors.
32
 A few supramolecular studies 
using tyrosine have been demonstrated, including complexation of vanadyl 






) with tyrosine Schiff base
62 
and a chiral coordination polymer 
composed of Cu(II), tyrosine and 4,4‘-bipy.63 
In comparison to the tryptophan and tyrosine side chains, the imidazole 
ring of histidine is abundantly involved in the metal-binding sites, as found in 
the cupredoxin azurin and CuA azurin (Chapter 4 and 5). In view of synthetic 
coordination chemistry, the histidine also offers a good ligand in forming 
interesting assembly pattern. This is evidenced from a self-assembled capsule 
derived from Cu(II)-histidine reduced Schiff base. The formation of this 
spacious capsule is facilitated by the imidazole ‗arm‘ of histidine which 
connects four monomeric units together.
64
 Similar work with Fe(III) gives 




After screening the amino acids of choice, our next direction is to 
further improve the ability of forming higher dimensional coordination 
networks. As discussed in Section 1.1.2, chemical modification is one of the 
alternatives. In this case, Schiff base will be the focus of the study. 
1.1.2.3 Amino Acid Schiff Bases 
 For decades, amino acid Schiff base has been a subject of interest as it 




Schiff base, named after Hugo Schiff, is a compound containing an 
imine or azomethine group (RC=N), with nitrogen atom connected to an 
aryl or alkyl group.
69-70
 The Schiff base has been considered as ―privileged 
ligand‖ due to their preparative accessibility.70 In synthetic chemistry, it finds 




a versatile use due to its moderate electron donors with easily tunable 
electronic and steric effects. In coordination chemistry, its ability to form 
stable complexes with most of the transition metals offers a valuable 
stereochemical model. Non-racemic Schiff bases can be easily prepared when 
chiral aldehydes or chiral amines, particularly amino acids are used. Since 
most naturally occurring amino acids are in the L-form, this study will 
emphasize on L-amino acids.
71
  
 The Schiff base can be synthesized by a reversible condensation of a 
primary amine with a carbonyl compound (Scheme 1.1). The nucleophilic 
addition of amine results in the formation of an intermediate hemiaminal, 





















Scheme 1.2 Synthesis of Schiff base. 
  
Conventionally, most of the amino acid Schiff bases isolated to date 
contain o-hydroxy aromatic imine group which acted as [ONO] tridentates. 
Thus, they provide an additional coordination site as compared to [NO] 
bidentate of the original amino acids. McIntire proposed that the stability of 
this type of Schiff bases can be explained on a basis of intramolecular H-








There are generally three different synthetic pathways for the 
preparation of amino acid Schiff bases:
74
 
I. metal salt + aldehyde + amine  
II. metal salt + Schiff base 
III. metal-aldehyde  + amine  
Method I is the most widely used method. It is also known as ‗one-pot‘ 
reaction wherein the ligand is not isolated but reacts in situ with the metal 
precursor. Although the mechanism behind remains elusive, it is undoubtable 
that the pre-organization of molecules play a decisive role. The next Method II 
is by reacting the pre-formed Schiff base with metal salt. It is preferred when 
preparation of the pure Schiff base is possible to be prepared. Method III is 
usually used for the preparation of macrocyclic compounds. This study mainly 
employs the first two approaches.    
Some of the reported amino acid Schiff bases are shown in Figure 1.4. 
To name a few, they are mostly of simple neutral amino acid such as glycine, 
valine, thronine, alanine, etc. In addition to the Schiff bases, the Vittal group 
has reported a series of reduced Schiff bases which involves a reduction of 
C=N bond, thus offering a more flexible backbone.
75-76
 
While the above reviews focus on structural studies, a few potential 
applications of the amino acid Schiff bases will be presented next. 
 
 





























































































































Figure 1.4 Some reported amino acid Schiff bases. The naming scheme is 
based on the protonated sites (e.g. H2), followed by single letter amino acid 
code (e.g. G = glycine; T = threonine, etc.). The last three letters are 
abbreviation for aryl moiety. Sal = N-(2-hydroxy-3-methoxy-salicylidene; Nap 
= N-(2-hydroxy-1-naphthalidene); Van = N-(2-hydroxy-3-methoxy-salicylidene 
or o-vanillin. The first letter ‗r‘ in the last few samples indicates reduced Schiff 
base. 




1.2 Potential Application of Amino Acid Schiff Base 
 The Schiff bases have been known to be bioactive against gram-
negative as well as gram-positive bacteria.
91
 Also, they have been used as 
biomimetic catalysts in catecholase activity,
77
 as well as aerobic oxidation of 
β-isophorone.92 Herein, only a few related applications will be discussed.  
1.2.1 Coordination Polymer and Metal-Organic Framework  
The term ―coordination polymer‖ (CP) had been introduced by J. C. 
Bailer in 1964.
93
 Another similar terminology, ―metal-organic framework 
(MOF)‖ was introduced later by Yaghi in 1995.94 To differentiate these two, it 
has been defined that CP is applicable on extended structures with 1D or two-




Both CP and MOF are subsets of crystal engineering. Their promising 
application has merited speedy growth since 2001.
94-95
 The feasibility of their 













CP can be constructed when a ligand contains multiple coordination 
sites. One of the synthesis approach is the incorporation of co-ligands,
105-107
  
as demonstrated in two previous mentioned studies.
38,63
 Another example was 
shown by Huang et al., wherein the complexation of Co(II), 4,4‘-bipy and L-
cysteic acid giving rise to a 2D brick-wall network with cavities filled with 
uncoordinated 4,4‘-bipy and water molecules. Such open cavities make it a 




potential absorbent for small guest molecules.
101
 Another approach to build 
CP will be discussed in more detailed in Chapter 3 Part C. 
In the frame of MOF, the amino acids with polyfunctionalities such as 
aspartate and glutamate, were employed as organic spacers or ligands.
108-109
 
Rosseinsky and co-workers have constructed a chiral nanoporous MOF, 
[Ni2(L-asp)2(4,4′-bipy)]·guests (L-asp = L-aspartate) that is enantioselective 
for the sorption of short-chain diols.
108
 Further post-synthesis modification on 
this MOF has introduced a Brønsted acid site for organic transformation such 
as methanolysis.
110
 Such works have clearly demonstrated the rich potential of 
amino acid for MOF construction. 
Despite its eminent application, the construction of MOF particularly, 
remains a formidable task. To ensure the framework is applicable for host-
guest interaction or gas absorption for instance, the MOF should be thermally 




1.2.2  Polynuclear Magnetic Materials 
For decades, polynuclear paramagnetic transition metal complexes 
have been a burgeoning interest due to their ferro- and antiferromagnetic 
behaviors.
112-113
 These molecule-based magnetic materials have profound 
potential in various technological applications, including quantum devices, 
magnetic memory and information storage. In this regime, single molecular 
magnets (SMMs) and single chain magnets (SCMs) have drawn renewed 
attention due to their slow relaxation of magnetization. 1D magnetic systems 




have been particularly attractive after Gatteschi and co-workers had 
discovered their retractable behavior in 2001.
114-116
 
With regard to the design of polynuclear complexes, different types of 
multidentate ligands are widely pursued. The ligands that bind two metal ions 
simultaneously have been termed as „binucleating ligands‟ by Robson in 
1970.
117
 In the ensuing studies, these Robson-type ligands bearing phenol-
based Schiff base were prevalently employed (Figure 1.5).
117-119
 The 
compartmental nature of these ligands is highly advantageous as it allows 
divergent coordination sites for bimetal binding, thus providing topologically 
ideal scaffold in mimicking bimetal biosites.
115-117 
Additionally, their planarity 
allows the efficient interaction between the metals bridged by phenolato 














Figure 1.5 Some examples of Robson-type ligands: (a) tetraimine-diphenol 
ligand by Robson (1970);
117





Later development introduced by Bosnich has incorporated additional 
picolyl pendant arms to improve the solubility and increase the number of 
coordination sites.
120,125
 The Bosnich-type ligands generally have hexa- and 
tetradentate sites (Figure 1.6).
122
 This allows the binding of metals with 







, etc are imparted to the system to form extended networks.
127-128
 




Typically, the syntheses of these binucleating ligands, especially of the 


















Figure 1.6 Some examples of Bosnich-type ligands: (a) 1,6-bis(2-pyridyl)-
2,5-bis(2-hydroxy-3formyl-5-methylbenzyl)-2,5-diazahexane by Bosnich 
(1992);
125




Structurally, the o-hydroxyaryl amino acid Schiff bases are similar to 
the aforementioned Robson- and Bosnich-type ligands. In fact, the simpler 
preparation of these Schiff bases can be advantageous. A few studies have 
proven the feasibility of the amino acid Schiff bases in preparing magnetically 
interesting materials. For instance, {K[Cu(sal-β-ala)(μ-NCS)]}n (sal-β-ala = N-
salicylidene-alanine; NCS = isothiocyanato) reported by Vančo et al. exhibits 
alternating ferro- and antiferromagnetic exchange.
130
 Another study on lysine-












 1.3 Project Aims and Thesis Overview for Part I 
 From the literature study, it was found that the supramolecular 
chemistry of arginine and aromatic amino acids is still relatively less explored. 
With their importance as discussed above, further investigation on their crystal 
engineering may shed new light on this field. More specifically, the objectives 
of this study are: 
i) Investigation of the supramolecular assembly of arginine Schiff 
bases. In conjunction with the structural study, the possible 
application of this Schiff bases as thrombin inhibitor will be 
examined as well. 
ii) Exploitation of the stacking interaction of aromatic amino acid 
(tryptophan, tyrosine and histidine) Schiff bases in the crystal 
engineering. Possible application of these Schiff bases will also 
be included. 
iii) Study of the coordination chemistry of these amino acid Schiff 
bases with different transition metals, with greater emphasize 
on Cu(II). The importance of Cu(II) will be presented in Part II 
Chapter 4.  
Part I of this thesis will be divided into two chapters. Chapter 2 will 
provide an exploratory study on arginine Schiff bases, whereas Chapter 3 will 
focus on the aforementioned aromatic amino acids. The Chapter 3 is 
composed of four parts: Chapter 3.1 describes a series of lipid-bilayer 
mimicking structures; Chapter 3.2 presents the metal aggregates of Schiff 
bases and their magnetic study; Chapter 3.3 and 3.4 investigate the CP and 




MOF derived from tyrosine Schiff bases. The experimental work is 
summarized in the last part of each chapter. All Schiff base ligands in the 
study are shown in Figure 1.7. Chapter 4 onwards will be the Part II of the 






















HRNap (2-a) HRNO2 (2-b) HRMe (2-c) 
NOH

































NaHHVan (3-d) NaHWVan (3-e) Na2YNO2 (3-f) 
Figure 1.7 The amino acid Schiff bases used in this study. 










Supramolecular Assemblies of a New Series of  
Copper-L-Arginine Schiff Bases 
 
 




2.0 Preface  
 Despite the wealth of studies on amino acid Schiff base, statistical 
results reveal that those of arginine are surprisingly sparse.
131-132
 With 328 
crystal structures of o-hydroxyaryl amino acid Schiff base available to date 
(December 2010), none involving arginine has been reported (Figure 2.1b).
133-
135
 In this chapter, we discuss the synthesis and structural characterization of 
three arginine Schiff base ligands and six copper complexes. Also, the docking 












Figure 2.1 (a) The structure of L-arginine. (b) The histogram showing the 
reported crystal structures of o-hydroxyaryl amino acid Schiff bases. 
 
 




2.1  Introduction 
In view of the synthetic utility of Schiff bases in coordination 
chemistry (as discussed in Section 1.1.2.3), we are interested in the 
construction of supramolecular architectures using L-arginine Schiff bases. 
Although numerous studies have been directed in supramolecular assembly of 
many amino acid Schiff bases, they are mainly denoted to simple amino acids. 




As mentioned in Section 1.1.2.1, arginine contains a guanidinium 
moiety that always remains protonated. This drives our interest to study the 
interplay between arginine and oxoanions through ion pairing and H-bonding. 





. They conclude that the bulkiness of the anions 
control the formation of helical and layer structures.
36 
In our case, the arginine 
Schiff bases coordinate to the metal center via tridentate [ONO] ligands. The 
anion effect will thus give different topology control. Also, while most studies 
focus on varying the metal centers or amino acids, little is done on modulating 
the electronic properties of hydroxyaryl. A work from Vittal‘s group has 
investigated such effect on catecholase activity of a series of dicopper(II) 
reduced Schiff-bases.
75 
The results show that the presence of electron 
withdrawing groups decrease the catecholase activity while the electron 
donating groups give the reverse effect. 
In this chapter, we examine the assembly outcomes by systematically 
varying the ring substituent (tuning the π system with polarization or ring 




enlargement), as well as the effect of oxoanions. Only Cu(II) complexes is 
focused here owing to their ease of crystallization in providing useful 
structural information for direct comparison. Six crystal structures of 
copper(II)-L-arginine Schiff bases together with a ligand are herein reported. 
For two of these structures, there exist two structurally different molecules in 
the unit cells. To the best of our knowledge, arginine Schiff bases have not 
been studied crystallographically yet, although other amino acid Schiff bases 
are common. 
2.2 Results and Discussion     
2.2.1 Syntheses  
As discussed in Section 1.1.2.3, a Schiff base can be prepared by 
simple condensation of amino acid with aldehyde. The synthesis of N-(2-
hydroxy-1-naphthalidene)-L-arginine (HRNap; 2-a) was reported in 1947 by 
McIntire in a moderate yield (70%), which required pretreatment with Ag2CO3 
under a moisture-free environment and longer reaction time (1-2 days).
72
 In 
this work, 2-a was obtained in high yield (94%), following a simpler method 
reported by Ebel and Chow.
62,132
  
As an attempt to elucidate the effect of para-substituent to –OH of 
hydroxyaryl, nitro and methyl are chosen as electron withdrawing and 
donating groups respectively. Two new L-arginine ligands, N-(2-hydroxy-5-
nitro-1-salicylidene)-L-arginine (HRNO2; 2-b) and N-(2-hydroxy-5-methyl-1-
salicylidene)-L-arginine (HRMe; 2-c) have been successfully synthesized in 
moderate yields (55 and 68%) (Scheme 2.1). The complexation of these 




ligands with Cu(II) is shown in Scheme 2.2. The complexes can be obtained 

















R = NO2 (2-b)
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2.2.2 Description of Crystal Structures 
2.2.2.1 HRNap (2-a)  
Single crystals of 2-a were obtained by slow evaporation of methanolic 
solution of the sample. We herein report the crystal structure of the first 
example of an arginine Schiff base, from which we can gain new insights into 
the self-assembled patterns of arginine derivatives. 2-a crystallizes in triclinic 
P1 with two water molecules of crystallization in an asymmetric unit (Figure 
2.2a). Notably, the bond order of C2–O1 and C22–O4 is estimated to be close 
to two, as depicted by their relatively shorter bond lengths of 1.279(4) and 
1.277(4) Å (given the normal aryl C–O bond in phenol = 1.362 Å and C=O = 
1.222 Å).
142
 In addition, the bond lengths of C3–C4 (1.339(5) Å) and C23–
C24 (1.342(5) Å) are shorter than the other aromatic C–C of the same ring, 
which proves that the pseudo aromatic system exists in a quinoid form.
143
 This 
quinoid effect of the N-aryl Schiff bases shifts the phenol proton to the imine 
nitrogen, causing HRNap to exist as a zwitterion. This is supported by the 
longer N1–C11 and N5–C31 bond lengths of 1.306(3) and 1.304(4) Å 
respectively (a typical C=N bond length is 1.279 Å).
142
 Extensive intra- and 
intermolecular H-bonding was found, with the interaction between the 
phenolate and guanidinium (N7–H7AO1vi 3.13, N8–H8BO1vi 2.85, N3–
H3AO4ii 3.17 and N4–H4BO4ii 2.79 Å; symmetry codes (vi): -1+x,1+y,z; 
(ii): x,-1+y,z), as well as the carboxylate and guanidinium (N2–H2O3ii 2.57, 
N3–H3BO3ii 3.24, N4–H4AO5ii 2.82, N6–H6AO6v 2.88  and N8–
H8AO2 2.83 Å; symmetry codes (ii): x,-1+y,z; (v) x,1+y,z) interconnects the 




2D layers (Figure 2.2b, Table 2.1). This interconnection results in the short 
C4C29 contact at 3.345 Å. Weak π-π interaction between the naphthalene 





 range in the region of 4.51-6.93 Å. 
 
Table 2.1 Hydrogen bond parameters for 2-a ligand.
a
 
D─HA d(HA)/Å d(DA)/Å <DHA/˚ 
O1W─H1WAO3i 1.89(3)    2.729(4)      153(3)    
N1─H1NO1 1.97    2.574(4)      137 
N2─H2O3ii 2.11 2.916(4)      153 
O1W─H1WBO2 1.88(3)    2.762(4)      164(3)      
O2W─H2WAO6iii 2.07(4)    2.713(4)      128(3)    
N3─H3AO2Wii 2.22 2.887(4)      133 
N3─H3AO4ii 2.48 3.172(4)      137 
N3─H3BO1Wiv 2.30 3.043(4)      143 
N3─H3BO3ii 2.55 3.237(4)      137 
O2W─H2WBO5 1.97(4)    2.821(4)      157(3)      
N4─H4AO5ii 1.99 2.815(4)      158 
N4─H4BO4ii 1.96 2.793(4)      159 
N5─H5NO4ii 1.99 2.577(4)      134 
N6─H6AO6v 2.12 2.876(4)      145 
N7─H7AO1vi 2.41 3.133(4)      141 
N7─H7AO1Wv 2.24 2.784(4)      130 
N7─H7BO2Wvi 2.41 3.166(4)      146 
N8─H8AO2 1.99 2.826(4)      162 
N8─H8BO1vi 2.03 2.849(4)      158 
a
 Symmetry codes: (i) -1+x,y,z; (ii) x,-1+y,z; (iii) 1+x,y,z; (iv) 1+x,-1+y,z; (v) 













Figure 2.2 (a) A perspective view of 2-a within the crystal lattice. All C─H 
hydrogen atoms have been omitted for clarity. The intramolecular H-bond is 
depicted as pink dotted lines. (b) Interconnection between the parallel 2D 
layers of 2-a via H-bonding between phenolate and guanidinium, as well as 
carboxylate and guanidinium. 




2.2.2.2 [Cu(RNap)(OAc)]·2H2O, 2-1 
Cu(II) complexes are stereochemically flexible. This may be due to 
some electrons in the sigma anti-bonding orbital, together with Jahn-Teller 
effect which result in a wide range of distorted stereochemistry.
144
 Therefore, 
it is not surprising that 2-1 adopts two different geometries in a unit cell. Such 
variation was also observed in a reported [Cu2(salNet2)2(μ-mal)]·MeOH 
(salNet2 = N-(2-(diethylamino)ethyl)salicyliden- aminate; mal = maleate).
145
 
  The complexation of 2-a with Cu(OAc)2·2H2O results in the 
isolation of 2-1, containing 2-1a and 2-1b that differ by the coordination 
modes of acetate (Figure 2.3a). The former adapts a square planar geometry 
with the coordination sphere completed by a tridentate RNap [ONO] 
donation and unidentate attachment of acetate. 2-1b shows a distorted 
square pyramidal geometry (structural indices η146 = 0.17) with an 
additional oxygen donor from the semi-chelating acetate. The basal plane 
of 2-1b is significantly more distorted than 2-1a, with O6–Cu2–O7 and 
N5–Cu2–O9 angles of 157.7(2)˚ and 167.7(2)˚ respectively. The larger 
deviation in 2-1b may be attributed to the semi-coordination
147
 of axial 
acetate ligand at a distance of 2.674(7) Å, which is in the range (~2.6 Å) of  
weak CuO interactions.134-135 
Viewing along a axis, these Cu(II) units form a channel-like structure 
with void volume ca. 771.2 Å
3
 (17.1 %). The dimension of the channel is 
small (approximately 8Å x 9Å), indicating the tight packing in 2-1. A 
schematic diagram of the channel formation is illustrated in Figure 2.3c, with 
2-1a and 2-1b shown as green and blue blocks respectively. Complex 2-1b 




forms 1D chains (projecting along a axis) that interact with each other by H-
bonding (N6–H6AO5iii 2.99, N7–H7AO6iv 2.98, N7–H7BO4iii 2.88, N8–
H8AO9iv 2.83 and N8–H8BO3iv 2.83 Å; symmetry codes (iii):1/2-x,2-
y,1/2+z; (iv): -1+x,y,z) (Table 2.3). The neighboring 2-1a species then act as 
linkers, holding two neighboring 2-1b chains in a perpendicular pattern. There 
is also evidence of π-π stacking in the channel. Aromatic stacking was 
observed between naphthalene rings of Cu2 and Cu1–chelate ring,148 with 
centroid-centroid distance at 3.587 Å. Four disordered water molecules fill up 
the small cavity with different proximities from the channel wall (Figure 
2.4b). O1W and O2W are relatively less disordered than O3W and O4W, and 
located closer to the wall of the channel. All hydrogen atoms of water 
molecules were not included in the refinement due to distortion.  
 
Table 2.2 Selected bond lengths [Å] and angles [°] for the 2-1. 
2-1a  2-1b  
Cu1–O1 1.872(4) Cu2–N5 1.897(5) 
Cu1–N1 1.906(5) Cu2–O6 1.902(5) 
Cu1–O4 1.928(4) Cu2–O9 1.936(5) 
Cu1–O2 1.955(4) Cu2–O7 1.952(5) 
  Cu2–O10 2.674(7) 
O1–Cu1–N1 93.73(19) N5–Cu2–O6 93.3(2) 
O1–Cu1–O4 91.70(18) N5–Cu2–O9 167.7(2) 
N1–Cu1–O4 173.19(19) O6–Cu2–O9 93.6(2) 
O1–Cu1–O2 169.1(2) N5vCu2–O7 84.18(19) 
N1–Cu1–O2 84.69(18) O6–Cu2–O7 157.7(2) 
O4–Cu1–O2 90.73(18) O9–Cu2–O7 93.2(2) 
 














Figure 2.3 (a) A perspective view of 2-1. All hydrogen atoms and solvent 
molecules have been omitted for clarity. (b) Packing diagram of 2-1 in 
stick model (colored by symmetry equivalence), in the project along a 
axis. 2-1a and 2-1b units are shown in green and blue respectively. Water 
molecules in the channel are shown as red balls, with O1W and O2W 
located close to framework, and O3W and O4W in the middle. (c) A 
schematic diagram of 2-1 illustrates the formation of the channel-like 
structure. Packing of 2-1b units (blue block) gives continuous 1D chains, 




Table 2.3 Hydrogen bond parameters for 2-1.
a 
D─HA d(HA)/ Å d(DA) /Å <DHA/ ˚ 
N2─H2O8i 2.13 2.985(6) 167 
N3─H3AO7i 2.02 2.882(6) 170 
N3─H3BO3i 2.09 2.904(7)      155 
N4─H4AO2i 2.12 2.982(6)      169 
N4─H4BO1Wii 2.08 2.898(7)      157 
N6─H6AO5iii 2.12 2.989(7)      176 
N7─H7AO6iv 2.18 2.982(7)      153 
N7─H7BO4iii 2.05 2.884(7)      160 
N8─H8AO9iv 2.03 2.830(8)      153 
N8─H8BO3iv 2.10 2.828(6)      141 
a
 Symmetry codes: (i) 1-x,1/2+y,3/2-z; (ii) 1-x,1/2+y,3/2-z; (iii) 1/2-x,2-
y,1/2+z; (iv) -1+x,y,z. 
 




2.2.2.3  [Cu(RNO2)Cl(H2O)]·{[Cu(RNO2)(H2O)2](ClO4)}·3H2O, 2-2  
 In order to examine the geometric effect of Cu(II) in the absence of 
additional coordination from acetate, we have studied the complexation of 
HRNO2 with Cu(ClO4)2·6H2O which gives product 2-2. The crystal lattice also 
contains two Cu(II) units, 2-2a and 2-2b with different coordination 
environments (Figure 2.4a). Both contain square pyramidal Cu(II) (η2a = 0.43; 
η2b = 0.06) with a common basal plane comprising the RNO2 [ONO] donors 
and aqua oxygen. They differ in the axial ligand for being Cl in 2-2a and aqua 
in 2-2b. The Cl
-
 source probably originates from L-arginine hydrochloride. 
Efforts to obtain crystals using chloride-free arginine did not yield suitable 
crystals. There is no direct coordination of perchlorate but it participates in a 
H-bonding network with guanidinium moieties and in a different fashion from 
chloride. The perchlorates connect to both 2-2a and 2-2b in an anti-parallel 
pattern (N3–H3BO14i 2.99 and N8–H8BO13viii 2.98 Å; symmetry codes 
(i): 1+x,y,z; (viii) x,y,-1+z). In contrast, the chloride anion of 2-2a is H-
bonded to lattice water and three Cu(II) units (N4–H4ACl1vii 3.23, O3W–
H3WACl1iii 3.11, N3–H3ACl1vii 3.48 and O5W–H5WACl1iii 3.12 Å; 
symmetry codes (vii) 1+x,1+y,z; (iii) -1+x,y,z)(Figure 2.4a and Table 2.5). 
The combination of these interactions leads to the formation of a comb-like 
structure with perchlorates sitting inside the cavities (Figure 2.4c). Apart from 
H-bonding interactions, there is aromatic stacking between the nitro-
containing aromatic rings with a centroid-centroid distance of 3.766 Å. Such 
comb-like array is similar to the reported {[Zn(L)2(H2O)]·H2O}n (L = 6-




quinolinecarboxylic acid). The connection between the comb-like chains is 













Figure 2.4 (a) A perspective view of 2-2 with H-bond interaction indicated as 
cyan dotted lines. Perchlorate and water molecules of crystallization are 
disordered. Only hydrogen atoms involved in H-bonding are shown for clarity. 
(b) Packing diagram of 2-2 viewed along b axis (colored by symmetry 
equivalence). 2-2a and 2-2b units are shown in green and blue respectively. 
Perchlorate anions are shown in yellow. (c) A schematic diagram of 2-2 
illustrates the formation of comb-like structure. 2-2a and 2-2b are represented 








Table 2.4 Selected bond lengths [Å] and angles [°] for 2-2. 
2-2a  2-2b  
Cu1-O1 1.920(2) Cu2–O6 1.915(2) 
Cu1-N1 1.941(2) Cu2–N6 1.931(3) 
Cu1-O2 1.957(2) Cu2–O7 1.956(2) 
Cu1–O1W 2.033(2) Cu2–O3W 1.955(3) 
Cu1–Cl1 2.5028(9) Cu2–O2W 2.283(3) 
N1–Cu1–O2 83.26(10) O6–Cu2–N6 93.10(10) 
O1–Cu1–O1W 91.37(10) N6–Cu2–O7 83.74(10) 
N1–Cu1–O1W 147.33(10) O6–Cu2–O7 169.76(10) 
O2–Cu1–Cl1 92.02(7) O6–Cu2–O3W 89.44(11) 
O1–Cu1–Cl1 94.80(7) O7–Cu2–O2W 97.93(10) 
O1–Cu1–N1 93.42(10) N6–Cu2–O2W 106.30(11) 
O1–Cu1–O2 173.17(10) O3W–Cu2–O2W 87.40(12) 
O2–Cu1–O1W 88.28(9) N6–Cu2–O3W 165.94(13) 
N1–Cu1–Cl1 120.18(8) O3W–Cu2–O7 91.34(11) 














Table 2.5 Hydrogen bond parameters for 2-2.
a
 
D─HA d(HA)/ Å d(DA) /Å <DHA/ ˚ 
O1W─H1WAO8 1.89(3) 2.699(4) 168(3) 
N2─H2O8i 1.95 2.801(4)      171 
O1W─H1WBO5Wii 1.86(3) 2.658(4)      174(3)      
O2W─H2WAO2iii 1.96(2)    2.772(3)      172(4)    
N3─H3BO14i 2.15 2.989(4)      167 
O2W─H2WBO4iv 2.21(3)    2.920(4)      144(3)    
O3W─H3WBO6Wv 1.88(3)    2.677(4)      177(5)    
O4W─H4WAO5Wvi 2.03(4)    2.816(4)      154(4)      
N7─H7AO4Wvi 2.18 2.829(4)      132      
O4W─H4WBO3W 2.56(4)    3.386(4)      170(4)      
N8─H8AO6vii 2.14 2.980(4)      166 
N8─H8BO13viii 2.14 2.979(4)      166 
N8─H8BO3iii 2.10 2.828(6)      141 
N9─H9AO2Wvii 2.27 3.032(4)      147 
N9─H9AO3Wvii 2.54 3.226(5)      138 
N9─H9BO1Wvi 2.33 3.016(4)      137 
O5W─H5WBO10ix 2.06(3)    2.793(4)      150(4)    
O6W─H6WAO3 1.97(3)    2.748(4)      152(3)      
O6W─H6WBO5viii 2.25(3)    3.097(4)      167(4 
N4─H4ACl1vii 2.42 3.226(4)      157 
O3W─H3WACl1iii 2.32(2)    3.110(3)      161(4)    
N3─H3ACl1vii 2.74 3.479(3)      144 
O5W─H5WACl1iii 2.31(3)    3.116(3)      166(4)    
a
 Symmetry codes: (i) 1+x,y,z; (ii) 1-x,1/2+y,3/2-z; (iii) -1+x,y,z; (iv) -









2.2.2.4 [Cu(RNO2)(0.5Cl)(1.5H2O)](0.5NO3)·0.5MeOH·H2O, 2-3 
There is a mononuclear Cu(II) unit in the crystal lattice of 2-3, with the 
basal plane consisting of tridentate RNO2 and a disordered site partially 
occupied by chloride and water molecule (Figure 2.5a). The axial position is 
completed by another aqua ligand at 2.363(2) Å. There are methanol (50% 
occupancy) and two lattice water molecules filling the crystal space. The 
Cu(II) unit adopts an almost ideal square pyramidal geometry with a relatively 
smaller η = 0.02 as compared to 2-1 and 2-2. Preservation of charge balance is 




 anions, as 
supported by elemental analysis.  
The NO3
-
 anion is disordered and H-bonded to guanidinium of two 
adjacent Cu(II) units and lattice water, O1W (N4‘–H4‘AO1n 3.04, N4–
H4AO3niii 3.19, N4–H4AO2n 3.18 and O1W–H2WO2nvi 3.16 Å; 
symmetry codes (iii) -x+1,-y+2,-z+1; (v) -x,-y+1,-z; (vi) -x+1,-y+1,-z+1) 
(Figure 2.5b and Table 2.7). Comparatively, Cl
- 
is only H-bonded to lattice 
water, O2W (O1W–H2WCl1Xv 3.24 Å; symmetry code (v) -x,-y+1,-z). 
Apart from the aforementioned anions, all H-bond donors of guanidinium 
form complementary H-bonds with various acceptors, including nitro group, 
carboxylates and aqua ligands (N3–H3AO3ii 2.95, N4–H4BO5iii 3.07, N5–
H5AO2ii 2.97 and N5–H5BO6iv 2.99 Å; symmetry codes (ii) -x+1,-y+1,-z; 
(iii) -x+1,-y+2,-z+1; (iv) x+1,y,z.) (Figure 2.5b and Table 2.7). Viewing along 
c axis, H-bonding between guanidinium and NO3
-
, as well as guanidinium and 
the nitro group may act in concert to form a channel-like structure (Figure 
2.6c). The void volume of the channel is smaller than 2-1, which is 101.9 Å
3 






 and methanol are located in the middle of the cavity, whereas 
O2W are positioned close to the framework. Also, π–π aromatic stacking was 
observed between nitro-containing aromatic ring and Cu(II)–chelate ring. The 
centroid-centroid distance between the slipped rings is approximately 3.636 Å. 
Compound 2-2 and 2-3 indicates that the Cu(II)-arginine Schiff base serves as 
cationic framework host with non-coordinating anions allocated inside. 
Apparently, the framework topology is affected by the types of anion. Similar 
inclusion of anion in the cationic channel-like framework has been reported by 
Guo and co-workers, using Ag(I) salt and isonicotinic acid N-oxide.
150 
 
Table 2.6   Selected bond lengths [Å] and angles [°] for 2-3. 
Cl1X–Cu1 2.341(2)  O7–Cu1 1.873(7) 
Cu1–O1 1.921(2)  Cu1–N1 1.943(2) 
Cu1–O2 1.958(2)  Cu1–O6 2.363(2) 
O7–Cu1–O1 98.3(2)  O7–Cu1–N1 166.45(19) 
O1–Cu1–N1 93.38(9)  O7–Cu1–O2 84.2(2) 
O1–Cu1–O2 167.90(9)  N1–Cu1–O2 83.00(9) 
O7–Cu1–Cl1X 12.2(2)  O1–Cu1–Cl1X 87.94(8) 
N1–Cu1–Cl1X 166.53(8)  O2–Cu1–Cl1X 92.95(8) 
O7–Cu1–O6 87.6(2)  O1–Cu1–O6 91.45(8) 
N1–Cu1–O6 99.04(8)  O2–Cu1–O6 100.50(8) 






























Figure 2.5 (a) A perspective view of 2-3. All hydrogen atoms have been 
omitted for clarity. (b) H-bond interaction (cyan dotted lines) in 2-3 view 
along c axis. NO3
-
 is trapped inside the channel. (c) A schematic diagram of 
2-3 illustrates the formation of channel-like structure. Two Cu(II)
 
units are 









Table 2.7 Hydrogen bond parameters for the 2-3.
a
 
D─HA d(HA)/ Å d(DA) /Å <DHA/ ˚ 
O6─H61O4i 2.14(2)    2.944(3)      165(4)    
O6─H62O1W 1.95(2)    2.743(4)      170(4)         
O7─H71O2W 2.06(6) 2.647(9)      125(6) 
N3─H3AO3ii 2.13 2.946(3) 156.2 
N4‘─H4A‘O1n 2.19  3.043(16) 165.4 
N4─H4AO3niii 2.39  3.185(14) 152.7 
N4─H4AO2n 2.53  3.178(10) 131.5 
N4─H4BO5iii 2.33  3.066(4) 141.8 
N5─H5AO2ii 2.21 2.972(3) 145.4 
N5─H5ACl1Xii 2.98 3.401(3) 112.0 
N5─H5BO6iv 2.12 2.985(3) 170.7 
O1W─H2WO2Wv 2.22(4) 2.909(9) 140(5) 
O1W─H2WO2nvi 2.55(5) 3.160(11) 130(5) 
O1W─H2WCl1Xv 2.75(4) 3.240(4) 119(4) 
O1W─H2WO3ii 1.99(2) 2.754(4) 153(5) 
a
 Symmetry codes: (i) -x,-y+2,-z+1; (ii) -x+1,-y+1,-z; (iii) -x+1,-y+2,-z+1; 
(iv) x+1,y,z; (v) -x,-y+1,-z; (vi) -x+1,-y+1,-z+1.       
 
2.2.2.5 [Cu2(RNO2)2(Pyr)4](C8H8)·4H2O, 2-4 
 Driven by the interesting results of 2-2 and 2-3, we further explore the 
counterion effect on the Cu(II)-arginine framework. A bulkier anion, 
terephthalate was chosen here. The crystal lattice of 2-4 consists of two Cu(II)
 
units (with two pyridine ligands coordinated to each copper), one terephthalate 
anion and four lattice water molecules (Figure 2.6a). The content of the 
asymmetric unit appears to be nearly centro-symmetric (with one pyridine 
slightly off) with the inversion point at the centre of the anion. The η value for 
both Cu1 and Cu2 are similar, which are 0.07 and 0.02. Unexpectedly, the two 
units have different stereochemistry, with Cu1 and Cu2 in S- and R-




configuration respectively, despite 2-4 crystallizing in a chiral space group, 
P21. Also, the b axis is unusually long (ca. 43 Å).  
Similar to 2-2 and 2-3, the anion plays a role in facilitating the 
connection between the Cu(II)
 
units. Each edge of terephthalate form eight-
membered H-bonded ring with guanidinium moieties (N3–H3AO13ii 2.93, 
N4–H4AO14ii 2.79, N8–H8AO11iii 2.94 and N8–H8BO12iv 3.34 Å; 
symmetry codes (ii) 1+x,y,1+z; (iii) -1+x,y,-1+z; (iv) x,y,-1+z.) (Figure 2.6a 
and Table 2.9). O12 (O12‘) and O14 (O14‘) of the anion are distorted. 
Interestingly, the four lattice water molecules mediate the H-bond interactions 
between two Cu(II) units in parallel, forming a 2D grid-pattern H-bond 
network along a axis (N2–H2O2Wi 2.91, N4–H4BO2W 2.95, N7–
H7AO1W 2.92 and N9–H9AO1Wiii 2.74 Å; symmetry codes (i) -1+x,y,z; 
(iii) -1+x,y,-1+z) (Figure 2.6b and Table 2.9). The terephthalate anions are 
aligned in the hydrophobic channels that comprised of alkyl chains of two 
arginines. Hence, a relatively bigger channel-like structure was formed. The 
void volume is 525.4 Å
3 
(18.0 %) with the bulky terephthalate residing inside 
(Figure 2.6c). In addition, two different patterns of π–π aromatic stacking can 
be found, i.e. slipped π-π stacking between pyridine and aromatic ring. Also, 
T-shaped edge-to-face interactions are observed with the hydrogen of pyridine 
pointed to aromatic ring.
151
 Contrary to 2-2 and 2-3, the nitro groups of aryl 
rings are not involved in significant H-bonding. 
 




Table 2.8 Selected bond lengths [Å] and angles [°] for 2-4. 
Cu1–O1 1.922(4)  Cu2–O6 1.948(4) 
Cu1–N1 1.962(5)  Cu2–N6 1.983(5) 
Cu1–O2 1.970(4)  Cu2–O7 1.949(4) 
Cu1–N12 2.050(5)  Cu2–N14 2.053(5) 
Cu1–N11 2.315(5)  Cu2–N13 2.307(5) 
O1–Cu1–N1 91.8(2)  O6–Cu2–O7 168.03(19) 
O1–Cu1–O2 169.78(19)  O6–Cu2–N6 91.95(19) 
N1–Cu1–O2 82.66(19)  O7–Cu2–N6 82.82(18) 
O1–Cu1–N12 91.65(19)  O6–Cu2–N14 91.1(2) 
N1–Cu1–N12 165.5(2)  O7–Cu2–N14 91.62(19) 
O2–Cu1–N12 91.68(18)  N6–Cu2–N14 166.7(2) 
O1–Cu1–N11 93.64(19)  O6–Cu2–N13 94.11(19) 
N1–Cu1–N11 103.38(19)  O7–Cu2–N13 97.57(18) 
O2–Cu1–N11 96.00(19)  N6–Cu2–N(3 103.61(18) 








  (a) 
 








Figure 2.6 (a) A perspective view of 2-4. Only hydrogen atoms involved in H-
bonding (cyan dotted lines) are shown. Only heteroatoms are labeled for 
clarity. (b) A grid-like H-bond network is facilitated by lattice water 
molecules, interconnecting the anion with Cu(II)
 
units. (c) A schematic 
diagram of 2-4 illustrates the formation of channel-like structure with 
terephthalate trapped in between. Cu1 and Cu2
 
units are shown in green and 
blue respectively. 




Table 2.9 Hydrogen bond parameters for the 2-4.
a
 
D─HA d(HA)/ Å d(DA) /Å <DHA/ ˚ 
N2─H2O2Wi 2.06 2.913(7)      165 
N3─H3AO13ii 2.09  2.933(8)      165 
N4─H4AO14ii 1.96  2.794(14)      160 
N4─H4BO2W 2.19 2.945(8)      146 
N7─H7AO1W 2.07  2.918(7      166 
N8─H8AO11iii 2.09 .941(7)      165 
N8─H8BO12iv 2.59 3.335(12)      144 
N9─H9BO12iii 1.89 2.735(12)      163 
N9─H9AO1Wi 2.20 2.958(7)      146 
N9─H9AO1Wiii 1.89 2.73(12)      163 
a
 Symmetry codes: (i) -1+x,y,z; (ii) 1+x,y,1+z; (iii) -1+x,y,-1+z; (iv) x,y,-
+z; (v) -x,-y+1,-z; (vi) -x+1,-y+1,-z+1.       
 
2.2.2.6  [Cu(RNO2)Cl], 2-5  
 Slow evaporation of the filtrate from the complexation reaction of 
Cu(p-pa) and HRNO2 ligand afforded 2-5. The chloride is proposed to 
originate from the unreacted CuCl2 during anion exchange. The mononuclear 
unit adapts a square planar geometry, with chloride anion deviating by 0.389 
Å from the [ONO] plane. There is no solvent molecule crystallized in 2-5. 
Surprisingly, 2-5 is found in an R-configuration due to racemization. 
Similar to 2-4, the nitro group is not involved in H-bonding. The main 
interaction is governed by bifurcated H-bonding between carboxylate and 
guanidinium (N3–H3NAO2i 3.10, N3–H3NBO3ii 2.97, N2–H2NO2i 
3.27 and N2–H2NO3i 2.97 Å; symmetry codes (i) -x,3-y,2-z; (ii) -
x,1/2+y,3/2-z), as well as Cl
- 
and guainidinium (N3–H3ACl1iii 3.32 and N4–
H4NBCl1iii 3.52 Å; symmetry code (iii) x,7/2-y,-1/2+z)(Figure 2.7b and 
Table 2.11). Viewing along b axis, two units interact with each other through 
extensive H-bond interaction in a complementary arrangement. This angle of 




interaction deposits 2-5 to form a tightly packed structure with no residual 
solvent accessible void (Figure 2.7c). Apart from H-bonding, stacking 
between aryl and metal-chelate ring may also responsible for the resulting 




         






Figure 2.7 (a) A perspective view of 2-5. All C–H hydrogen atoms have 
been omitted for clarity. (b) H-bonding interaction (cyan dotted lines) in 2-5 
view along b axis. (c) Packing diagram of 2-5 (space-filling model) along b 
axis. 
 
Table 2.10 Selected bond lengths [Å] and angles [°] for 2-5. 
Cu1–O1 1.8947(16)  Cu1–O2 1.9773(16) 
Cu1–N1 1.9313(18)  Cu1–Cl1 2.2252(8) 
O1–Cu1–N1 93.48(8)  O1–Cu1–O2 175.10(7) 
N1–Cu1–O2 83.49(7)  O1–Cu1–Cl1 92.73(6) 
N1–Cu1–Cl1 171.29(5)  O2–Cu1–Cl1 90.70(5) 
 
Table 2.11 Hydrogen bond parameters for the 2-5.
a
 
D─HA d(HA)/ Å d(DA) /Å <DHA/ ˚ 
N3─H3NACl1i 2.80 3.316(2) 123 
N3─H3NAO2i 2.36  3.102(3)      151 
N3─H3NBO3ii 2.20  2.968(3)      158 
N2─H2NO2i 2.59 3.274(3)      144 
N2─H2NO3i 2.25 2.966(3)      149 
N4─H4NBCl1iii 2.72 3.521(2)          167 
a
 Symmetry codes: (i) -x,3-y,2-z; (ii) -x,1/2+y,3/2-z; (iii) x,7/2-y,-1/2+z.       
 




2.2.2.7  [Cu(RMe)(OAc)]·5H2O, 2-6 
The crystal structure of 2-6 reveals a single Cu(II) unit in square 
pyramidal geometry, with η = 0.11. Similar to complex 2-1, the strong 
coordinating acetate anion tends to bind to the metal centre, but with no H-
bond interaction with the guanidinium moiety. The axial oxygen is also 
weakly bonded to copper (2.575(2) Å). Notably, guanidinium and carboxylate 
groups form eight-membered H-bonded ring, which give 1D zig zag chains 
along b axis (N3–H3AO3iv 3.00 and N4–H4AO2iv 2.87 Å; symmetry code 
(iv): 1/2+x,1/2-y,1-z)(Table 2.13). Facilitated by the H-bond interaction of 
H2O(5W), these supramolecular chains then crosslink with each other in a 
complementary pattern (Figure 2.8d). As shown in Figure 2.8b, two O5W 
connect a pair of C2-symmetry-related molecules of 2-6 via O5 and N3 
(O5W–H5WAO5 2.77, O5W–H5WBO5‘vi 2.99, O1W–H1WAO5Wi 
2.90 and N3–H3BO5W 2.99 Å; symmetry codes (vi): 1-x,y,1/2-z; (i): -
1/2+x,-1/2+y,z) (Figure 2.8b and Table 2.13). Collectively, these H-bonds 
help to form a tightly-packed 2D structure. Stacking of aryl–metal chelate ring 
and aryl-planar guanidinium is also observed, with centroid-centroid distances 
at 3.474 and 3.780 Å respectively.
148,152
 Packing along the c axis gives a 
zeolite-like structure with water molecules trapped in the distinctive 
hydrophilic channels (Figure 2.8c). The ratio of hydrophobic to hydrophilic 
channels is approximately 1:2. The cavity size of 2-6 is larger than 2-1, with 
void volume 1105.0 Å
3
 (23.4 %) (with O5W retained). O5W is located in the 
2D layers. In comparison, O1W positions close to the cavity wall and 




interconnects O5W with other water molecules which are located in the 
middle of the channel (Figure 2.8c). 
 
Table 2.12 Selected bond lengths [Å] and angles [°] for 2-6. 
Cu1–O1 1.881(2) Cu1–N1 1.917(2) 
Cu1–O2 1.940(2) Cu1–O4 1.978(2) 
Cu1–O5 2.575(2)   
O1–Cu1–N1 95.24(10) O1–Cu1–O2 175.39(10) 
N1–Cu1–O2 84.00(10) O1–Cu1–O4 92.80(10) 





































Figure 2.8 (a) A perspective view of 2-6. All hydrogen atoms have been 
omitted for clarity. (b) Two C2-symmetry-related molecules of 2-6 
connected by two O5W. (c) Packing diagram along c axis shows alternating 
arrangement of water chain in 2-6. Water molecules are shown as red balls. 
(d) A schematic diagram of 2-6 illustrates the formation of channel-like 
structure. 
 




Table 2.13 Hydrogen bond parameters for 2-6.
a
 
D─HA d(HA)/ Å d(DA) /Å <DHA/ ˚ 
O1W─H1WAO5Wi 2.09(4)    2.904(4)      160(6)    
N2─H2O3Wii 1.98 2.836(4)      166 
O2W─H2WAO3iii 2.20(4)    2.785(4)      127(4)    
N3─H3AO3iv 2.14 3.002(3)      170 
N3─H3BO5W 2.16    2.992(4)      160    
O2W─H2WBO1W 2.03(4)    2.785(5)      152(4)      
N4─H4AO2iv 2.03  2.871(4)      162      
N4─H4BO3Wiii 2.39 3.064(4)      135      
O3W─H3WAO4i 1.98(4)    2.795(3)      166(3)         
O3W─H3WBO2W 2.01(3)    2.821(4)      164(4)      
O4W─H4WAO4v 2.27(6)    3.044(5)      160(7)    
O4W─H4WBO1W 2.00(6)    2.776(7)      155(6)      
O5W─H5WAO5 1.93(2)    2.774(3)      175(4)     
O5W─H5WBO5‘vi 2.18(2)    2.989(4)      158(4)    
a
 Symmetry codes: (i) -1/2+x,-1/2+y,z; (ii) 1+x,y,z; (iii) x,-y,1-z; (iv) -1+x,y,z; 
(v) 1/2-x,-1/2+y,1/2-z; (vi) 1-x,y,1/2-z. 
2.2.2.8  Comparison of Copper-Arginine Crystal Structures  
The orientation of arginine side chains among the Cu(II) complexes 
was compared by superimposing their crystal structures. This is done by 
overlapping the rigid portion of aryl ring, phenoxy O and imine C═N, while 
keeping the remaining parts flexible. The different orientation is within 




The first comparison was made by superimposing those samples that 
contain two different molecules in an asymmetric unit, i.e. compound 2-1 and 
2-2. Superimposition of Cu1 and Cu2 in 2-4 is not presented since they are of 
a different configuration. The superimposition of both Cu(II) units in 2-1 and 
2-2 shows substantially different configurations, with the side chains in 2-1 




much more deviated from each other (Figure 2.9). The side chains of 2-1a are 
oriented perpendicular to the naphthalene rings whereas those of 2-1b form 
the wall of the cavity. The different pattern may be attributed to the orientation 
of acetate anions. The acetates in both units are tilted, especially in 2-1b, 
presumably due to the weak coordination of axial acetate. In contrast, both 
Cu(II)
 
units in 2-2 give similar orientation, with the carboxylate of 2-2a more 
protruded out of the basal plane.  
The mononuclear Cu(II)
 
unit in 2-6 was then used as a template for a 
thorough comparison with other complexes, except 2-4 due to racemization 
and different coordination environments (2-4 has additional pyridines 
coordinated) (Figure 2.6a). The orientation of 2-5 is significantly different 
from other complexes due to its R-configuration (Figure 2.10). Overlaid 
structures of square pyramidal 2-1b and 2-6 reveal that the axial Cu–O (OAc) 
bond in 2-6 is more perpendicular to the basal plane (Figure 2.11b). The plane 
angle between the axial acetate oxygen and basal coordination plane in 2-1b 
and 2-6 are 70.1º and 88.6º respectively. Also, it is noteworthy that the basal 
planes of 2-2b and 2-6 are apparently much more deviated than those of 2-2a 
and 2-6 (Figure 2.11c & d). This is due to the free O of carboxylate in 2-2 (O3 
and O8) being involved in different H-bonding (Table 2.5) which resulted in a 
different orientation.  
 
 






Figure 2.9 Superimposed images of 2-1a and 2-1b (left) (shown in green 
and blue respectively); 2-2a and 2-2b (right) (shown in green and blue 
respectively). The arginine side chains in 2-1 are obviously much deviated 
than that in 2-2. 
 
 
Figure 2.10 Superimposed image of 2-5 (yellow) and 2-6 (orange). The 




















Figure 2.11 Superimposed images of 2-6 (orange) with (a) 2-1a, (b) 2-1b, (c) 
2-2a and (d) 2-2b respectively. 
 
2.2.3 Spectroscopic Studies 
NMR results of arginine Schiff bases are given in the Appendix II 
(softcopy). All the Schiff base ligands show HC=N peaks with ~8.4-9.0 ppm. 





C HMQC NMR. The 2-b ligand is insoluble in common 
organic solvent except basic methanol. Hence, the 
13
C NMR analysis of 2-b is 






H NMR analysis shows the existence of two geometrically 
different isomers, presumably anti and syn isomers with ratio 5:1.  
Selected IR absorbance data is tabulated in Table 2.14. The IR spectra 
of all free ligands reveals that the sharp ν(N–H) peaks are shifted to lower 
wavelength upon coordination.
155
 All complexes exhibited 260-280 cm
-1
 
difference for νasym(COO) and νsym(COO), indicating terminal coordination of 
carboxylate groups.
156-157
 Those nitro-containing samples show two strong 
ν(N=O) stretching bands at ~1600 and 1310 cm-1.139  
Table 2.14 Selected IR absorption bands (cm
-1
) of Cu(II)-arginine Schiff 
bases. 









2-a 3350 3168 1629 - 1543 1354 - 1183 
2-b 3433 3068 1650 1606 1544 1388 1312 1227 
2-c 3391 3173 1642 - 1568 1371 - 1277 
2-1 3366 3183 1677, 
1623 
- 1577 1393, 
1340 
- 1185 
2-2 3364 3215 1647 1604 1554 1383 1318 1110 
2-3 3385 3204 1674 1601 1552 1384 1322 1099 
2-4 3397 - 1642 1604 1551 1373 1317 1102 
2-5 3338 3191 1668 1601 1547 1385 1321 1100 
2-6 3377 3202 1637 - - 1364 - 1285 
 
The solution properties of the complexes were studied using 
electrospray ionization mass spectroscopy (ESI-MS) and UV-visible 
spectroscopy (Appendix III; softcopy), except for 2-5 owing to its poor 
solubility. UV-visible spectra for all complexes show weak d-d transitions at 





 This suggests that the structures of these 
complexes do not change much in the solution. 




Table 2.15 Electronic absorption of Cu(II)-arginine Schiff bases in MeOH, 
unless otherwise stated. 
Complex         Absorption bands (Methanol)/ nm
a 
CT d-d (ε) 
2-1 316(10500), 388(9250) 661(100) 
2-2 362(29188) 670(304) 
2-3 368(11550) 670(150) 
2-4
b 336(50800) 672(500) 
2-6 374(6040) 646(106) 




A clean dominant peak of [Cu(ligand)(MeOH)]
+
 was observed in 
positive mode ESI-MS spectra for most of the Cu(II)
 
complexes. However, 2-1 
and 2-2 which contain two different Cu(II) species in the crystal lattice show 





at m/z 803.0 and 768.9 respectively. 2-4 gives a base peak at m/z 549.2 in 
negative mode, corresponding to [Cu(RNO2) + p-pa]
- 
(Figure 2.12).  
 
 





Figure 2.12 Negative mode ESI spectrum of 2-4 and its simulated isotopic 
spectrum. 
 The thermal stability of the complexes was analyzed using 
thermogravimetric analysis (TGA). Consistent with the XRD result, 2-5 which 
contains no crystallized solvent or water shows only a decomposition peak at 
245 ˚C. The other complexes show the loss of water molecules of 
crystallization below 150 ˚C. Notably, crystals of 2-6 loss three water 
molecules at ambient condition upon removal from mother liquor, as 
evidenced from the TGA data and the lost of crystallinity (Figure 2.13). 
Similarly, 2-3 shows the loss of methanol upon dried. All complexes 




decompose below 225 ˚C. Please see Appendix III for TGA data of other 
samples. 
 
Figure 2.13 TGA profile of 2-6. 
 
2.2.4 Racemization of Amino Acid 
Majority of the living creatures produce L-form amino acids.
71
 
However, scientists discovered that these amino acids will racemize 
spontaneously to D-form overtime after an object dies. This phenomenon is 
important as it acts as a ‗clock‘ that allows the age determination of protein-
containing materials.
158-159
 However, the rate of racemization remains elusive 
as it is highly sensitive to a number of environmental factors, such as 
temperature, water concentration, pH, presence of aldehydes or metal ions, 
etc.  
Accordingly, studies showed that higher reaction temperature, 
presence of strong base, acid, aldehyde or metal could increase the rate of 




amino acid racemization in laboratory work.
160
 The mechanism may begin 
with the protonation of imine, followed by the removal of α-H.161-162 Also, 
metal ions may accelerate the process by activating the acidic α-H and making 
it more susceptible to removal by base or by stabilizing the transition state of 
the resulted carbanion.
163
 Another possible factor suggested by Rehder in the 
racemization of vanadyl-tyrosine Schiff base was due to the unreacted amino 
acid or water, in analogy to the function of racemase enzymes. The proposed 






















  In this study, 2-3 crystallizes in racemic space group, similar to some 
reported metal-amino acids.
62,164-165
 Also, 2-4 contains two Cu(II) units with 
different stereochemistry and 2-5 racemizes to R-configuration. No 
crystallographic evidence of racemization was observed for 2-a, 2-1, 2-2 and 
2-6 (Flack parameters = 0.1053, 0.0246, 0.0234 and 0.0317 respectively). The 
circular dichroism (CD) for their bulk crystals was first examined.
 
Owing to 
the relatively higher Flack parameter value of 2-a, 2-c ligand was chosen for 
comparison (2-b was omitted due to its poor solubility). The CD result 
confirms the chirality of 2-a,
33,58 
 even with small ∆ε enhancement than 2-c 
(Figure 2.14a).  
For compound 2-1, 2-2 and 2-6, the CD results correlate well to the 
absolute configuration from the Flack parameter (Figure 2.14b). All 




complexes display an appreciable negative Cotton effect in 300-400 nm and a 
weak negative band at 600-800 nm.
58,164
 To monitor the racemization, CD 
spectra of RNO2 derived complexes (2-2, 2-3, 2-4 and 2-5) was measured as 
dissolved crystals, immediately after the reaction and after five days (Figure 
2.15). Compound 2-4 was only measured as dissolved crystals, whereas 2-5 
was measured after the reaction and after five days since the crystals are 
insoluble in common organic solvent and water. The d-d region indicates that 
all complexes are chiral after the reaction. However, the CD spectra of 
dissolved crystals reveal that 2-4 racemized to a higher extent than 2-2 and 2-3 
(Figure 2.15a). This may be due to the basic pyridine that is used in the 
crystallization of 2-4, which accelerated the racemization. Comparing the CD 
spectra after reaction, 2-5 was racemized to a higher extent than 2-2 and 2-3 
(Figure 2.15b). This may be due to the use of higher amount of NaOH during 
anion exchange (Experimental Section 2.3.3), which generates more bases for 
α-H removal. Interestingly, CD spectra after five days indicate that 2-2 and 2-
5 undergo partial racemization overtime (Figure 2.15c). This is in accordance 
with Manohar‘s study wherein complete racemization was observed in water 
over time. However, reaction in aqueous methanol showed only partial 
racemization. They reasoned that this may be due to the removal of α-H by 
water.
164 
However, the reason that 2-3 retained the chirality to a much higher 













Figure 2.14 (a) CD spectra of 2-a and 2-c in MeOH. (b) CD spectra of 2-1, 


























Figure 2.15 CD spectra of Cu(II)-RNO2 derived complexes as (a) dissolved 
crystals, (b) after reaction and (c) after 5 days. 
2.2.5 Docking Studies with Thrombin Enzyme 
Thrombosis, the formation of blood clot in blood vessel, can lead to a 
number of critical health risks such as stroke and myocardiac infarction. A 
well-studied approach to treat thrombotic diseases is using thrombin inhibitor. 
Thrombin is a trypsin-like serine proteinase. Upon injury, the tissue factor will 
interact with plasma factor VII, subsequently activate coagulation cascade to 
produce thrombin. Thrombin in turn acts as coagulation protein by cleaving 




The crystal structure of thrombin was first determined via co-
crystallization with inhibitor PPACK (Phe-Pro-Arg-chloromethylketone) in 
1989.
168
 The inhibitor (substrate) binding pocket has been designated as S1, 




S2 and S3. Asp189 located at the bottom of S1 pocket is responsible for the 
specificity of thombin. The enzyme prefers to cleave after positively charged 
residue, particularly arginine, binds to Asp189. In contrast, the S2 pocket is 
relatively hydrophobic, containing side chains of Tyr60A and Trp60D. The S3 
pocket is also hydrophobic and interacting favorably with aromatic groups, 
despite it is largely exposed directly to the solvent.
169 
Thus, a typical thrombin inhibitor contains a benzamidine or arginine 
moiety which establishes crucial electrostatic interaction with Asp189 in S1 
pocket.
52
 Also, these inhibitors usually have aromatic moiety to suit the 
hydrophobic site of the remainder of S1 pocket. The lipophilicity of these 
inhibitors ensures the efficiency of drug absorption without compromise in 
aqueous solubility.
170
 In 2001, Toyota and co-workers have reported Cu(II) 
and Fe(III) Schiff base chelates bearing amidino group that exhibited 
inhibitory activities against thrombin and trypsin.
171-172
 The Ki value for 




M, comparable to other known 
inhibitors. Apart from establishing the crucial electrostatic interaction with 
Asp189, the indole ring of copper complexes fits well into hydrophobic pocket 
consists of His57, Leu99, Tyr60A, Trp60D and Trp215.
171
  
Inspired by Toyota‘s work, we believe these Cu(II)-arginine 
complexes will exhibit similar inhibition as well. As depicted by their 
structures, these complexes contain guanidinium moiety to exhibit specific 
electrostatic interaction with Asp189. Also, the hydroxyaryl groups with 
different substituents may come in close contact with the hydrophobic pockets 
with different binding affinity. In contrast to most of the published inhibitors 




which require laborious synthesis, these Schiff base compounds have the 
advantage of simplicity in preparation. Furthermore, they are relatively 
smaller as compared to peptide-based inhibitors such as PPACK. Despite the 
drawback of strong basicity of guanidinium, oral bioavailability is not a 
relevant issue in hemocompatible materials.
173-174
   





 (Figure 2.16). Firstly, the PDB files were 
created with lattice water and anions removed. This is followed by computing 
the lowest energy state of the Cu(II)-arginine complexes docking in the 
possible position in the receptor (thrombin active site). Partial flexibility was 
employed during the docking process, with the receptor held rigid while the 
ligand was flexible. The conformation with the most favorable free energy of 
binding (FEB) was selected and the estimated inhibitory concentration (Ki) 






where R = universal gas constant = 1.986 cal.mol
-1
K
-1; ΔG = Gibbs free 
energy; T = temperature = 298 K. 




















Figure 2.16 Docking of (a) PPACK (PDB: 1HLT),
176
 (b) Cu(II)-RNap. (c) 
Cu(II)-RNO2 and  (d) Cu(II)-RMe with thrombin using LigPlot
178
 program. 




The conformations with most favorable FEB or lowest Ki for PPACK, 
Cu(II)-RNap, Cu(II)-RNO2 and Cu(II)-RMe are summarized in Table 2.16. 
The FEB and predicted Ki for all compounds were similar. All compounds 
exhibit crucial interaction with Asp189 (2.91-3.08 Å), which is comparable to 
PPACK (3.15-3.20 Å). However, these arginine complexes make less H-bond 
interactions with the channel as compared to PPACK. Apart from the specific 
interaction with Asp189, the RNO2 and RMe complexes are predicted to form 
H-bond with Tyr60A and Ala190 respectively. Despite only single H-bond 
observed for Cu(II)-RNap, its predicted Ki  was somehow lower than the 
others. This may attributed to its larger hydrophobic portion of naphthalene 
rings that fitted well into the S2 pocket (Figure 2.16b). 
Table 2.16 Summary of FEB and predicted Ki for the docking results. 
Ligand FEB (kcal/ mol) Predicted Ki (μM) 
Cu(II)-RNap -9.7 0.076
 
Cu(II)-RNO2 -9.2 0.177 
Cu(II)-RMe -9.1 0.210 
 
2.3  Experimental 
2.3.1 Materials and Physical Methods 
The chemicals were obtained from commercial sources and used 
without further purification. All the solvents used were of reagent grade. NMR 
spectra were recorded with Bruker AMX 500 spectrometer using CD3OH as 
internal standard (3.31 ppm in 
1
H and 49.0 ppm in 
13
C NMR). Infrared spectra 
(4000-400 cm
-1
) were recorded on Perkin-Elmer 1600 FTIR 
spectrophotometer with KBr pellets. The electronic transmittance spectra were 
recorded on Shimadzu UV-2450. Electrospray ionization mass spectra (ESI-




MS) were measured on a Finnigan MAT 731 LCQ spectrometer using manual 
injector (Rheodyne). The peak identification was based on m/z values and 
isotopic matching patterns. Circular dichroism was measured using 
spectropolarimeter Jasco J-810 in 1 mm path length cell. Elemental analyses 
were performed on Perkin-Elmer PE 2400 elemental analyzer in the Micro 
Analytical Laboratory, Department of Chemistry, National University of 
Singapore. Water and solvent present in the compounds were determined 
using a SDT 2960 TGA Thermal Analyzer with a heating rate of 10 °C per 
min. Room temperature magnetic susceptibility measurement were analyzed 
using Johnson-Mathey Magnetic Susceptibility balance. The calculation of 
effective magnetic moment was corrected for diamagnetism using Pascal‘s 
constants. 
All XRD measurement was conducted on a Bruker-AXS SMART 
APEX CCD single-crystal diffractometer with a Mo-Kα sealed tube at -50˚C 
(except 2-2 at r.t.). The software SMART was used for collecting frames of 
data, indexing reflection lists and determining lattice parameters;
179
 SAINT for 
frames integration and scaling; and SADABS for empirical absorption 
correction.
180
 All structures were solved by direct methods and refined on |F|
2
 
by full-matrix least squares using SHELXTL.
181
 Unless otherwise stated, all 
non-hydrogen atoms were refined anisotropically whereas hydrogen atoms 
were placed in their ideal positions and refined isotropically. The void 
volumes were calculated using PLATON program.
182
  
H1n and H5n of 2-a ligand were identified from the electron density 
map. Also, hydrogen atoms of full lattice water in 2-2, 2-3, 2-4 and 2-6 and 




amine hydrogen in 2-2 and 2-6 were located. O3W and O3W‘ in 2-1 are 
disordered with 60:40 site occupancy, similarly for O4W and O4W‘. No 
hydrogen atom was added to O2W and methanol in 2-2. The carboxylates of 
terephthalate anion (O12, O12‘, O14 and O14‘) in 2-4 are disordered and only 
refined isotropically.  
2.3.2 Preparation of Ligands 
N-(2-hydroxy-1-naphthalidene)-L-arginine (HRNap; 2-a)  
A mixture of L-arginine (523 mg, 3 mmol) and 2-hydroxy-1-naphthaldehyde 
(517 mg, 3 mmol) in MeOH (120 mL) was refluxed at 65 °C for 45 minutes. 
The bright yellow solution was then filtered, concentrated on a rotary 
evaporator and precipitated out with large amount of acetone to give the 
resultant yellow powder. Slow evaporation of 2-a in methanol afforded yellow 
plate crystals. Yield: 978 mg (2.8 mmol, 94%). Decomposition point: 205 °C. 
C17H20N4O3·H2O (346.39): calcd. C 59.0, H 6.4, N 16.2, found C 60.0, H 6.4, 
N 16.9. 
1
H NMR (500 MHz, CD3OD, ppm): 1.73 (m, 2H, H15), 2.03 (m, 2H, 
H14), 3.24 (t, JHH = 6.9 Hz, 2H, H16), 4.25 (m, 1H, H12), 6.76 (m, 1H, H4), 7.19 
(m, 1H, H6), 7.41 (m, 1H, H7), 7.57 (d, m, 1H, H5), 7.71 (m, 1H, H3), 7.99 (m, 
1H, H8), 8.95 (s, 1H, H11). 
13
C NMR (125 MHz, CD3OD, ppm):  26.1 (C15), 
32.5 (C14), 42.3 (C16), 66.3 (C12), 107.5 (C1), 119.3 (C8), 123.6 (C6), 126.6 
(C4), 127.2 (C10), 129.4 (C7), 130.1 (C5), 136.1 (C9), 139.8 (C3), 158.5 (C11), 
158.7 (C11), 176.4 (C17), 181.3 (C13).  
N-(2-hydroxy-5-nitro-1-salicylidene)-L-arginine (HRNO2; 2-b) 
2-b was synthesized in a similar way to 2-a, using 2-hydroxy-5-nitro 
benzaldehyde (501 mg, 3 mmol). The ligand was obtained as yellow 




precipitate without distilling off the solvent. The yellow powder was insoluble 
in normal organic solvent, except in basic methanol (doped with base). Yield: 
537 mg (1.7 mmol, 55%). Decomposition point: 227 °C. C13H17O5N5 
(325.31): calcd. C 48.3, H 5.3, N 21.7, found C 48.1, H 5.4, N 21.7. 
1
H NMR 
(500 MHz, CD3OD + NaOH, ppm): 1.61 (m, 2H, H11), 1.90 (m, 2H, H10), 3.16 
(m, 2H, H12), 3.75 (m, 1H, H8), 6.49 (d, JHH = 9.45, 1H, H3), 7. 94 (dd, JHH = 
9.45, JHH = 3.15, 1H, H4), 8.41 (s, 1H, H7), 8.45 (d, JHH = 3.15, 1H, H6).  
N-(2-hydroxy 5-methyl-1-salicylidene)-L-arginine (HRMe; 2-c) 
2-c was prepared in a similar way to 2-a by using 2-hydroxy-5-methyl 
benzaldehyde in a relatively smaller quantity (55 mg, 0.4 mmol). A light 
yellow product was precipitated out upon distilling off the solvent, and this 
was subsequently washed with Et2O and vacuum dried. Yield: 84 mg (0.3 
mmol, 68%). Decomposition point: 200 °C. C14H20O3N4·H2O (310.35): calcd. 
C 54.2, H 7.2, N 18.1, found C 53.5, H 7.0, N 18.1. 
1
H NMR (500 MHz, 
CD3OD, ppm): 1.65 (m, 2H, H11), 1.95 (m, 2H, H10), 2.25 (s, 3H, H14), 3.22 
(m, 2H, H12), 3.92 (m, 1H, H8), 6.73 (m, 1H, H3), 7.11 (m, 1H, H4), 7.12 
(m,1H, H6), 8.34 (s, 1H, H7).
 13
C NMR (125 MHz, CD3OD, ppm):  20.3 (C14), 
26.6 (C11), 32.5 (C10), 42.2 (C12), 74.1 (C8), 118.5 (C3), 119.4 (C1), 128.0 (C5), 
132.9 (C6), 135.1 (C4), 158.7 (C13), 162.9 (C2), 166.3 (C7), 178.4 (C9).  
2.3.3 Complexation 
[Cu(RNap)(OAc)]·2H2O, 2-1 
To the methanol solution (4 mL) of 2-a (69 mg, 0.2 mmol), equimolar of 
Cu(OAc)2·2H2O (40 mg) in water (2 mL) was added and the solution was 
stirred for 3 h. Greenish plate crystals suitable for X-ray diffraction studies 




were obtained after one week by diffusing acetone into the resulting green 
solution at 5 °C. The same product was obtained by in situ reaction of L-
arginine, 2-hydroxy-1-naphthaldehyde and Cu(OAc)2·2H2O in similar 
conditions. Yield: 48 mg (0.1 mmol, 49%). C19H22CuN4O5·2H2O (485.98): 
calcd. C 47.0, H 5.4, N 11.5, found C 46.0, H 5.0, N 11.3. μeff (298 K) = 1.54 
B.M. ESI-MS: [Cu(RNap)(MeOH)]
+ 
(m/z 421.5, 100 %), [2(Cu(RNap) + Na]
+ 
(m/z 803.0, 50 %). TGA: weight loss (%) calcd. for 2H2O: 7.4, found 8.7.   
[Cu(RNO2)Cl(H2O)]·{[Cu(RNO2)(H2O)2](ClO4)}·3H2O, 2-2 
L-arginine hydrochloride (211 mg, 1 mmol) and NaOH (40 mg, 1 mmol) were 
dissolved in ethanol/water mixture (1:1, v/v) and heated to about 65 °C. A 
suspension of of 2-hydroxy-5-nitro benzaldehyde (167 mg, 1 mmol) in ethanol 
(4 mL) was then added to the solution, to afford a yellow precipitate. 
Cu(ClO4)2·6H2O (371 mg, 1 mmol) in water (2 mL) was added after 1 h, 
resulting in a clear bluish green solution. The reaction was continuously 
heated for 2 h and filtered after cold to r.t. The solution was then filtered, and 
left for slow evaporation to give green crystals after three days. Yield: 320 mg 
(0.3 mmol, 32%). (C13H18ClCuN5O6)·(C13H20ClCuN5O11)·3H2O (1014.68): 
calcd. C 30.8, H 4.4, N 13.8, Cl 7.0, found C 30.6, H 4.5, N 13.4, Cl 6.9. μeff -
(298 K) = 1.20 B.M. ESI-MS: [Cu(RNO2)]
+ 
(m/z 385.0, 40 %), 
[Cu(RNO2)(MeOH)]
+ 
(m/z 416.5, 100 %), [2Cu(RNO2)]
+ 
(m/z 768.9, 20 %). 
TGA: weight loss (%) calcd. for 3 lattice H2O: 5.3, found 6.9; calcd. for 3 
coordinated H2O: 5.3, found 4.3. 
 
 





Compound 2-3 was prepared similar to 2-2 by using Cu(NO3)2·3H2O (242 mg, 
1 mmol). Greenish-blue needle-like needle crystals were formed by slow 
evaporation on the next day. Yield: 201 mg (0.4 mmol, 41%). 
C13H19CuN5O6.5Cl0.5·0.5NO3·H2O (479.61): calcd. C 32.6, H 4.4, N 16.1, Cl 
3.7, found C 33.0, H 4.9, N 16.2, Cl 3.5. μeff (298 K) = 1.84 B.M. at 25°C. 
ESI-MS: [Cu(RNO2)(MeOH)]
+ 
(m/z 416.5, 100 %). TGA: weight loss (%) 
calcd. for 1.5 coordinated H2O + 1 lattice H2O: 9.4, found 10.3. 
[Cu2(RNO2)2(Pyr)4](C8H8)·4H2O, 2-4  
Compound 2-4 was prepared similar as 2-2 by using CuCl2·2H2O (170 mg, 1 
mmol). After a half-hour reflux, the anion was exchanged by adding 
equimolar of NaCl and terephthalic acid. A green precipitate was obtained. 
Yield: 133 mg (0.2 mmol, 21%).  C13H16CuN5O5·Cu(p-pa)·H2O (631.52): 
calcd. C 39.9, H 3.5, N 11.1, found C 40.3, H 3.9, N 10.9. μeff (298 K) = 2.69 
B.M. at 25°C. Greenish-blue thin plates, 2-4 were obtained by dissolving the 
green powder in pyridine and slowly diffusing with Et2O. The yield of the 
crystal is very low. Attempts to obtain a suitable amount for other analysis 
have failed. ESI-MS: [Cu(RNO2)(C8H8)]
- 
(m/z 549.2, 100 %). TGA (crystals): 
weight loss (%) calcd. for 4 lattice H2O: 5.4, found 6.4. 
[Cu(RNO2)Cl], 2-5 
2-5 was obtained from slow evaporation of the green filtrate of 2-4. Thin, 
hexagonal green crystals were obtained after two weeks. 2-5 is not soluble in 
any common organic solvent. Yield: 51 mg (0.1 mmol, 12%). 




C13H16ClCuN5O5 (421.30): calcd. C 37.1, H 3.8, N 16.6, Cl 8.4, found C 37.1, 
H 4.0, N 16.3, Cl 8.7. μeff (298 K) =  1.44 B.M. at 25°C.  
[Cu(RMe)(OAc)]·5H2O, 2-6 
 To a mixture of 4 mL ethanol and 3 mL water of L-arginine (35 mg, 0.2 
mmol), 2-hydroxy-5-methyl benzaldehyde (27 mg, 0.2 mmol) in ethanol was 
added and stirred for 1 h to give a yellow cloudy solution. Cu(OAc)2·2H2O 
(40 mg, 0.2 mmol) was then added to yield a clear green solution and stirred 
overnight at r.t. The mixture of water and ethanol deposited green needle 
crystals upon slow evaporation at r.t. The same product was obtained by using 
equimolar of L-arginine hydrochloride and NaOH as a substitution to L-
arginine. Yield: 31 mg (0.07 mmol, 34%). C16H22CuO5N4·2H2O (450.00): 
calcd. C 42.7, H 5.8, N 12.5, found C 43.3, H 5.6, N 12.2. μeff (298 K) = 2.05 
B.M. at 25°C. ESI-MS: [Cu(RMe)(MeOH)]
+ 
(m/z 385.5, 100 %). TGA: weight 
loss (%) calcd. for 2H2O: 8.0, found 7.5. 
2.4 Summary and Conclusions 
This study unveiled the combinative effect of the rigidity of Schiff 
base and flexibility of L-arginine side chain in producing different assemblies 
both at the local metal geometric and the crystal architectural and packing 
levels.  
Complexation of 2-a and 2-c with Cu(OAc)2·2H2O afforded channel 
structures, 2-1 and 2-6 with different cavity sizes influenced by the subtle 
changes in aryl moieties. The acetate ligands in 2-1 exhibit unidentate and 
semi-chelation modes in two different Cu(II) units. A series of Cu(II)-RNO2 
complexes with different anions (2-2, 2-3, 2-4 and 2-5) was prepared. The 




perchlorate anion in 2-2 acts as linker between two different Cu(II) units, 
giving rise to a comb-like structure hosting the perchlorate ions. In contrast, 
guanidinium groups in 2-3 were H-bonded to nitrate anion and nitro groups, 
resulted in a channel structure with nitrate and solvent molecules resided 
inside. The bulky terephthalate anion in 2-4 was aligned well in the 
hydrophobic region comprised of arginine alkyl chains, forming a channel-like 
structure with larger void volume. 2-5 was obtained from the filtrate of 2-4. 
The unreacted Cl
- 
during anion exchange was coordinated to the copper centre. 
This produced a tightly packed structure with no residual solvent accessible 
void. Comparison of these Cu(II) complexes suggests that the orientation of 
arginine side chain plays an important role in determining the outcome of the 
assembles, which resembles the influence of rotameric side chains in the 
protein structures. Unexpected racemization was observed in some complexes, 
presumably due to the removal of α-H by water or base. 
These crystallographic studies of the Cu(II) supramolecular assemblies 
of L-arginine Schiff bases will help the exploration of their potential 
application as thrombin inhibitors. Our preliminary docking results indicated 
that these complexes displayed similar binding modes to the copper(II) and 
iron(III) Schiff bases reported by Toyota et al.
174-175
 Apart from the crucial 
interaction with key residue Asp189, the hydrophobic part of aromatic rings 
also fitted well into the hydrophobic P-pocket of the enzyme. 
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3.0  Preface 
Search using Cambridge Structural Database (CSD; December 2010) 
shows that tryptophan, histidine and tyrosine represent only 8.5 % of the 
reported o-hydroxyaryl amino acid Schiff bases (Figure 2.1b).
133-135
 This 
reveals that their crystal engineering is largely unexplored. Herein, the 
structural diversities of these amino acids Schiff bases will be presented. The 
three amino acids share the common characteristic of having aromatic side 
chains, which are potential for exhibiting aromatic interactions. In addition, 
the variation of metal center was studied as well. In Chapter 3.1, three 
complexes with lipid-bilayer-resembling packing are demonstrated. In the 
following subchapter, detailed characterization of N-(2-hydroxy-3-methoxy-
salicylidene)-L-histidine and three Ni(II) aggregates is discussed. Compound 
3-4 and 3-5 with interesting magnetic property is further investigated by 
superconductive quantum interference device (SQUID). The following two 
chapters (Chapter 3.3 and Chapter 3.4) will focus on a tyrosine-derived Na-
Fe(III) CP (3-7) and a novel MOF (3-8). All experiment works will be given 




Figure 3.1 The structure of (a) L-tryptophan, (b) L-tyrosine and (c) L-histidine. 
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3.1 Lipid-Bilayer-Mimicking Solid-State Structures of Cu(II) and 
Ni(II) with L-Tyrosine and L-Tryptophan Schiff Base Derivatives 
3.1.1 Introduction 
As discussed in Section 1.1.1, the lipid bilayer contains unique 
compartmentalized architecture of hydrophobic and hydrophilic regions. The 
construction of this bilayer structure has been a long-term target for chemists 
to harness its biological implication into useful application.
183
 A broad variety 
of building blocks with specific functional feature have been employed, 



















Despite the wealth of studies on artificial vesicles and bilayers, 
relatively little is reported on bilayer-mimicking solid-state structures. In 
nature, the spontaneous assembly of bilayers is due to the hydrophobic effect 
on phospholipids. Learning from the amphiphilic structure of phospholipids, a 
few studies have shown that simple amino acid can also distinctly form 
bilayers. Similarly, the amino acid has the dual properties of the hydrophilic 
functional groups (i.e. amine and carboxylate) and the hydrophobic side 
chains.
194-202
 Görbitz et al. have recently summarized the thickness of bilayers 
obtained from a series of amino acid crystal structures.
202
 While most of the 
studies focus on the side chain variation which generate hydrophobic layer of 
different thickness, little investigation is devoted to the hydrophilic region. It 
is also noteworthy that the bilayers in the simple amino acids are loosely 




packed. Inspired the crystal structure of [Cu(Sal-Trp)(H2O)2] (Sal-Trp = N-(2-
hydroxy-1-benzylidene)-tryptophan) reported by García-Raso et al. in 1996,
83
 
we reckoned that metal-amino acid Schiff bases may generate similar bilayer 
packing, but with a more amenable and controllable manner over the layer 
thickness.  
In this subchapter, a new series of solid-state bilayer resembling 
structures derived from metal-aromatic amino acid Schiff bases was discussed. 
The segregation into bilayer sheets was achieved by distinctive H-bonding of 
metal site and aromatic stacking of the Schiff base ligands in an alternating 
arrangement.  
3.1.2 Results and Discussion 
3.1.2.1 Syntheses 
Two known aromatic amino acid Schiff bases, N-(2-hydroxy-1-
naphthalidene)-L-tryptophan (H2WNap; 3-a) and N-(2-hydroxy-1-
naphthalidene)-L-tyrosine (Na2YNap; 3-b) have been chosen to illustrate the 
possible hydrophobic interaction of amino acid side chain (Scheme 3.1). In 
2001, Şakiyan et al. studied the complexation of a series of N-(2-hydroxy-1-
naphthalidene) Schiff bases with Mn(III), and obtained the sodium salt of 3-a 
in a moderate yield of 74 %.
85
 Here, 3-a is obtained as a neutral compound in 
a near-quantitative yield (96 %). The second ligand in this study, 3-b was 
prepared similarly to that reported by Rehder and co-workers, but with no 
esterification of the carboxylate group.
62
 Complexation of these Schiff bases 
with M(II) (M = Ni, Cu) is shown in Scheme 3.1. The Ni(II) complex 3-3 was 




prepared by Method I whereas the rest were synthesized by Method II (Section 
1.1.2.3). The products were obtained in 21–74% yields. 




























































3.1.2.2     Description of Crystal Structures 
3.1.2.2.1  [Cu2(WNap)2(H2O)2]·2H2O, 3-1 
Complexation of 3-a with Cu(NO3)2·3H2O gives 3-1 as a dinuclear 
structure (Scheme 3.1). It contains two geometrically different Cu(II)
 
centers 
bridged by a carboxylate group of 3-a. Similar to the reported [Cu(Sal-
Trp)(H2O)2],
83
 the 3-a Schiff base serves as a tridentate [ONO] ligand on one 
metal. The indole ring is non-coordinating. Such pendant indole group is a 
common occurrence in biological system,
203
 although indole in a chemical 
system can coordinate to metal via nitrogen and carbon donors (by converting 




 X-ray single-crystal diffraction analysis 
suggests that Cu1 is approximately square planar, with the [ONO] ligand and 
bridging O6 forming the coordination plane (O1–Cu1–O2 and N1–Cu1–O6 
are 169.8(2)˚ and 171.8(2)˚ respectively) (Figure 3.2). O6 and Cu1 are ca. 0.60 
and 0.17 Å above the coordination plane respectively. The neighboring metal 
(Cu2) is square pyramidal (structural indices η146 = 0.18), with the 
coordination sphere made up by the [ONO] ligand and two aqua ligands, one 
of which is on the axial position (Cu2–O8 2.305(5) Å) (Table 3.1).  
The lattice water molecules, O1W and O2W form extensive H-bond 
interactions and connect to the adjacent Cu(II) units in close proximity (O8–
H8WAO1Wi 2.92, O1W–H1WAO6ii 2.83; O1W–H1WBO2 2.75; O7–
H7WAO2Wi 2.70, O8–H8WBO2Wiii 2.83, O2W–H2WBO8iv 2.83 and 
O2W–H2WAO3 2.71 Å; symmetry codes (i): x,1+y,z; (ii): 1+x,y,z; (iii): -
1+x,1+y,z; (iv): 1+x,-1+y,z) (Figure 3.2b, Table 3.2). The intermolecular 
stacking between aromatic rings occurs in a „face-tilted-T‟ fashion151 (Figure 




3.3b). It may be attributed to ζ-π attraction between the N–H of indole and the 
electron rich naphthalene ring (N–Hnaphthalene plane distances are 2.431 
and 2.439 Å for Cu1 and Cu2 respectively (Table 3.3)). Structurally, this 
aromatic stacking form is distinctively different from the H-bond network, 
resulting in discrete hydrophobic and hydrophilic regions (Figure 3.4b). 
 
Table 3.1 Selected bond lengths [Å] and angles [°] for 3-1. 
Cu1–O1 1.889 (5) Cu2–O4 1.897(5) 
Cu1–N1 1.909(5) Cu2–N3 1.918(6) 
Cu1–O2 1.951(5) Cu2–O5 1.963(5) 
Cu1–O6 1.965(5) Cu2–O7 1.979(5) 
  Cu2–O8 2.305(5) 
O1–Cu1–N1 92.9(2) O4–Cu2–N3 94.7(2) 
O1–Cu1–O2 169.8(2) O4–Cu2–O5 177.4(2) 
N1–Cu1–O2 84.7(2) N3–Cu2–O5 83.6(2) 
O1–Cu1–O6 90.9(2) O4–Cu2–O7 91.2(2) 
N1–Cu1–O6 171.8(2) N3–Cu2–O7 166.7(2) 
O2–Cu1–O6 92.8(2) O5–Cu2–O7 90.1(2) 
  O4–Cu2–O8 86.2(2) 
  N3–Cu2–O8 93.9(2) 
  O5–Cu2–O8 95.8(2) 

















Figure 3.2 (a) A perspective view of 3-1 with the hydrogen atoms and solvent 
molecules omitted for clarity. (b) The H-bond interaction (blue dotted lines) in 
3-1 viewed along a axis. 




Table 3.2 Hydrogen bond parameters for 3-1.
a 
D─H d(HA)/Å d(DA)/Å <DHA/˚ 
O7─H7WAO2Wi 1.92    2.704 151 
O7─H7WBO1ii 1.86    2.654      153 
O8─H8WAO1Wi 2.14 2.916  155 
O8─H8WBO2Wiii 2.52 2.833 104 
O1W─H1WAO6ii 2.01    2.829      163 
O1W─H1WBO2 2.06    2.750      139    
O2W─H2WBO8iv 2.22 2.833 130 
O2W─H2WAO3 2.08 2.708      131 
a
 Symmetry codes: (i) x,1+y,z; (ii) 1+x,y,z; (iii) -1+x,1+y,z; (iv) 1+x,-1+y,z. 
 
 





























































































Figure 3.3 Comparisons of aromatic stackings (purple dotted lines) in 
[Cu(Sal-Trp)(H2O)2]
83
 and 3-1. (a) Two different aromatic stacking patterns 























Figure 3.4 Packing diagrams of (a) [Cu(Sal-Trp)(H2O)2],
83
 (b) 3-1, (c) 3-2 
and (d) 3-3 view along a axis in space-filling model. The hydrophilic layer 
(indicated mainly in red) consists of ligated oxygen, imine nitrogen and 
metal center (orange for Cu(II) in [Cu(Sal-Trp)(H2O)2] and 3-1; green for 
Ni(II) in 3-2 and 3-3). The hydrophobic region (indicated mainly in grey) is 
made up of naphthalene and indole rings (phenol in 3-3). 




3.1.2.2.2 [Ni(WNap)(H2O)2(MeOH)]·H2O, 3-2 
  In an attempt to expand the hydrophilic layer, Cu
2+
 is replaced by Ni
2+
 
in the synthesis in order to take advantage of the more symmetrical octahedral 
coordination sphere. X-ray crystallographic analysis revealed, as expected, an 
octahedral Ni(II) complexed by a tridentate mer-[ONO] 3-a ligand, which 
shares an equatorial plane with an aqua ligand trans to the imine. The axial 
sites are occupied by aqua (Ni1–O2W 2.096(3) Å) and MeOH (Ni1–O1S 
2.104(3) Å) (Figure 3.5a, Table 3.4). 
Unlike 3-1, there is no indication for 3-a to serve any bridging function. 
Instead, each mononuclear Ni(II) moiety are intermolecularly connected to its 
four neighbors by H-bonding between the carboxylate (O2 and O3) and 
solvate (O1W, O2W and O1S) (O1S–H1SO3i 2.67, O1W–H1WAO3i 2.86, 
O1W–H1WBO3ii 2.70 and O2W–H2WBO2ii 2.76 Å; symmetry codes (i): 
-1+x,y,z; (ii): 1-x,1/2+y,-z) (Table 3.5). This H-bonding network is further 
reinforced by interaction among the lattice water, O3W to aqua ligands and 
phenoxy O (O2W–H2WAO3W 2.72, O3W–H3WAO1Wii 2.92 and O3W–
H3WBO1i 2.73 Å; symmetry codes (i): -1+x,y,z; (ii): 1-x,1/2+y,-z) (Figure 
3.5b, Table 3.5). Similar ζ-π attraction between the N–H of indole and 
naphthalene ring was observed, with relatively longer distance at 2.482 Å 
(Figure 3.5b, Table 3.3). There is a similar hydrophobic region as in 3-1, with 
similar thickness of 5 Å (Figure 3.4c). However, the offset (displacement) 
distance of N–H from ring center is considerably smaller (~0.72 Å), indicating 












Figure 3.5 (a) A perspective view of 3-2 with all hydrogen atoms and solvent 
molecules omitted for clarity. (b) H-bond interaction (blue dotted lines) and 
aromatic stacking (purple dotted lines) in 3-2. 
 




Table 3.4 Selected bond lengths [Å] and angles [°] for 3-2. 
Ni1–N1 1.979(3)  Ni1–O1 1.980(3) 
Ni1–O2 2.074(3)  Ni1–O2W 2.096 (3) 
Ni1–O1S 2.104(3)  Ni1–O1W 2.104(2) 
N1–Ni1–O1 92.16(11)  N1–Ni1–O2 81.33(11) 
O1–Ni1–O2 173.41(10)  N1–Ni1–O2W 90.73(12) 
O1–Ni1–O2W 91.30(12)  O2–Ni1–O2W 87.80(12) 
N1–Ni1–O1S 94.13(12)  O1–Ni1–O1S 87.74(12) 
O2–Ni1–O1S 93.70(11)  O2W–Ni1–O1S 175.08(11) 
N1–Ni1–O1W 175.56(13)  O1–Ni1–O1W 92.28(11) 
O2–Ni1–O1W 94.24(10)  O2W–Ni1–O1W 89.08(12) 
O1S–Ni1–O1W 86.14(12)    
 
Table 3.5 Hydrogen bond parameters for 3-2.
 a
 
D─H d(HA)/Å d(DA)/Å <DHA/˚ 
O1S─H1SO3i 1.88(3) 2.667(4) 155(4) 
O1W─H1WAO3i 2.04(4) 2.855(4)      167(4) 
O1W─H1WBO3ii 1.86(3) 2.696(4)      175(3) 
O2W─H2WAO3W 1.95(2) 2.720(5) 153(4) 
O2W─H2WBO2ii 1.92(3)    2.763(4)      169(4)    
O3W─H3WAO1Wii 2.10(5)    2.918(5)      160(5)    
O3W─H3WBO1i 1.90(5)    2.731(5)      168(5)    
a
 Symmetry codes: (i) -1+x,y,z; (ii) 1-x,1/2+y,-z. 
3.1.2.2.3 [Ni(YNap)(H2O)2(MeOH)]·1.5H2O, 3-3 




) produced only a 
marginal effect in expanding the hydrophilic layer, the alternative is to 
examine the effect of the ligand. Hence, tyrosine which contains an additional 
hydroxyl –OH was then chosen. X-ray single-crystal diffraction analysis of 3-
3 suggested two asymmetric Ni(II) moieties (Ni1 and Ni2) in the unit cell with 
three lattice water molecules. The mononuclear Ni(II) is isostructural
206,207
 to 
that of 3-2 (Figure 3.6a). Apart from exhibiting the typical H-bonding as in 3-




1 and 3-2, the intermolecular interactions are predominantly maintained by H-
bonding across the phenol groups of tyrosine with the lattice water (O5W) in a 
zig-zag pattern (O8–H8O4i 2.72, O5W–H5WAO8ii 2.75 and O4–
H4O5Wii 2.62 Å; symmetry codes (i): -1+x,y,z; (ii): 1+x,y,z) (Figure 3.6b, 
Table 3.7). This forms a loosely packed OO interacted network viewed 
along b axis, giving rise to a mixed layer of H-bonding and hydrophobic 
interaction. We termed this region as „amphiphilic layer‟ (Figure 3.4d). At the 
edges of this amphiphilic layer, both Ni1 and Ni2 show discrete H-bond 
interactions, thus extending the hydrophilic layers. Each Ni(II) moiety is 
connected to the adjacent units via carboxylate O and solvate (O1S–H1SO3i 
2.64, O2W–H2WBO3iii 2.66, O1W–H1WAO2iii 2.75, O2S–H2SO7ii 
2.67, O3W–H3WBO6v 2.77, O4W–H4WAO7v 2.68 and O4W–
H4WBO7ii 2.84 Å; symmetry codes (i): -1+x,y,z; (ii): 1+x,y,z; (iii): 2-
x,1/2+y,-z; (v): 1-x,1/2+y,1-z), further facilitated by the lattice water O6W and 
O7W (O1W–H1WBO7Wii 2.79, O2W–H2WAO7Wiv 2.75 and O4W–
H4WBO6Wii 2.98 Å; symmetry codes (ii): 1+x,y,z; (iv): -1-x,-1/2+y,-z) 
(Figure 3.6b, Table 3.7). Replacement of indole in tryptophan by phenol in 
tyrosine inverts the aromatic interaction pattern. Instead of N–H of indole 
facing the naphthalene rings, the stacking occurs with naphthalene Ar–H 
pointing towards the tyrosine side chain (Ar–Htyrosine ring distances for 
Ni1 and Ni2 are 2.781 and 2.952 Å respectively) (Figure 3.6b, Table 3.3). This 
may be attributable to the enrichment of electron density in tyrosine ring by 
the electron donating –OH group.  




Table 3.6 Selected bond lengths [Å] and angles [°] for 3-3. 
Ni1–N1 1.989(3)  Ni2–N2 1.982(3) 
Ni1–O1 1.992(3)  Ni2–O5 1.992(3) 
Ni1–O2 2.047(2)  Ni2–O6 2.060(2) 
Ni1–O2W 2.084(2)  Ni2–O3W 2.100(3) 
Ni1–O1S 2.100(3)  Ni2–O2S 2.101(3) 
Ni1–O1W 2.109(3)  Ni2–O4W 2.104(3) 
N1–Ni1–O1 91.08(11)  N2–Ni2–O5 91.70(11) 
N1–Ni1–O2 81.87(11)  N2–Ni2–O6 82.04(11) 
O1–Ni1–O2 172.94(9)  O5–Ni2–O6 173.73(10) 
N1–Ni1–O2W 174.82(11)  N2–Ni2–O3W 88.85(13) 
O1–Ni1–O2W 93.36(11)  O5–Ni2–O3W 90.55(11) 
O2–Ni1–O2W 93.70(10)  O6–Ni2–O3W 88.89(11) 
N1–Ni1–O1S 95.26(13)  N2–Ni2–O2S 96.03(13) 
O1–Ni1–O1S 89.46(11)  O5–Ni2–O2S 89.05(11) 
O2–Ni1–O1S 90.82(11)  O6–Ni2–O2S 92.04(11) 
O2W–Ni1–O1S 87.45(12)  O3W–Ni2–O2S 175.11(10) 
N1–Ni1–O1W 88.29(13)  N2–Ni2–O4W 173.98(11) 
O1–Ni1–O1W 90.97(11)  O5–Ni2–O4W 93.92(11) 
O2–Ni1–O1W 89.19(11)  O6–Ni2–O4W 92.31(10) 
O2W–Ni1–O1W 88.97(11)  O3W–Ni2–O4W 88.94(12) 
O1S–Ni1–O1W 176.42(10)  O2S–Ni2–O4W 86.23(12) 
 




Table 3.7 Hydrogen bond parameters for 3-3.
 a
 
D─H d(HA)/Å d(DA)/Å <DHA/˚ 
O1S─H1SO3i 1.82 2.6395      175 
O2S─H2SO7ii 1.91 2.6670      154 
O4─H4O5Wii 1.79 2.6194      167      
O1W─H1WAO2iii 1.94 2.7536      170    
O8─H8O4i 1.88 2.7209      174 
O1W─H1WBO7Wii 2.07    2.7942      161    
O2W─H2WAO7Wiv 1.94    2.7529      176 
O2W─H2WB O3iii 1.91 2.6626      163      
O3W─H3WAO6W 1.91 2.7218      171 
O3W─H3WBO6v 1.96 2.7681      173 
O4W─H4WAO7v 1.87 2.6808      175 
O4W─H4WBO6Wii 2.31 2.9809      140 
O4W─H4WBO7ii  2.32 2.8430      122 
O5W─H5WAO8ii 1.94 2.7539      173 
O6W─H6WAO4Wv 2.09 2.8971      166 
O6W─H6WBO5i 1.94 2.7204      159 
O7W─H7WAO1 1.88 2.6602      158 
O7W─H7WBO2W 2.18 2.7994      133    
a
 Symmetry codes: (i) -1+x,y,z; (ii) 1+x,y,z; (iii) 2-x,1/2+y,-z; (iv) -1-x,-





























Figure 3.6 (a) A perspective view of 3-3 with all hydrogen atoms and solvent 
molecules omitted for clarity. (b) H-bond interaction (blue dotted lines) and 
aromatic stacking (purple dotted lines) in 3-3. The tyrosine side chains forms 
a zig zag H-bond network. 
 




3.1.2.3  Structural Comparisons 
 In general, compound 3-1, 3-2 and 3-3 exhibit similar bilayer packing 
as other simple amino acid crystals. Nonetheless, tighter packing in 
hydrophobic region with smaller voids was observed in these metal complexes. 
This tight packing maybe attributable to the additional aromatic stacking in the 
Schiff bases apart from van der Waals interaction between amino acid side 
chains.
194-203
 To measure the diameter of the bilayers, Görbitz et al. used the 
midpoints Cα–Cβ bonds as borders between the different regions.203 Such 
measurement is not applicable here as the Schiff bases have two separate 
hydrophobic parts (i.e. o-hydroxyaryl moiety and amino acid side chain). 
Additionally, the solvent ligands and metal ions are included in the 
hydrophilic regions. Hence, direct comparison with the simple amino acids 




The packing diagram of [Cu(Sal-Trp)(H2O)2] and the three complexes 
in this study are shown in Figure 3.4. The layer thickness was measured by 
average edge length of the desired region. All compounds show hydrophobic 
region with similar thickness, except [Cu(Sal-Trp)(H2O)2]. Two types of 
aromatic stacking were observed in [Cu(Sal-Trp)(H2O)2], represented by 
aromatic-indole in T-shaped edge-to-face structure and indole-indole stacking 
in face-tilted T pattern.
151
 The alternating arrangement of these two stackings 
with offsets 0.77 and 1.09 Å respectively, forms a broad hydrophobic layer 
(width ca. 9 Å) sandwiched between the hydrophilic sites of Cu(II)
 
center 
(Figure 3.3a and 3.4a, Table 3.3). In comparison, the „tighter‟ and narrower 




hydrophobic layer (width ca. 5 Å) in compound 3-1 to 3-3 may be attributable 
to the existence of single type face-tilted-T stacking (Figure 3.3b; only 3-1 is 
shown as representative).  
Similar to simple amino acid crystals that give constant hydrophilic 
layer (4.95–6.17 Å),194-203 the substitution of metal center from Cu2+ to Ni2+ 
allow only marginal adjustment of hydrophilic region by ~1-2 Å (Figure 3.4a-
d) but in a tighter packing manner. However, this layer can be increased 
separately by changing the ligand side chain to tyrosine, subsequently forming 
the amphiphilic layer (Figure 3.4d). 
3.1.2.4 Spectroscopic Studies 
The 
1
H-NMR of the HC=N peaks of the Schiff base ligands occur at  
~8.2–8.8 ppm (Appendix II; softcopy). The assignment of the peaks in the 




C HMQC NMR. 
Table 3.8 Selected IR absorption bands (cm
-1
) of 3-a, 3-b and their 
complexes. 
Sample ν(OH) ν(NH)  νas (C=O) ν(C=N) νs (C=O) ν(CO) 
3-a 3405 3046 1636 1550 1356 1097 
3-b 3410 2941 1622 1513 1397 1248 





3-2 3432 - 1629 1549 1401 1180 
3-3 3257 - 1625 1543 1386 1183 
 
The IR spectrum of 3-1 shows two stretching vibrations for both 
asymmetry and symmetry modes of the unidentate and bidentate (chelating) 
carboxylates, consistent with the X-ray structure.
208
 All complexes exhibit 
difference of νasym(COO) and νsym(COO) with the range of 210-240 cm
-1 




(Table 3.8), indicating the presence of terminal coordination of carboxylate 
groups.
155,156 
The solution properties of the complexes were studied using ESI-MS 
and UV-visible spectroscopy (Appendix III; softcopy). A weak band 
assignable to d-d transition in Cu(II)
 
was observed at 644 nm of 3-1,
144
 
whereas 3-2 shows a weaker but noticeable d-d band (ε = 40 M-1cm-1) at lower 
wavelength region (610 nm). However, no observable d-d transition band was 
found for 3-3 even in concentrated solution. This may be masked by the 
adjacent intense charge transfer (CT) band (ε = 19720 M-1cm-1 at 400 nm) 
(Table 3.9).
79, 209 
All samples exhibit clean dominant peak in positive mode 
ESI-MS spectra, corresponding to the dinuclear species, whose formation 
(from mononuclear species like 3-2 and 3-3) can be explained by solvate 
dissociation followed by dimerisation (Figure 3.7; only ESI-MS spectrum of 
3-2 is shown as representative). 
 
Figure 3.7 Positive mode ESI spectrum of 3-2 and its simulated isotopic 
spectrum. 




Table 3.9 Electronic absorption of complexes 3-1 to 3-3. 
Complex Absorption bands (Methanol)/ nm
a 










a  λmax(ε).   
The thermal stability of the complexes was analyzed using 
thermogravimetric analysis (TGA). All the solvent molecules were retained 
after air-dried. The samples decompose after 250 ˚C, which is higher 
temperature than Cu(II)-arginine Schiff bases (Chapter 2). Only TGA profile 
of 3-1 was shown as representative (Figure 3.8; please see Appendix III for 
complete data).  
 
Figure 3.8 TGA profile of 3-1. 




3.1.3  Summary and Conclusions 
 In this subchapter, the rational design of bilayer structures in solid state 
using simple metal(II)-L-tryptophan and L-tyrosine Schiff bases has been 
demonstrated. The stacking of aromatic amino acid Schiff bases shows a 
promising way to generate hydrophobic layer, which can be segregated from 
the hydrophilic region of metal-ligated heteroatom site. The isostructural 
crystal packing of this homologues series indicates that the bilayer pattern is a 
common feature in these complexes.
206-207
 The width of the hydrophilic layer 





 does not extend the hydrophilic layer significantly, 
introduction of tyrosine has successfully expanded it by inducing a separate 
„amphiphilic‟ layer. We have shown that by learning the fundamental 
principles from the natural lipid bilayers, a simple compartmentalized design 













B)    Preparation, Characterization and Property 













3.2 Preparation, Characterization and Property Study of Metal 
Aggregates of Amino Acid Schiff Bases 
3.2.1 Introduction 
Inspired by the binucleating ligands in the magneto compounds 
(Section 1.2.2), we utilize the rich geometrical diversity of amino acid Schiff 
bases to prepare polynuclear aggregates. Although numerous studies have 
shown that these Schiff bases are powerful building blocks in supramolecular 
chemistry, their use in synthesizing metal aggregates with interesting magnetic 
properties is largely unexplored.
130
  
In accessing this, three Ni(II) aggregates were prepared by reacting the 
Ni(II) salt with N-(2-hydroxy-3-methoxy-salicylidene) (or o-vanillin) amino 
acid (amino acid = L-tyrosine, L-histidine and L-tryptophan). The methoxy (–
OMe) group was introduced at ortho position to phenoxy O, offering a 
tetradentate [OONO] for multinuclear complexation. While the detailed 
characterization of these compounds was discussed in this study, their 
magnetic properties were investigated as well. This study is thus paramount as 
it has uncovered the feasibility of amino acid Schiff bases in preparing metal 
aggregates. 
3.2.2 Results and Discussion 
3.2.2.1 Syntheses 
Two new ligands, N-(2-hydroxy-3-methoxy-salicylidene)-L-tyrosine 
(Na2YVan; 3-c) and N-(2-hydroxy-3-methoxy-salicylidene)-L-tryptophan 
(NaHWVan; 3-e), together with a reported N-(2-hydroxy-3-methoxy-






 were synthesized in a moderate 
yield (70-85%). The complexation involved in this study was summarized in 
Scheme 3.2. The Ni(II) aggregates were prepared either by Method I or 
Method II (Section 1.1.2.3). 




















































































































3.2.2.2    Description of Crystal Structures 
3.2.2.2.1 H2HVan (3-d)  
The 3-d crystal was obtained according to the method reported by 
Şakiyan et. al.85 The sodium salt, NaHHVan was neutralized with glacial 
acetic acid and deposited yellow crystal on the next day. Similar crystal 
structure was reported recently by Janiak and co-workers but prepared as 
neutral ligand without pH modification.
82
  
Similar as the reported structure
82
 and 3-a (Chapter 2), the proton of 
phenol –OH shifts to imine nitrogen and form intramolecular H-bond at 
2.563(4) Å. Notably, 3-d exists as double zwitterions state as proven by Janiak 
using electron density distribution and solid state MAS NMR.
82
 Each 
protonated imidazole NH establishes different H-bond, with one connects to 
phenolate O of an adjacent unit, and another one forms bifurcated H-bond 
with two carboxylate O of another molecule (N2–H2NO2ii 2.64, N2–
H2NO3ii 3.04 and N3–H3NO1iii 2.60 Å; symmetry codes (ii) 2-
x,1/2+y,3/2-z; (iii) -1+x,y,z) (Figure 3.9b and Table 3.10). This interaction 
results in zig zag like structure viewing along a axis. Also, an edge-to-face 
stacking was observed between imidazole N–H and benzaldehyde ring, with 














Figure 3.9 (a) A perspective view of 3-d with C–H hydrogen atoms have been 
omitted for clarity. Intramolecular H-bond is depicted as pink dotted line. (b) 
Intermolecular H-bond interaction (cyan dotted lines) in 3-d. 





Table 3.10 Hydrogen bond parameters for 3-d.
a
  
D─HA d(HA)/Å d(DA)/Å <DHA/˚ 
O1W─H1WAO2 1.04(7)    2.908(4)      170(6)      
N1─H1NO1 1.79(4)    2.563(4)      141(4)      
N1─H1NO3 2.27(5) 2.634(4)      104(3)      
O1W─H1WBO3i 1.98(5)    2.956(4)      175(5)    
N2─H2NO2ii 1.81 (4)    2.643(4)      173(5)    
N2─H2NO3ii 2.55(5)    3.043(4)      119(4)    
N3─H3NO1iii 1.74(4)    2.604(4)      171(4)    
a
 Symmetry codes: (i) 2-x,-1/2+y,3/2-z; (ii) 2-x,1/2+y,3/2-z; (iii) -1+x,y,z. 
 
3.2.2.2.2 [Ni4(YVan)4(H2O)3(MeOH)]·H2O·6MeOH, 3-4 
 A novel tetranickel complex 3-4 with all metals in dissimilar 
coordination environment was obtained by reacting 3-c with Ni(OAc)2·4H2O. 
All Ni(II)
 
are in typical octahedral geometry with the equatorial plane 
comprised of tridentate [ONO] and either a carboxylate or phenoxy O from 
adjacent unit. The equatorial ligands from neighbouring unit tend to bulge out 
of the plane, with those of terminal units are apparently much deviated off. 
The axial positions of terminal Ni3 and Ni4 are occupied by methoxy OMe 
and carboxylate O, whereas those of the middle Ni1 and Ni2 are completed by 
solvent molecules (one water and one methanol for Ni1; two aqua ligands for 
Ni2) (Figure 3.10).  
According to Mingos and Wales rule, a metal-metal bond should be 
smaller than 115% of the sum of covalent radii.
210-211
 The NiNi distances in 
3-4 are: Ni1Ni2 = 3.137 Å, Ni1Ni3 = 3.413 Å and Ni2Ni4 = 3.402 Å. 
Hence, no metal-metal bond is observed since they are longer than 3.1 Å.
  
It is 




noticeable that the carboxylate groups in 3-4 features two different binding 
modes, being unidentates in the terminal units and bidentates in the middle 
region. 
 
Figure 3.10 A perspective view of 3-4. All hydrogen atoms and solvent 
molecules have been omitted for clarity. All heteroatom and Ni(II) are labeled 
and shown as ball model. 
 
The tyrosine side chains of the terminal units are more tilted towards 
the metal coordination plane, with interplane angles of 34º and 43º in 
comparison to that of middle units (48º and 76º). These phenol rings are not 
involved in metal binding, but forming extensive H-bond with oxygen donor 
ligands of neighboring tetranuclear units and solvent molecules. No interesting 
packing structure is observed due to its topologically complex structure.  




Table 3.11 Selected bond lengths [Å] and angles [°] for 3-4. 
Ni1–O1 1.9668(15) Ni2–O6 1.9629(15) Ni3–O11 1.9727(15) 
Ni1–N1 1.971(2) Ni2–N2 1.968(2) Ni3–N3 1.993(2) 
Ni1–O7 2.0288(16) Ni2–O2 2.0298(16) Ni3–O12 2.0421(16) 
Ni1–O2 2.0431(15) Ni2–O7 2.0418(16) Ni3–O1 2.0574(16) 
Ni1–O2X 2.0905(17) Ni2–O4X 2.1079(18) Ni3–O8 2.1222(16) 
Ni1–O1X 2.1219(15) Ni2–O3X 2.1303(15) Ni3–O5 2.1766(16) 
Ni4–N4 1.9730(19) Ni4–O17 2.0589(16) Ni4–O6 2.0457(15) 


















































































































































It should be noted that there are twelve Ni(II) o-hydroxyaryl amino 
acid Schiff bases have been reported to date (December 2010).
133-135
 Among 
these, only a multinuclear aggregate, [Ni2(Sal-Gly)2(imz)4] (Sal-Gly 
=  salicylideneglycine; imz = imidazole)
213
 was reported. Its packing shows a 
quasi 3D porous framework. The next compound in this study shows that 
using histidine instead of individual imidazole ligands generates an interesting 
channel-like structure. 
3.2.2.2.3  [Ni3(HVan)2(OAc)2(H2O)2]·H2O·0.5MeOH·0.5IPA, 3-5  
A nickel aggregate comprising of two Schiff bases, two acetate anions 
and three Ni(II) was obtained by reacting NaHHVan with Ni(OAc)2·4H2O. 
Ni2 is located on the two-fold axis, bridging two Ni1 as shown in Figure 3.11a. 
The structure is similar to a Ni(II) polyamine Schiff base reported by Elmali et 
al., in which three Ni(II) are bridged through phenoxy and acetate O in a 
relatively bent manner.
213
 In 3-5, each acetate anion bridges two Ni(II) in a 
syn-syn mode. Similar as 3-4, the NiNi separation in 3-5 is long (3.454 Å) 
and non-bonding. The equatorial plane of Ni1 is composed of [ONO] 
tridentate Schiff base and an acetate O, whereas the axial ligands are made of 
imidazole N and aqua ligand. Conversely, octahedral geometry of Ni2 consists 
of two phenoxy O, two methoxy O and two acetate O (Figure 3.11a).  
Viewing along a axis, each six molecules interact to form a 
macrocyclic via H-bond between the uncoordinated carboxylate O and 




imidazole NH (N3–H3NO3iii 2.82 Å; symmetry code (iii) 1/2-x,-1/2+y,3/4-
z) (Figure 3.11b and Table 3.13). Repeated arrangement of this macrocyclic 
along c axis gives a channel-like structure, with dimension ca. 8 Å x 5 Å and 
void volume of 887.8 Å
3 
(21.5 %) (Figure 3.11c). The crystallized solvent 
molecules, i.e. isopropanol, methanol and water are positioned inside the 
cavity with only water sustained H-bonding to the framework (O7–
H7WAO1Wi 2.85, O1W–H1WBO5iv 2.86 Å; symmetry codes (i) 1-x,1-y,-




















Table 3.12 Selected bond lengths [Å] and angles [°] for 3-5. 
Ni1–N1 1.9922(15)  Ni2–O1#1 2.0163(12) 
Ni1–O5 2.0225(14)  Ni2–O1 2.0163(12) 
Ni1–N2 2.0565(17)  Ni2–O6 2.0340(13) 
Ni1–O1 2.0613(13)  Ni2–O6#1 2.0340(13) 
Ni1–O2 2.0637(14)  Ni2–O4 2.1242(13) 
Ni1–O7 2.1503(15)  Ni2–O4#1 2.1242(13) 
N1–Ni1–O5 170.93(6)  O1#1–Ni2–O6 87.24(5) 
N1–Ni1–N2 85.95(7)  O1–Ni2–O6 103.33(5) 
O5–Ni1–N2 93.40(6)  O1#1–Ni2–O6#1 103.33(5) 
N1–Ni1–O1 88.74(6)  O1–Ni2–O6#1 87.24(5) 
O5–Ni1–O1 100.33(5)  O6–Ni2–O6#1 94.79(8) 
N2–Ni1–O1 94.12(6)  O1#1–Ni2–O4 90.89(5) 
N1–Ni1–O2 80.79(6)  O1–Ni2–O4 78.31(5) 
O5–Ni1–O2 90.20(6)  O6–Ni2–O4 177.90(5) 
N2–Ni1–O2 92.03(6)  O6#1–Ni2–O4 86.56(5) 
O1–Ni1–O2 167.45(5)  O1#1–Ni2–O4#1 78.31(5) 
N1–Ni1–O7 93.72(6)  O1–Ni2–O4#1 90.89(5) 
O5–Ni1–O7 87.34(6)  O6–Ni2–O4#1 86.56(5) 
N2–Ni1–O7 177.38(6)  O6#1–Ni2–O4#1 177.90(5) 
O1–Ni1–O7 83.27(5)  O4–Ni2–O4#1 92.14(7) 
O2–Ni1–O7 90.48(6)  O1#1–Ni2–O1 164.50(7) 
 
 




Table 3.13 Hydrogen bond parameters for 3-5.
a 
D─H d(HA)/Å d(DA)/Å <DHA/˚ 
O7─H7WAO1Wi 2.046(17)    2.848(3)   148.1(16)    
O7─H7WBO6ii 1.98(2)    2.833(2)   159.0(18)    
N3─H3NO3iii 2.04(2)    2.821(2)      155(2)        
O2S─H2SBO1W 2.03 2.858(6)      175   
O1W─H1WAO1S 2.06(3)    2.663(6)      120(2)      
O1W─H1WBO5iv 2.08(2)    2.858(3)      141(3)      
C1S─H1S1O2v 2.27    2.813(7)      114 
C1S─H1S2O1W 2.13 2.545(7)      104      
C1S─H1S2O2S 2.18 3.035(9)      147 
O3W─H3WBO6v 1.96 2.7681      173 
O4W─H4WAO7v 1.87 2.6808      175 
O4W─H4WBO6Wii 2.31 2.9809      140 
O4W─H4WBO7ii  2.32 2.8430      122 
O5W─H5WAO8ii 1.94 2.7539      173 
O6W─H6WAO4Wv 2.09 2.8971      166 
O6W─H6WBO5i 1.94 2.7204      159 
O7W─H7WAO1 1.88 2.6602      158 
O7W─H7WBO2W 2.18 2.7994      133    
a
 Symmetry codes: (i) 1-x,1-y,-1/2+z; (ii) y,x,-z; (iii) 1/2-x,-1/2+y,3/4-z; (iv) 










































Figure 3.11 (a) A perspective view of 3-5 with all hydrogen atoms and 
solvent molecules have been omitted for clarity. Only heteroatoms are 
labeled and shown as ball model. (b) A macrocyclic formed by six 
molecules interconnected with through H-bond view along a axis. (c) 
Packing diagram of 3-5 view along c axis in stick (left) and space-filling 
(right) diagram. All lattice solvent molecules are removed for clarity. The 
channel size is approximately 5 Å x 8 Å. 
 
3.2.2.2.4  [Ni4(WVan)4(DMSO)2(H2O)2]·4DMSO·3EtOH, 3-6 
 The crystal structure 3-6 is isostructural to that of 3-4, which forms a 
tetranickel aggregates with similar coordination environment. The two 
complexes are being different in the amino acid side chain and solvent ligands. 
The middle Ni1 and Ni2 in 3-6 are coordinated to water and dimethyl 
sulfoxide (DMSO) in the axial positions (Figure 3.12a). The NiNi distances 
in 3-6 are also similar as in 3-4, with the distance between the middle units is 





























Figure 3.12 (a) A perspective view of 3-6. All hydrogen and solvent 
molecules have been omitted. Only heteroatoms are labeled and shown as 
ball model. (b) The H-bond interaction in 3-6 (blue dotted lines). The 
molecule that forms complete H-bond via NH of indole rings are highlighted 
in green. (c) Packing of 3-6 view along c axis.  
 
Interestingly, the imidazole rings of the tetranickel forms different H-
bond network: the imidazole N of Ni3 and Ni2 is H-bonded to carboxylate O5 
and O11 of adjacent molecules (N4─H4AO11ii 2.87, N6─H6AO15iii 2.88 
Å; symmetry codes (ii) 1-x,1/2+y,-z; (iii) x,y,-1+z); whereas the one of Ni1 
and Ni4 interacts with O of free DMSO solvent (N8─H8AO4Si 3.01, 
N2─H2AO6S 2.82 Å; symmetry codes (i) -1+x,y,z) (Figure 3.12b and Table 
3.15). The interaction between imidazole N and carboxylate O deposits 1D zig 
zag chains along c axis. The free DMSO and EtOH molecules then fill the 
crystal space between the chains, as shown in Figure 3.12c. 




 Table 3.14 Selected bond lengths [Å] and angles [°] for 3-6. 
Ni1–N1 1.965(6) Ni3–N5 1.983(6) Ni2–N3 1.967(6) 
Ni1–O1 1.969(5) Ni3–O9 2.007(5) Ni2–O5 1.980(5) 
Ni1–O6 1.995(5) Ni3–O10 2.054(6) Ni2–O2 2.034(5) 
Ni1–O2 2.049(5) Ni3–O1 2.072(5) Ni2–O6 2.055(5) 
Ni1–O2S 2.130(5) Ni3–O7 2.129(5) Ni2–O1S 2.097(5) 
Ni1–O1W 2.163(5) Ni3–O4 2.210(5) Ni2–O2W 2.106(6) 
Ni4–O13 1.995(5) Ni4–N7 1.996(7) Ni4–O8 2.207(5) 
Ni4–O14
  
2.055(5) Ni4–O5 2.092(5) Ni4–O3 2.144(5) 
O1–Ni1–N1 97.1(2) O5–Ni2–N3 98.1(2) O9–Ni3–N5 92.4(2) 
O1–Ni1–O6 102.8(2) O2–Ni2–O5 102.6(2) O9–Ni3–
O10 
173.3(2) 
N1–Ni1–O6 159.3(2) N3–Ni2–O2 159.2(2) N5–Ni3–O9 81.4(2) 
O1–Ni1–O2 176.6(2) O5–Ni2–O6 176.2(2) O9–Ni3–O1 89.9(2) 
N1–Ni1–O2 79.9(2) N3–Ni2–O6 80.2(2) N5–Ni3–O1 167.0(2) 


































































O13–Ni4–O3 91.1(2) N7–Ni4–O3 86.7(2) O7–Ni3–O4 177.3(2) 
O5–Ni4–O3 105.3(2) O13–Ni4–
O8 
92.1(2) N7–Ni4–O8 94.5(2) 
O14–Ni4–O8 85.9(2) O5–Ni4–O8 73.5(2) O3–Ni4–O8 176.5(2) 




Table 3.15 Hydrogen bond parameters for 3-6.
a
 
D─H d(HA)/Å d(DA)/Å <DHA/˚ 
O1W─H1WS5i 2.74(4)    3.511(6)      153(6)    
O1W─H1WO5Si 2.02(6)    2.740(8)      142(7)    
N2─H2AO6S 2.01(6)    2.824(12)      154.00      
O1W─H2WO9 2.01(6)    2.755(7) 148(8)      
O1W─H2WO12 2.53(5) 3.110(8)      128(6)      
O2W─H3WO13 2.02(8)    2.754(8)      147(8)      
O2W─H3WO16 2.37(7)    3.057(9)      141(8)      
N4─H4AO11ii 2.0100   2.870(10)      177.00         
O2W─H4WO1W 1.98(3)    .795(8)      167(8)      
N6─H6AO15iii 2.0500   2.879(10)      161.00    
N8─H8AO4Si 2.1700   3.008(13)      166.00    
O8S─H8SO11iv 2.1600   2.726(17)      126.00    
a
 Symmetry codes: (i) -1+x,y,z; (ii) 1-x,1/2+y,-z; (iii) x,y,-1+z; (iv) x,y,1+z. 
3.2.2.3 Spectroscopic Studies 
The 
1
H-NMR of the HC=N peaks of the Schiff base ligands occur at  
~7.4–8.0 ppm (Appendix II; softcopy). The slightly more upfield value 
indicates that HC=N of vaniline derived Schiff bases is more shielded than 
other ligands. The assignment of the peaks in the aromatic region is further 




C HMQC NMR. The HMQC NMR for 
Na2YVan is unsatisfactory and not included. However, the assignment of 
13
C 
is further confirmed by Distortionless Enhancement by Polarization Transfer 
(DEPT) NMR. 
In this study, all complexes contain both bidentate and unidentate 
carboxylates, as depicted by the existence of two νasym(COO) and νsym(COO) 
bands in each samples (Table 3.16).
153,154
 The C=O strectching band in 3-5 
and 3-6 are very prominent and overlapping with the C=N band.
 
 




Table 3.16 Selected IR absorption bands (cm
-1
) of 3-c to 3-e and complexes 3-
4 to 3-6. 














3-c 3425 2963 1636 1506 1371 1172 1227 
3-d 3419 - 1637 1504 1372 1170 1226 
3-e 3405 - 1628 1503 1357 1085 1226 
















No significant d-d transition was observed for all complexes (Table 
3.17). Similar as 3-3 (Chapter 3.1), this Laporte-forbidden transition may be 




Table 3.17 Electronic absorption of complexes 3-4 to 3-6. 




3-4 280(39200), 372(20400) 
3-5 278(18000), 372(9100) 
3-6
b 282(27900), 374(12100) 
a  λmax(ε). 
b
 in MeOH/H2O (1:2, v/v) 
 
 Interestingly, these metal aggregates display different structural 
behavior in solution as shown by ESI-MS. The tetranuclear 3-4 is dissociated 
into monomeric, dimeric, trimeric and tetrameric species, with the 
predominant peak at m/z 1114.0 assignable to trimeric [3NiYVan]
-
. Similarly, 
the trinuclear 3-5 shows dissociation into monomeric and dimeric species. 
However, no any peak corresponds to undissociated trimeric species was 
observed. Although 3-6 is structurally analogues to 3-4 in solid state, it 








Figure 3.13  Positive mode ESI spectrum of 3-6 and its simulated isotopic 
spectrum. 
  
TGA analysis shows the lost of solvent molecules and coordinated 
solvent ligands consistent to XRD result for both 3-4 and 3-6. These 
compounds decompose at 235 and 260 ˚C respectively. The TGA profile of 3-
4 shows the loss of three MeOH solvent molecules upon dried, supported by 
elemental analysis. 3-5 shows the loss of solvent and aqua ligands upon heat 
up to 165 ˚C. Notably, a subsequent weight loss of 18.5 % correspond to 
Ni(OAc)2 was observed, indicates the dissociation of the trinuclear aggregates 




before a total decomposition (Figure 3.14). For complete IR, UV-vis, ESI-MS 
and TGA data, please refer to Appendix III. 
 
Figure 3.14 TGA profile of 3-5. 
 
3.2.2.4 Magnetic Studies 
The temperature dependence of the molar magnetic susceptibility, χm 
was measured on crystalline samples of 3-4 and 3-5. The measurement was 
performed from 305 to 10 K at magnetic field of 1000 G. The χmT for 3-4 and 
3-5 are 4.36 and 2.92 emu.K.mol
-1 
respectively, in agreement with the 
expected value for four and three non-interacting Ni(II) ions (S=1) (4.0 and 
3.0 emu.K.mol
-1
). Upon cooling, 3-4 and 3-5 present marked dissimilarity: the 
χmT of 3-4 decreased significantly to reach a minimum value of 2.99 
emu.K.mol
-1 
at 10 K (Figure 3.15a), whereas 3-5 shows slight increment to a 
maximum of 3.06 emu.K.mol
-1 
(Figure 3.15b).  




The result reveals small ferromagnetic interaction in 3-5. The bridging 
phenoxy in 3-5 defines Ni–O–Ni angle of 116˚, which is out of the 80-100˚ 
range for ferromagnetic coupling (Figure 3.11a).
214-215
 This suggests that the 
dominant ferromagnetic superexchange greatly depends on the carboxylate 
bridge. Although a syn-syn carboxylato ligand tends to induce moderate 
antiferromagnetic coupling by providing small metal-metal distances,
216-217
 
several exceptional cases have been reported.
218-221  
The observed result in 3-5 
is similar to the reported Ni3(BTC)2(μ-H2O)2·6H2O (BTC = benzene-1,3,5-
tricarboxylate acid). The dominant ferromagnetic coupling may arise from the 
non-planarity of the bridging carboxylate plane and equatorial plane of the 
middle Ni2. This may result in the ineffective overlap of Ni(II) magnetic 
orbitals, subsequently tilt the balance to favour ferromagnetic coupling.
221
 
 The above explanation is in accordance with the antiferromagnetic 
coupling observed in 3-4. The Ni–O(phenoxy)–Ni angle is identical to 3-5 (ca. 
116˚).This indicates the increase antiferromagnetic exchange coupling 
integral. More importantly, the syn-syn carboxylato ligand in 3-4 is more 
planar, thus mediating additional antiferromagnetic exchange pathways. 
Attempt to prepare pure 3-6 in bulk failed. However, the isostructural XRD 
analysis and similar μeff (298 K) value of 3-6 may imply that it has similar 













Figure 3.15 Temperature dependence of χmT for (a) 3-4 and (b) 3-5 under 
1000 G. 
3.2.3  Summary and Conclusions 
 In this subchapter, a series of Ni(II) aggregates was prepared using N-
(2-hydroxy-3-methoxy-salicylidene)-L-amino acid (amino acid = tyrosine, 
tryptophan and histidine). The incorporation of methoxy group provides an 
additional coordination site to form multinuclear complexes. Complexation of 




3-c and 3-e with Ni(OAc)2·4H2O gives 3-4 and 3-6 that are isostructural to 
each other in solid state. However, they give different dissociation pattern in 
solution state. The histidine derived trinickel aggregate 3-5 contains two Ni(II) 
bind to 3-d and a Ni(II) in middle bridged by two acetates. TGA analysis 
shows the dissociation of Ni(OAc)2 before the decomposition point. Magnetic 
susceptibility measurement of 3-4 and 3-5 reveal antiferromagnetic and 
ferromagnetic interaction respectively. To close, this work has translated the 






















C)    Heteronuclear Coordination Polymer 









3.3 Heteronuclear Coordination Polymer Derived from L-Tyrosine 
Schiff Bases 
3.3.1 Introduction 
 Driven by their potential applications in many domains, rational design 
of CP has drawn remarkable attention. As discussed in Section 1.2.1, the CP 
construction can be  achieved by additional incorporation of co-ligands, such 
as 4,4‘-bipyridyl, 2,2‘-bipyridyl, 1,10-phenanthroline, etc. A recent example 
from Li et al. have successfully built helical nanobelts from Ag(I) and D-, L- 
or DL-cysteine, enriching the available toolbox in the amino acid CP 
construction without co-ligands.
222
 Another study has reported a 1D CP of 
{[Zn(tyr)2(H2O)]H2O}nCu(tyr)2]n, with the exobidentate carboxylato-bridging 
ligand led to the formation of polymeric structures.
223 
However, simple metal-
amino acid systems are known to produce low dimensional network in most 
cases.
42
 To have a more predictable and rational design of CP, Ma et al. have 
designed a multifunctional amino acid, N-[(3-carboxyphenyl)-sulfonyl]glycine 
to extend the network dimension.
107
 Although co-ligand was utilized in the 
system, the multidimensional amino acid has discernibly extended the 
coordination network.   
Complexes in Chapter 3 Part B have shown the ability of vanillin 
─OMe coordinate to second metal center. In this part, a novel CP was 
obtained simply by reacting vanillin-derived Schiff base with Fe(III), which is 
a metal center with high coordination number. The formation is presumably 
driven by the octahedrally coordinated Fe(III) carries an unequal charge of -1. 




The charge-balance by Na ion, together with the extended-topology of ligands 
then leads to the formation of heteronuclear CP.  
3.3.2 Results and Discussion 
3.3.2.1 Syntheses 
Attempts to prepare Na2YNO2 (N-2-hydroxy-5-nitro-1-salicylidene)-L-
tyrosine; 3-f) have failed. Red powder 
{Na[Fe(YNO2)2]·2H2O·0.1THF·0.7CH2Cl2}n was obtained by Method I 
(Section 1.1.2.3), without isolating the preformed ligand. The synthesis is 
illustrated in Scheme 3.3. Crystal 3-7, {Na[Fe(YNO2)2]·0.5H2O·0.5THF. 
CH2Cl2}n was then obtained by slow diffusion of CH2Cl2 into the red powder 
dissolved in THF. The ruby red crystals is unstable and decomposed when 
removed from the mother solution. 



































3.3.2.2 Structure Description of 
{Na[Fe(YNO2)2]·0.5H2O·0.5THF·CH2Cl2}n, 3-7 
 3-7 reveals a Na-centered heteronuclear CP with a few disordered 
solvent molecules in the crystal lattice (Figure 3.16a and b). The coordination 
sphere of Fe(III) is created by two symmetrically independent Schiff bases (L1 
and L2). The overall -1 charge is balanced by Na1 and Na2 with half 
occupancy each. Na1 is in a special position, connecting to four L1 via 
carboxylate O2 and O3, and two nitro O5. Notably, Na2 is disordered and split 
into two positions. Its coordination environment is similar to Na1, but ligated 
to L2. The non-disordered Na2 ligand consists of four carboxylate O (O12 and 
O13) and two tyrosine hydroxyl O14. In contrast, the disordered Na2 is eight-
coordinated, with two additional O1s from THF solvent molecules. The 
Cambridge Structural Databse (CSD) statistical study (December 2010) shows 
that there are 36 cases reported the Na─O (unprotonated phenol) bond, with 
average distance of 2.3 Å.
133-135
 Nonetheless, such Na─O (tyrosine) is rarely 
reported. The richer coordination of the disordered Na2 is presumably due to 
the disorder tyrosine side chain orientated away, thus allowing the allocation 
of THF for additional binding. Owing to the different coordination 
environment of the two Na2; the asymmetric unit of 3-7 is shown separately in 
Figure 3.16a and Figure 3.16b for clarity. 














Figure 3.16 (a) A perspective view of 3-7 with all hydrogen atoms have been 
omitted for clarity. The Na2 is non-disordered. All heteroatoms are labeled. 
Only heteroatoms of metal site are shown in ball models. (b) Another 
asymmetric unit of 3-7 with disordered Na2. (c) The packing diagram of 3-7 
view along c axis. Na2 and tyrosine phenol O14 are shown as pink and red 
balls respectively. 
As shown in Figure 3.16, the two Fe(III) are substantially far apart (ca. 
6 Å), bridging by two Na with θFe-Na1-Fe = 91º and θFe-Na2-Fe = 95º respectively.  
The packing of 3-7 deposits 1D layers perpendicular to c axis. Each layer then 
further cross-links with each other through Na2, with the tyrosine side chains 
protrude into the next layer (Figure 3.16c). These layers are not parallel due to 
two- and four-fold symmetries, but in a rather staggered conformation. The 
packing of this CP forms a final 3D network which contains ca. 1027.7 Å
3
 
(13.7 %) void volume upon removal of free CH2Cl2 solvent.
 
The [Na2Fe2O4] 
core in 3-7 is similar to the reported [Fe(acacen)(NaOEt)]2 (H2acacen = N,N′-
ethylenebis(3-hydroxy-1-methylbut-2-enylideneamine). However, the reported 
[Fe(acacen)(NaOEt)]2 is a ferrous aggregate instead of ferric polymer.
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Table 3.18 Selected bond lengths [Å] and angles [°] for 3-7. 
Fe1–O1 1.918(3) Na2–O12 2.311(5) Na1–O5#1 2.308(3) 
Fe1–O11 1.946(3) Na2–O12#3 2.408(5) Na1–O5#2 2.308(3) 
Fe1–O12 2.043(3) Na2–O13#3 2.526(5) Na1–O2 2.373(3) 
Fe1–O2 2.027(2) Na2–O14#4 2.445(9) Na1–O2#3 2.373(3) 
Fe1–N3 2.096(3) Na2–O14#5 2.511(9) Na1–O3 2.466(3) 
Fe1–N1 2.127(3) Na2–O14‘#4 1.589(7) Na1–O3#3 2.466 (3) 
Na2–O1s#6 2.778(9) Na2–O14‘#5 2.386(7) Na2-
O1s#3 
2.313(9) 
O1–Fe1–O11 96.79(15) N3–Fe1–N1 170.90(12) O1–Fe1–
N3 
102.76(13) 
O1–Fe1–O2 161.16(13) O2–Fe1–N1 77.46(11) O11–Fe1–
N3 
85.05(13) 
O11–Fe1–O2 92.96(13) O12–Fe1–N1 105.98(12) O2–Fe1–
N3 
94.09(11) 





















































3.3.2.3 Spectroscopic Studies of 3-7 
The IR absorption result of 3-7 is summarized in Table 3.19. The 
bidentate and unidentate carboxylates in L1 and L2 give two νasym(COO) and 
νsym(COO) bands, in accordance with the XRD result (Figure 3.16).
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      Table 3.19 Selected IR absorption bands (cm
-1




















 Fe(III) in 3-7, the d-d transition is both spin- and 
Laporte-forbidden. Hence, the d-d transition is extremely weak and not 
observed in UV-visible spectrum.
225 
Three intense CT bands were observed at 







In ESI-MS, only a clean dominant peak correspond to 
monomeric species [Fe(YNO2)2]
- 
was found, indicating the Na-ligand bonds 
was broken due to solvation (Figure 3.17). No TGA analysis was attempted 
because the crystals were decomposed upon removed from mother liquor.
 





Figure 3.17 Negative mode ESI spectrum of 3-7 and its simulated isotopic 
spectrum. 
 
3.3.3 Summary and Conclusions 
 Heterometallic CP is acknowledgedly a potential candidate for 
applications such as sorption and photoluminescence.
226
 In this work, the first 
example of Na-Fe(III) CP derived from amino acid has been synthesized. 
Although the CP is unstable under ambient condition and thus unsuitable for 
further development, such design has undoubtedly represented a simple and 









D)   Calixarene-Resembling Tetramer from a 









3.4 Part D 
3.4.1 Calixarene-Resembling Tetramer from a Cu(II)-L-Tyrosine Schiff 
Base Complex 
 Section 1.2.1 has discussed the potential use of aspartate and glutamate 
in building metal-organic framework (MOF). Limited by the scarcity of the 
polyfunctional amino acids, the amino acid derived MOF is at its embryonic 
stage. In our effort to exploit the new candidate for this purpose, tyrosine may 
offer a potential choice despite its phenol side chain is rarely involved in 
coordination.  
Structurally, the tyrosine binds to metal via N,O-chelation, with the 
phenol –OH remains free due to steric effect. Despite this, a few exceptional 
cases have been reported. For example, the deprotonated phenolate in tyrosine 
containing peptides connects a dimeric complex.
227-228
 The previous study in 
Chapter 3.3 has also reported an unprotonated phenol binds to Na. The first 
structurally characterized Cu–O(phenol) without deprotonation was first 
demonstrated by Yamauchi and co-workers in [Cu(Tyr-His)] (Tyr-His = L-
tyrosyl-histidine),
229
 followed by the Vittal work in 
[Cu(Hsgly)(phen)](ClO4)·1.5H2O (Hsgly = N-(2-hydroxylbenzyl)-α-glycine; 




Herein, a tyrosine-derived calixarene-resembled MOF, 3-8 has been 
studied. The name ―calixarene‖ was coined by Gutsche in 1989,230 to define a 
macrocyclic oligomer obtained from the hydroxylalkylation of phenol and 
formaldehyde. Interestingly, compound 3-8 bears resemblance to the 
calix[4]arene in cone conformation (Figure 3.18). Such novel compound may 




open up the possible new class of amino acid-based MOF for further 















Cone Partial cone 1,3-alternate 1.2-alternate 
Figure 3.18 The conformation of calix[4]arenes.
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3.4.2 Results and Discussion 
3.4.2.1 Syntheses 
No new ligand is reported in this subchapter. Compound 3-8 was 
prepared in situ using Method I (Section 1.1.2.3), without separating the 
preformed ligand (Scheme 3.4). The obtained yield is moderate, which is ca. 
60 %.  


















3-b 3-8  




3.4.2.2 Crystal Structures of [Cu(YNap)(H2O)]·0.75H2O·0.25MeOH, 3-8 
3-8 cystallizes in space group I4 with one molecule of C20H17NO5Cu, 
two water molecules of three-quarters occupancy and one methanol of quarter 
occupancy. The base comprises of tridentate [ONO] Schiff base and an aqua 
ligand attains the coplanar conformation of the Cu(II) center. It is noteworthy 
that the axial site of the Cu(II) unit is completed by the tyrosine hydroxyl 
group with the Cu1–O4 at 2.480(2) Å, resulting in a square pyramidal 
geometry with structural indices η146 = 0.06. Such bond length is comparable 





 The Cu(II) ion is ca. 0.162 
Å displaced from the basal plane toward the phenol –OH.  
Interestingly, the [CuONO] core plane is bent toward two tyrosine 
phenol side chains with interplanar angles of 56.90° and 58.19° respectively. 
This forms a calixarene-resembled tetramer with a methanol and water 
molecule trapped inside the channel, and another water molecule located 
outside (Figure 3.19a). The dimension of the bowl-like structure is 
summarized in Figure 3.19d. The bigger upper rim (16.1 Å x 16.1 Å) consists 
of the naphthalene rings whereas the smaller lower rim (7.5 Å x 7.5 Å) is 
made of four uncoordinated carboxylate O3. The height (8 Å) is measured 
from the top of the naphthalene ring to the bottom plane which consists of four 
O3. From the top view of the calixarene-like tetramer, there is a smaller cavity 
consisting of tyrosine side chain (9 Å x 9 Å) (The dimension of the cavity is 
measured based on centroid-centroid distance of the corresponding aromatic 
rings). The calculated void volume of 3-8 is 16.3 %. 




These tetramers are interconnected with each other through medium H-
bond of aqua ligand, phenolate O and tyrosine side chain O4–H4AO3i 3.23, 
O4–H4AO5i 3.23, O5–H6OO2ii 2.64 and O5–H5OO1iii 2.69 Å; 
symmetry codes (i) -y+1,x,z; (ii) -x+3/2,-y+3/2,z-1/2; (iii) -x+3/2,-
y+3/2,z+1/2) (Figure 3.19b, Table 3.21). Along with this, there is an aromatic 
stacking between naphthalene ring C1C2C3C4C10 and metal-chelate ring 
C13CuN1O2C12, with centroid-centroid distance of 3.658 Å. Viewing along a 
axis, there are two different channels which contain only water molecules and 
a mixture of water and methanol arranged in an alternating pattern (Figure 
3.19c).  
Table 3.20 Selected bond lengths [Å] and angles [°] for 3-8. 
Cu1-N1 1.922(2)  Cu1-O1 1.905(2) 
Cu1-O5 1.941(2)  Cu1-O2 1.947(3) 
Cu1-O4 2.480(2)         
O1-Cu1-O5 90.64(10)  N1-Cu1-O5 168.00(13) 
O1-Cu1-O2 171.48(10)  N1-Cu1-O2 84.84(11) 
O5-Cu1-O2 89.02(10)    
 
Table 3.19 Hydrogen bond parameters for 3-8.
a 
D─H d(HA)/Å d(DA)/Å <DHA/˚ 
O4─H4AO3i 2.64 3.228(4) 129.4 
O4─H4AO5i 2.47 3.232(4) 153.9 
O5─H6OO2ii 1.91(3) 2.639(3)  143(4) 
O5─H5OO1iii 1.846(10) 2.684(3) 168(4)  
a
























Figure 3.19 (a) A perspective view of 3-8 in crystal lattice. All hydrogen 
atoms except of phenol side chain are omitted. The apical position of the 
Cu(II) center is occupied by phenol –OH of tyrosine. Each Cu(II) core plan is 
bent towards two tyrosine side chains and form a calixarene-like tetramer. (b) 
Intermolecular H-bond interaction in 3-8 view along c axis. The inset zooms 
in the interaction site for clearer picture. The largest sphere that can fit within 
the channel is indicated in yellow. (c) Two different channels are arranged in 
an alternating pattern view along a axis. (d) The schematic diagram 
summarizes the dimension of the calixarene-like tetramer from side view 
(left) and top view (right). 
 




3.4.2.3 TGA and Powder XRD Analysis of 3-8 
3-8 was anticipated to have potential use in gas storage or host-guest 
reaction, owing to its high porosity structure. For such application, it is 
desirable to remove the captured solvent without disrupting the framework. 
Thus, it is essential to monitor the stability of the framework using TGA and 
powder XRD analysis. 
In TGA profile, 3-8 shows the lost of solvent molecules from 140‒180 
˚C (observed: 4.9%; calculated: 4.9%). This is followed by second step of 
weight loss, corresponding to the aqua ligand (observed: 3.2%; calculated: 
4.1%). The complex is decomposed after the removal of aqua ligands, 
suggesting that these ligands may be important in structural stabilization. 
Next, the compound was heat treated under vacuum to remove the solvent but 
not aqua ligands. This is monitored with TGA analysis (Figure 3.20). 
Unfortunately, the powder XRD results before and after solvent removal 
shows slightly different pattern (Figure 3.21). This may suggest that 3-8 is 
susceptible to the conventional thermal activation and the framework has been 
















Figure 3.20 TGA profile of 3-8 (a) before and (b) after removal of solvent 
molecules. 





Figure 3.21 Powder XRD patterns of 3-8 before and after heat treatment 
show the collapse of the framework. 
 
3.4.2.4 Spectroscopic Studies 
The IR result of 3-8 was tabulated in Table 3.22. The difference 
between νasym(COO) and νsym(COO) is >270 cm
-1
, assignable to the terminal 
coordination mode of the carboxylate, agrees well with the XRD result.
155-156 
 
Table 3.20 Selected IR absorption bands (cm
-1
) of 3-8. 











3-8 3123 2920 1628 1513 1358 1245 
  































The tetrameric state of 3-8 does not retained well in solution, as 
depicted by the ESI-MS, with only 10 % abundance found. Instead, the 
dominant peak is attributable to the dimeric [2CuYNap + Na]
+
, showing the 
dissociation of 3-8 (Figure 3.22). 
3.4.3 Summary and Conclusions 
 A novel calixarene-resembled tetramer, 3-8 was obtained by reacting 
L-tyrosine Schiff base with Cu(II) in situ. Each monomer was connected via a 
rare coordination interaction of protonated phenol ─OH of tyrosine side chain 
and Cu(II) center. The tetramers are further stabilized by extension H-bond 
network, giving rise to an alternating channels with different solvent 
molecules trapped inside. Such MOF is highly potential for gas storage or 
host-guest reaction. However, attempt to remove the solvent without 
disrupting the framework was failed. Different approach of guest-removal 
under mild condition will be the future direction. More suggestion will be 















E)   Experimental 




3.5 Part E 
3.5.1 Materials and Physical Methods 
All syntheses were carried out without taking precaution to exclude air 
or moisture. The chemicals were obtained from commercial sources and used 
as received. The solvents used were of reagent grade. NMR spectra were 
recorded with Bruker AMX 500 spectrometer by using DMSO (2.50 ppm in 
1
H and 39.5 ppm in 
13
C NMR) for 3-a and CD3OH (3.31 ppm in 
1
H and 49.0 
ppm in 
13
C NMR) for other ligands. Infrared spectra (4000-400 cm
-1
) were 
recorded on Perkin-Elmer 1600 FTIR spectrophotometer with KBr pellets. 
The electronic transmittance spectra were recorded on Shimadzu UV-2450 in 
MeOH. Electrospray ionization mass spectra (ESI-MS) were measured on a 
Finnigan MAT 731 LCQ spectrometer using syringe pump method. The peak 
identification was based on m/z values and isotopic matching patterns. C, H, N 
elemental analyses were performed on Perkin-Elmer PE 2400 elemental 
analyzer in the Micro Analytical Laboratory, Department of Chemistry, 
National University of Singapore. Water and solvent molecules present in the 
compounds were determined using a SDT 2960 TGA Thermal Analyzer with 
a heating rate of 10 °C per min. Variable temperature magnetic properties 
were measured with SQUID, Quantum Design magnetometer in Institute of 
Materials Research and Engineering (IMRE); whereas the room temperature 
magnetic susceptibility measurement were analyzed using Johnson-Mathey 
Magnetic Susceptibility balance. The calculation of effective magnetic 
moment was corrected for diamagnetism using Pascal‘s constants.  




The X-ray data was collected and analyzed by CMMAC staffs, with 
help from Prof. Koh Lip Lin and Dr. Xue Feng.  The data was collected using 
a Bruker-AXS SMART APEX CCD single-crystal diffractometer with a Mo-
Kα sealed tube at low temperature. The software SMART was used for 
collecting frames of data, indexing reflection lists and determination of lattice 
parameters;
179
 SAINT for frames integration and scaling; and SADABS for 
empirical absorption correction.
180
 All structures were solved by direct 
methods and refined on |F|
2
 by full-matrix least squares using SHELXTL.
181
  
Unless otherwise stated, all non-hydrogen atoms were refined 
anisotropically whereas hydrogen atoms were placed in their ideal positions 
and refined isotropically. No hydrogen atom was added to O7W in 3-5, as well 
as O1W and O2W in 3-8. All the solvent molecules in 3-8 were not refined 
anisotropically. In 3-6, the DMSO ligated to Ni2 and two free DMSO are 
disordered. Restraints in bond lengths were applied to the disordered parts. In 
3-7, one phenol ring of tyrosine, Na2 and CH2Cl2 are disordered. The THF and 
water are in two different parts around same location and is linked to the 
disorder of the phenol ring. The crystallographic data is tabulated in Appendix 
I (Table A2).  
3.5.2  Preparation of Ligands 
(Chapter 3.1 and 3.4) 
N-(2-hydroxy-1-naphthalidene)-L-tryptophan (H2WNap; 3-a) 
L-tryptophan (612 mg, 3 mmol) and 2-hydroxy-1-naphthaldehyde (517 mg, 3 
mmol) were dissolved in MeOH (140 mL) and refluxed at 65 °C for 45 min. 
The yellow solution was then cooled to r.t., filtered and concentrated under 




partial vacuum. CH2Cl2 was added to the yellow residue to give yellow 
powder. Yield: 1.04 g (2.9 mmol, 96%). Decomposition point: 206 °C. 
C22H18N2O3·0.05MeOH (359.99): calcd. C 73.6, H 5.1, N 7.8, found C 73.7, H 
5.6, N 8.3. 
1
H NMR (500 MHz, DMSO, ppm): 3.38 (m, 2H, H14), 4.72 (m, 1H, 
H12), 6.69 (d, J = 9.5 Hz, 1H, H8), 6.98 (m, 1H, H20), 7.06 (m, 1H, H19), 7.16 
(m, 2H, H15
 
& H6), 7.33 (m, 2H, H21
 
& H7), 7.56 (d, J = 8.2 Hz, 1H, H5), 7.59 
(d, J = 8.2 Hz, 1H, H3), 7.69 (m, 2H, H18
 
& H4), 8.78 (s, 1H, H11), 10.90 (s, 
1H, NH). 
13
C NMR (125 MHz, DMSO, ppm):  29.4 (C14), 64.1 (C12), 105.8 
(C16), 108.7 (C1), 111.3 (C21), 118.3 (C3), 118.4 (C18), 118.5 (C20), 121.0 (C19), 
122. 2 (C15), 124.2 (C6), 125.1 (C17), 125.3 (C8), 127.0 (C7), 127.7 (C10), 128.8 
(C5), 134.1 (C9), 136.1 (C22), 136.3 (C4), 158.4 (C11), 172.0 (C2), 176.3 (C13).  
N-(2-hydroxy-1-naphthalidene)-L-tyrosine (Na2YNap; 3-b) 
L-tyrosine (180 mg, 1 mmol) and NaOH (80 mg, 2 mmol) were dissolved in 
MeOH (50 mL). 2-hydroxy-1-naphthaldehyde (172 mg, 1 mmol) was then 
added. The solution was refluxed at 65 °C for 45 min, filtered and 
concentrated in vacuo. Excess acetone was added to precipitate the yellow 
powder of 3-b. The product was collected and dried in vacuum. The Schiff 
base is hygroscopic and hence, kept in dessicator for further analysis. Yield: 
256 mg (0.6 mmol, 59%). Decomposition point: 250 °C. C20H15NNa2O4·3H2O 
(433.36): calcd. C 55.4, H 4.9, N 3.2, found C 54.1, H 4.8, N 3.4. 
1
H NMR 
(500 MHz, CD3OH, ppm): 3.16 (m, 2H, H14), 4.24 (m, 1H, H12), 6.67 (m, 2H, 
H19
 
& H17), 6.73 (d, J = 9.5 Hz, 1H, H3), 7.08 (m, 2H, H20
 
& H16), 7.13 (m, 1H, 
H6), 7.29 (m, 1H, H7), 7.50 (d, J = 8.2 Hz, 1H, H8), 7.51 (d, J = 8.2 Hz, 1H, 
H5), 7.65 (d, 1H, J = 9.5 Hz, H4), 8.19 (s, 1H, H11). 
13
C NMR (125 MHz, 




CD3OH, ppm):  41.6 (C14), 69.0 (C12), 106.8 (C17), 116.7 (C19), 117.1 (C3), 
119.1 (C16), 123.3 (C20), 126.8 (C6), 127.0 (C7), 128.3 (C8), 129.2 (C5), 129.9 
(C4), 131.3 (C15), 131.9 (C10), 136.1 (C1), 139.5 (C9), 158.1 (C11), 170.4 (C2), 
176.3 (C18), 181.4 (C13). 
(Chapter 3.2) 
N-(2-hydroxy-3-methoxy-salicylidene)-L-tyrosine (Na2YVan; 3-c) 
To a solution of L-tyrosine (180 mg, 1 mmol) with NaOH (80 mg, 2 mmol) in 
50mL methanol, o-vaniline (152 mg, 1 mmol) was added. The reaction 
mixture was stirred at 65 °C for 45 minutes, then filtered and concentrated on 
rotovap. Acetone was added to precipitate out the yellow Schiff base which 
was then left to dry under vacuum prior for collection. The ligand is 
hygroscopic and kept in dessicator for further analysis. Yield: 289 mg (0.7 
mmol, 70%). Decomposition point: 180 °C. C17H15NNa2O5·3H2O (413.33): 
calcd. C 49.4, H 5.1, N 3.4, found C 49.3, H 5.2, N 3.4. 
1
H NMR (500 MHz, 
CD3OH, ppm): 2.79 (m, 2H, H10), 3.34 (s, 3H, H17), 4.05 (m, 1H, H8), 6.35 (m, 
1H, H5), 6.56 (m, 3H, H4, H12& H16), 6.81 (m, 1H, H6), 6.88 (m, 2H, H13& 
H15), 7.50 (s, 1H, H7). 
13
C NMR (125 MHz, CD3OH, ppm):  41.6 (C10), 56.0 
(C17), 71.6 (C8), 114.3 (C15), 114.9 (C13), 116.3 (C4), 118.7 (C6), 118.7 (C5), 
125.3 (C1), 125.8 (C16), 131.2 (C11), 131.5 (C12), 152.6 (C2), 163.7 (C3), 165.3 
(C7), 166.8 (C14), 176.6 (C9).  
N-(2-hydroxy-3-methoxy-salicylidene)-L-histidine (NaHHVan; 3-d) 
3-d ligand was prepared similar to 3-c (equimolar of L-histidine and NaOH) 
using EtOH as solvent. The yellow crystals of H2HVan were obtained by 
adding glacial acetic acid (0.1 ml) to neutralize the ligands. The remaining 




solution was then rotovap and kept in air.
15
 After 1 day, yellow crystals 
suitable for X-ray analysis appeared. Yield (as sodium salt): 288 mg (0.85 
mmol, 85%). Decomposition point: 175 °C. C14H14N3NaO4·1.5H2O (338.29): 
calcd. C 49.7, H 50, N 12.4, found C 49.9, H 5.1, N 12.5. 
1
H NMR (500 MHz, 
CD3OH, ppm): 3.23 (m, 2H, H10), 3.80 (s, 3H, H14), 4.24 (m, 1H, H8), 6.49 (t, 
J = 7.6 Hz, 1H, H5), 6.72 (d, J = 7.6 Hz, 1H, H4), 6.82 (s, 1H, H13), 6.86 (d, J = 
7.6 Hz, 1H, H6), 7.56 (s, 1H, H12), 7.95 (s, 1H, H7). 
13
C NMR (125 MHz, 
CD3OH, ppm): 32.8 (C10), 56.1 (C14), 70.4 (C8), 115.2 (C5), 115.6 (C6), 125.4 
(C4), 120.1 (C1), 135.6 (C11), 136.2 (C12), 149.3 (C2), 151.9 (C3), 165.9 (C7), 
176.3 (C9).  
N-(2-hydroxy-3-methoxy-salicylidene)-L-tryptophan (NaHWVan; 3-e) 
3-e was prepared similar to 3-c, except that diethyl ether was used to 
precipitate the product instead of acetone. Yield: 289 mg (0.7 mmol, 73%). 
Decomposition point: 110 °C.  C19H17N2NaO4·2H2O·0.5H2O (412.39): calcd. 
C 56.8, H 5.6, N 6.8, found C 56.3, H 4.8, N 6.9. 
1
H NMR (500 MHz, 
CD3OH, ppm): 3.38 (m, 2H, H10), 3.78 (s, 3H, H19), 4.23 (m, 1H, H8), 6.32 (t, 
J = 7.8 Hz, 1H, H5), 6.41 (m, 1H, H4), 6.78 (m, 1H, H6), 6.99 (m, 2H, H11
 
& 
H15), 7.07 (m, 1H, H16), 7.31 (m, 1H, H17), 7.41 (s, 1H, H7), 7.68 (m, 1H, H14). 
13
C NMR (125 MHz, CD3OH, ppm):  32.1 (C10), 56.1 (C19), 69.9 (C8), 111.4 
(C12), 112.3 (C17), 114.4 (C3), 115.1 (C6), 116.4 (C1), 119.5 (C14), 120.0 (C15), 
122.5 (C16), 125.4 (C11), 125.6 (C4), 128.5 (C13), 138.2 (C18), 152.7 (C2), 165.2 
(C7), 166.6 (C3), 176.7 (C9).  
 







To a clear solution of 3-a (72 mg, 0.2 mmol) in DMSO: EtOH (1:3) was added 
an aqueous solution of Cu(NO3)2·3H2O (24 mg, 0.1 mmol) and the mixture 
was stirred for 3 h. The resulting green solution was filtered and diffused 
slowly into water through a buffer ethanol solution to furnish green needle 
crystals after a week. Yield: 37 mg (0.04 mmol, 21%). C44H37Cu2N4O8·2H2O 
(912.91): calcd. C 57.9, H 4.5, N 6.1, found C 58.3, H 4.3, N 6.1. μeff (298 K) 
= 1.62 B.M. ESI-MS: [2Cu(WNap) + Na]
+ 
(m/z 863.0, 100 %). TGA: weight 
loss (%) calcd. for 2 lattice H2O: 4.1, found 4.5; calcd. for 2 coordinated H2O: 
4.1, found 3.1. 
[Ni(WNap)(H2O)2(MeOH)]·H2O, 3-2 
Compound 3-2 was synthesized similarly to 3-1, except with equimolar of 
Ni(OAc)2·4H2O (124 mg, 0.5 mmol) and 3-a (180 mg, 0.5 mmol). The 
resulting light green precipitate was washed with ethanol, acetone and diethyl 
ether. Layering the solution of the green precipitate in DMSO: EtOH with 
water yielded plate crystals after one week. Yield: 179 mg (0.4 mmol, 74%). 
C23H24NiN2O6 (483.16) (loss of lattice water upon dried): calcd. C 57.2, H 5.0, 
N 5.8, found C 57.3, H 5.0, N 6.1. μeff (298 K) =  3.46 B.M. ESI-MS: 
[2Ni(WNap) + Na]
+ 
(m/z 851.1, 100 %). TGA: weight loss (%) calcd. for 
MeOH: 6.6, found 6.3; calcd. for 1 aqua ligand: 3.7, found 4.9, calcd. for 
another aqua ligand: 3.7, found 3.6. 
 




 [Ni(YNap)(H2O)2(MeOH)]·1.5H2O, 3-3 
To a warm solution of L-tyrosine (360 mg, 2 mmol) and NaOH (160 mg, 4 
mmol) in water (100 mL) was added drop wise with 2-hydroxy-1-
naphthaldehyde (340 mg, 2 mmol) in MeOH (15 mL) and heated at 55-60 °C 
for 30 min. A solution of Ni(OAc)2·4H2O (995 mg, 4 mmol) in water (10 mL) 
was added to the ligand formed in-situ in the above mixture and stirred for 
overnight. The resulting dark green precipitate was then filtered, washed and 
vacuum dried. Green plate crystals suitable for X-ray diffraction were 
obtained after two weeks by layering the saturated MeOH solution of the 
sample with water. Yield: 351 mg (0.7 mmol, 36%). C21H23NNiO7·1.5H2O  
(487.14): calcd. C 51.8, H 5.4, N 2.9, found C 51.7, H 5.1, N 3.0. μeff (298 K) 
=  3.01 B.M. ESI-MS: [2Ni(YNap) + Na]
+ 
(m/z 805.1, 100 %). TGA: weight 
loss (%) calcd. for 1.5 lattice H2O, 1 coordinated MeOH and 1 aqua ligand: 
15.8, found 14.9; calcd. for 1 aqua ligand: 3.7, found 3.3. 
(Chapter 3.2) 
[Ni4(YVan)4(H2O)3(MeOH)]·H2O·6MeOH, 3-4 
To 10 mL methanolic solution containing 3-c (207 mg, 0.5mmol), 5mL 
aqueous solution containing Ni(OAc)2·4H2O (124 mg, 0.5mmol) was added, 
under stirring. The solution was refluxed for 3 h at 60 ºC and filtered. Dark 
green block crystals suitable for X-ray diffraction were obtained from the 
filtrate after several days. Yield: 422 mg (0.25 mmol, 50 %). 
C69H70N4Ni4O24·H2O·3MeOH (1688.22) (loss of 3MeOH upon dried): calcd. 
C 51.2, H 5.0, N, 3.3, found C 50.9, H 4.7, N, 3.6. μeff (298 K) = 7.15 B.M. 
ESI-MS: [NiYVan + OAc]
- 
(m/z 430.0, 55 %), [2NiYVan]
-
 (m/z 741.1, 90 %),  






 (m/z 1114.0, 100 %), [4NiYVan]
-
 (m/z 1484.9, 30 %). TGA: 
weight loss (%) calcd. for 1 lattice H2O + 3MeOH: 6.8, found 7.3; calcd. for 3 
aqua ligands + 1 coordinated MeOH: 5.1, found 5.1. 
[Ni3(HVan)2(OAc)2(H2O)2]·H2O·0.5MeOH·0.5IPA, 3-5 
L-histidine (78 mg, 0.5 mmol) was dissolved in a solvent mixture of methanol 
and water (1:1) (16.5 ml) and o-vanillin (76 mg, 0.5 mmol) was added to it. 
After stirring for 0.5 h at r.t., Ni(OAc)2.4H2O (124 mg, 0.5 mmol) was added 
to the solution, and the mixture was again stirred overnight at r.t. After 
filtration, the solution was layered with IPA, and dark green crystals suitable 
for X-ray analysis appeared after a week. Yield: 87 mg (0.09 mmol, 17 %). 
C32H38N6Ni3O14·H2O·0.5MeOH·0.5IPA (986.84): calcd. C 41.4, H 4.7, N 8.5, 









 (m/z 713.0, 100 %). TGA: 
weight loss (%) calcd. for 0.5MeOH + 0.5IPA + 3H2O: 11.7, found 13.1; 
calcd. for Ni(OAc)2: 17.9, found 18.5. 
 [Ni4(WVan)4(DMSO)2(H2O)2]·4DMSO·3EtOH, 3-6 
L-Tryptophan (204 mg, 1 mmol) was dissolved in a solvent mixture of 
methanol and water (1:2) (10ml) and stirred for 0.5 h at 60 C. Likewise, o-
vanillin (152 mg, 1 mmol) was dissolved in the same solvent (10ml) and 
added to the tryptophan solution. The mixture was stirred for 3 h at 60 C. 
After that, Ni(OAc)2·4H2O (249 mg, 1 mmol) dissolved in 10ml of the solvent 
was added to the solution, and the mixture was again stirred overnight at 60 C. 
The green precipitate obtained was vacuum dried. Green crystals suitable for 
X-ray analysis appeared a week after layering the dissolved powder in DMSO 




with an equal amount of ethanol. Yield: C80H81N8Ni4O20S2·4DMSO·3EtOH 
(2224.18): calcd. C 50.8, H, 5.6; N, 5.0, found C 48.7, H 5.3, N, 4.8. μeff (298 
K) = 7.01 B.M. ESI-MS: [2NiWVan + MeOH]
+ 
(m/z 820.8, 40 %), [2NiWVan 




 (m/z 874.8, 100 %). TGA: weight loss (%) calcd. for 
3EtOH: 6.2, found 5.8; calcd. for 6DMSO+ 2 aqua ligands: 22.0, found 20.7. 
(Chapter 3.3) 
{Na[Fe(YNO2)2]·0.5H2O·0.5THF·CH2Cl2}n, 3-7 
A mixture of L-tyrosine (0.4 mmol) and NaOH (72 mg, 0.8 mmol) in 20 mL of 
THF: H2O (1:1) was heated until dissolved. 2-hydroxy-5-nitro benzaldehyde 
(67 mg, 0.4 mmol) in THF was added and reflux for another 0.5 h. 
Fe(NO3)3·9H2O (68 mg, 0.2 mmol) was then added to the solution and 
refluxed overnight. The red solution was filtered on the next day and subjected 
to rotovap until dry. The red and sticky stain was washed repeatedly with THF 
and precipitated using CH2Cl2. The red powder was vacuum dried. Red 
diamond-like crystals were obtained on the next day by layering the dissolved 
powder in THF with CH2Cl2. Yield (powder): 117 mg (0.14 mmol, 69 %). 
C32H24FeN4NaO12·2H2O·0.1THF·0.7CH2Cl2 (838.08): calcd. C 47.4, H 3.6, N 
6.7, Cl 5.9, found C 47.3, H 3.5, N, 6.7, Cl 5.8. ESI-MS: [Fe(YNO2)2]
- 
(m/z 
712.1, 100 %). 
 (Chapter 3.4) 
[Cu(YNap)(H2O)]·0.75H2O·0.25MeOH, 3-8 
To a methanolic aqueous warm solution of L-tyrosine (181 mg, 1 mmol), 
NaOH (80 mg, 2 mmol) and 2-hydroxy-1-naphthaldehyde (172 mg, 1 mmol), 
Cu(OAc)2.2H2O (200 mg, 1 mmol) in minimal water was added drop wise. 




The mixture was heated overnight at 58 °C. The green precipitate was filtered 
off, washed with water, cold ethanol and diethyl ether and dried under vacuum 
prior for collection. The precipitates were dissolved in hot methanol and 
filtered to give a dark green solution. The saturated solution in methanol was 
diffused slowly into water through a buffer methanol layer, furnished green 
needle crystals after days. Yield: 262 mg (0.6 mmol, 60 %). 
C20H17CuO5N·0.25MeOH·0.75H2O (436.42): calcd. C 55.7, H 4.5, N 3.2, 
found C 57.3, H 4.3, N 3.2. μeff (298 K) = 1.54 B.M. ESI-MS: [2CuYNap + 
Na]
+
 (m/z 815.3, 100 %), [3CuYNap + Na]
+
 (m/z 1210.8, 25 %), [4CuYNap + 
Na]
+
 (m/z 1606.7, 10 %). TGA: weight loss (%) calcd. for 0.25 MeOH + 0.75 
H2O: 4.9, found 4.9; calcd. for 1H2O: 4.1, found 3.2. 
 

























4.1  From Small Molecules to Macromolecules: Metalloprotein Design 
 Over the past hundred years, innumerable structural and reactivity 
studies have been collected by chemists on small and middle sized molecules. 
The introduction of supramolecular chemistry in 1970s‘ has apparently 
merged the multidiscipline fields of chemistry, biology, physics, engineering, 
etc.
15
 Today, it should be stressed that that is no clear-cut division between 
those fields. In fact, such interdisciplinary overlay substantiates a better 
achievement in science. 
Mimicking the macromolecules assemblies with metal-amino acid 
Schiff bases (Part I) has simplified the complicated structural system for 
valuable insights. Furthermore, it allows the engineering of intermolecular 
interaction and mutual recognition in a desirable manner. To further expand 
our knowledge beyond the molecular level, Part II of this thesis will focus on 
the design and engineering of metalloprotein.  
Similarly, the metalloprotein employs amino acids as building blocks. 
Yet it provides a more direct model to the biological systems. This enables us 
to closely mimic the native counterpart without significant structural 
compromise. The subsequent sections highlight a few metalloproteins of 
interest in this project. 
 4.2 Metals in Biological Systems 
 In view of metal in the biological system, it involves a variety of 
groups across the periodic table, ranging from alkali metals to transition 




elements. Hence, it is not surprising that almost half of all proteins found in 
the nature are metalloproteins.
231-232
 
The metals address prominent roles in the energy conversion cycle, 
structural function (as cofactors), catalysis, etc.
232
 Manganese (Mn), for 
example, is an indispensable metal found in the oxygen-evolving complex 
(OEC) of photosystem II (PS II).
233
 The reason why nature employs the 
Mn4CaOx cluster in OEC remains elusive (Figure 4.1a). Some studies propose 
that its abundance and rich redox chemistry with several accessible oxidation 
states could be the main factors.
234
 Iron is another transition element that 
found most abundantly in the human body. Haem, the iron-porphyrin group, is 
an essential prosthetic group found in the oxygen carrier system, electron 
transport chain, as well as cytochrome p450 superfamily (Figure 4.1b). Iron-
sulfur clusters (FenSn) is another class of non-haem iron proteins found in the 
electron transfer (ET) process (Figure 4.1c).
235-236
 The Part II of the thesis will 
focus on another important ET protein, viz. copper protein, which will be 
reviewed in the next sections. 
Apart from protein, the interaction of metal ions with nucleic acid is 
also highly important. Mono- and divalent cations, particularly magnesium, 
are important in stabilizing the polyanionic nucleic acids during folding.
232
 



























Figure 4.1 (a) The structural model of Mn4CaOx cluster in PSII.
237
 (b) Haem 
B, the most abundant haem found in myoglobin and hemoglobin for oxygen 
carrier system. (c) [Fe4S4] cluster found in the high potential iron protein. 
 
4.2.1 Copper Protein 
Copper is one of the essential metals broadly incorporated in the living 
systems for specific metabolic functioning. Generally, there are three types of 
copper proteins classified based on spectroscopic and functional properties, 
which are type 1 (T1), type 2 (T2) and type 3 (T3). Two additional classes 
were discovered later, i.e. CuA and CuZ (Table 4.1).
238-240
  
These proteins are usually chromatic due to their characteristic 
structural features. The blue T1 and purple CuA are also termed as 
‗cupredoxin‘, which means the copper-containing redox proteins. As the name 
implies, they are prevalently involved in crucial ET processes, including 
aerobic respiration in cytochrome c oxidase (CcO), anaerobic respiration in 
nitrous oxide reductase (N2OR) and nitrite reduction in nitrite reductase (NIR). 
In comparison, the red T2 protein is usually found in the catalytic site. 
Recently, a new class of cupredoxin called ‗type zero‘ was introduced by Gray 




and coworkers, which shows marked similarities to T1 but with T2 absorption 
pattern.
239
 This project will focus on T1 azurin (Az) and a biosynthetic protein 
of CuA protein, viz. CuA azurin (CuA Az). 
 
 
Table 4.1 General classification of copper proteins.
238  
Type Mononuclear Dinuclear Tetranuclear 
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4.2.1.1 Blue Copper Protein: Azurin 
Az is a T1 copper protein found in the periplasmic fraction of 
denitrifying bacteria, Pseudomonas Aeruginosa. It is a small mononuclear 
protein (128 amino acids; 14.6 kDa), built up of eight β strands arranged in a 
Greek topology (Figure 4.2). Az is one of the most prominent cupredoxin 
members being well studied over decades. This is primarily due to its pivotal 
role in facilitating both intra- and inter-protein electron transfers, as well as its 
ease of crystallization to provide valuable structural information.
239-240
 
Similar to other cupredoxins, Az contains a copper ion which is 
strongly ligated to Cys112, His117 and His46. Its axial position is occupied by 
a weakly bound Met121 which draws the metal ion about 13pm above the 
equatorial plane. There is an additional weak ionic interaction with the Gly45 
carbonyl to give a distorted trigonal bipyramidal geometry. This makes the Az 
structurally discernible from other cupredoxins (Figure 4.2).
238,242-245 
The 
geometry allows low reorganization energy (0.6-0.8 eV) for redox 
interconversion as it is a compromise between the preferred tetragonal of 
Cu(II) and tetrahedral geometry of Cu(I).
246
 
T1 cupredoxin confers several key spectroscopic features. Its 
characteristic intense blue color has been attributed to the highly covalent 
nature of Cu–S bond (Cys112 in Az), which results in an intense charge 
transfer (CT) band at 600 nm (ε = 3000-6000 M-1cm-1).238,242-245 Another 
characteristic property that resulted from this strong covalent interaction is the 
axial EPR spectrum with narrow parallel hyperfine coupling constant (g║= 






 In addition, T1 cupredoxin has 




remarkably higher redox potential as compared to the normal aqua copper 
complexes (E˚ = 150 mV). For example, E˚ for Az at pH4.0 is about 341 ± 3 
mV vs normal hydrogen electrode (NHE).
249
 This intriguing redox activity has 
sparked great interests in investigating its electrochemistry and structural 
correlation among scientists. 
 
Figure 4.2 Crystal structure of cupredoxin Az (PDB 4AZU)
250 
of oxidized 
Pseudomonas Aeruginosa. His117 is located at the surface, whereas His46 is 
buried in the hydrophobic patch consists of Met13, Val43, Met44, Phe114 and 
Pro115 (indicated as semi-transparent space-filling model). The inset shows 
the copper binding site of the Az. 
4.2.1.2 Purple CuA Azurin 
Purple CuA is a class of copper protein being discovered later after T1, 
T2 and T3 proteins. It is found in the terminal position of respiratory chain in 
cytochrome c oxidase (CcO)
251-252 
and nitrous oxide reductase (N2OR),
253-254
 
and as terminal oxidase in sulfolobus acidocaldarius (SoxH).
260
 The CuA is a 
binuclear complex with an unpaired electron delocalized between two copper 




centers. The mixed-valent Cu(1.5)Cu(1.5) are bridged by two Cys ligands in 
a diamond core pattern,
252,257-259
 as shown in Figure 4.3. This rigid structure is 
proposed to endow the protein with lower reorganization energy.
260-262
  
 As its name implies, the purple CuA displays distinctive purple color, 
assignable to the Scys → Cu CT band in 480 and 530 nm.
263
 Furthermore, its 
binuclear copper center also exhibits a characteristic seven-line hyperfine 
structure in EPR. The redox potential for CuA has been reported in the range of 
80-220 mV, attributed to the Cu(1.5)Cu(1.5)→Cu(1)Cu(1) couple. No studies 
have been reported for Cu(+2)Cu(+2)→Cu(1.5)Cu(1.5) so far.263-264 
Due to the fact that the CuA typically occurs in multi-domain proteins, 
its analysis is substantially obscured by haem spectral interference. As such, 
numerous studies have been focus on truncated fragments
265-270
 as well as 
synthetic models, including small inorganic compounds
271-274




In 1996, Hay et al. had successfully constructed biosynthetic CuA 
model from T1 blue Az, namely purple CuA azurin.
278 
This is done by loop-
directed mutagenesis, which replaces the Az ligand loop (CTFPGHSALM) 
with the corresponding P. denitrificans COX binding loop (CSELCGINHA). 
This engineered CuA Az displays similar spectroscopy properties as the native 









Figure 4.3 The mixed-valent Cu(1.5)Cu(1.5) center in a diamond core 
pattern of CuA Az.
280
 
4.3 Engineering Nature Structurally and Functionally 
 The metalloprotein design can be conducted using three different 
methodologies, which are I) de novo design (design ‗from scratch‘), II) design 
from native protein scaffold and III) unnatural protein design.
231
 While the de 
novo design suffers from the limited available scaffolds, making use of the 
available native proteins has brought much success in this field. The natural 
protein scaffolds have been proven to be more amenable, stable and easier to 
crystallize. In addition, it was found that similar scaffolds have been utilized 
repeatedly by proteins of different functions. With the available technologies 
such as site-directed mutagenesis (mutation created at a defined site) and loop-
directed mutagenesis (mutation by replacing the metal-binding loop), a myriad 








For example, nitrite oxide reductase (NOR) is a denitrification 
metalloenzyme that poses certain difficulties in obtaining optimal yield and 
crystal structure. Engineering its active site with the structurally homologous 
haem-copper oxidases (HCOs) provides the informative XRD structural 




However, the native metalloprotein contains only 20 amino acids. To 
achieve beyond what is available in the nature, the third methodology allows 
the incorporation of unnatural amino acid into protein.
283
 Hill and co-workers 
have replaced a conserved trysoine (Tyr10 in Pyrococcus furiosis) close to 
metal factor in rubredoxin with Tyr analogues contain –H, –NO2, –CN and –F. 
The modification shows that the electronic communication between this Tyr 




4.4 Potential Application of Redox Protein 
Thanks to the advanced biotechnology, enzymes have gradually 
received much industrial interest. The advantages of biocatalysts such as 
environmentally benign, high stereo- and enantioselectivity have endowed 
them with a unique position in pharmaceutical and agrochemical industries.
 280
   
Particularly, the ability of the redox enzymes to generate small power 
output from biologically derived fuels (eg. glucose and oxygen) has spurred 
intensive efforts to exploit their application as energy-yielding devices.
285-288
 




For instance, Sony Corporation has developed a glucose-powered bio-fuel cell 
(BFC) using multi-copper bilirubin oxidase. This BFC is capable of generating 
high power densities of 1.45 mW/cm
2 
at 0.3 V. However, it requires the 
cellophane membrane as separator between anode and cathode compartments, 
which hinder its miniaturization for implant development.
289
 Later, Gao et al. 
has reported a membraneless BFC using carbon nanotube fibre. It provides 
high specific surface area and overcome the mass transport limitation.
290
 
High-potential laccase is another primary candidate that has been 





 and wastewater 
decontamination.
294-296
 Despite its variety application, the T1 site of this multi-
copper oxidase is particularly interesting for oxygen reduction. Blanford et al. 
has developed a novel strategy for stable attachment of laccase on the 




Nevertheless, the commercialization of redox proteins has been 
notably hindered by several limitations. These include limited enzyme 
availability, stability, optimization of directed electron transfer (DET) kinetics, 
etc.
298 
4.5 Determinants of Redox Properties of Cupredoxins 
The redox potential of cupredoxin can vary greatly, ranging from 200-
1000 mV. The variation is important because different potentials are required 
as driving force to perform different biological processes. Hence, it is of 
compelling reason to decipher the conundrum by site-directed mutagenesis 




studies. Over decades, a few key determinants of the redox properties of 
cupredoxins have been unraveled, which will be discussed in the following 
sections. 
4.5.1  Metal-ligand Interaction 
It has been long known that the mutation in both inner and outer 
coordination spheres of cupredoxins can affect the redox properties 
significantly. For example, the mutation of axial Met121 in Az can tune the 
potential over the range of 300 mV.
238,244-245,298-299
  Another illustrative case 
can be seen from a thorough comparison among the cupredoxins (Figure 4.4). 
Stellacyanine, as the only cupredoxin that is strongly ligated to axial Gln, 
gives the lowest potential among all (E˚ = 184 mV). Similarly, the higher 
potential of plastocyanin and rusticyanin are ascribed to their Met carbonyl 
backbone being pointed further away from the copper centre.
243,300
 It has been 
reasoned that strong metal-axial ligand leads to stabilization of Cu(II) and 
weaken the  Cu–S (Cys) bond, eventually downshifting the redox potential.301 
However, site-directed mutagenesis with natural amino acids has the 
limitation of changing other undesired factors, such as sterics and electronic 
properties. Lu and coworkers have deconvoluted these factors by 
isostructurally replacing Met121 with unnatural norleucine, selenomethionine, 
trifluoromethionine, etc. The results suggest that hydrophobicity of axial 













4.5.2 Hydrophobic Effect 
T1 cupredoxins contain a copper centre embedded in a topologically 
conserved Greek key domain. Interestingly, this protein scaffold is widely 
employed by ~600 different types of proteins, despite their low sequence 
homology. It was proposed that the hydrophobic encapsulation may be 
responsible for their high redox potential. A primary example can be seen 
from the high-potential rusticyanin, which has preponderance hydrophobic 
residues (largely aromatics) around the metal centre. This may bury the copper 








Some studies have shown that hydrophobicity in the secondary 
coordination sphere can exert significant effect as well. Marshall et al. has 
demonstrated that tailoring the hydrophobicity and hydrogen bonding in the 
secondary coordination sphere can tune the potential of Az over 700 mV.
305
 A 
similar study on pseudoazurin (PAZ) has shown that Met16Phe mutation can 
exhibit π-π interaction with the imidazole ring of active site ligand His81 and 
increase the potential by ~60 mV.
306 
Also, Berry et al. has studied a series of 
Phe mutants in secondary coordination sphere of Az.
303
 The data reveals that 
hydrophobicity may only exert small effect on the redox potential. Instead, 
other factors such as H-bonding may have more appreciable influence. 
4.5.3 Hydrogen Bonding Effect 
In Az, most of the H-bond interaction occurs in the ligand loops 
containing His46, Cys112 and His117.
241
 Perturbation of this H-bonding may 
allow Cu(I) to revert more to its preferred geometry, subsequently increasing 
the redox potential.
307 
For example, Asn47 is highly conserved in cupredoxins. As shown in 
Figure 4.5, it forms H-bond to Cys112 and Ser113. Hoitink et al. has shown 
that an Asn47Leu replacement deletes the H-bond and increases the potential 
by 110 mV.
308
 Notably, Asn47 is absent in rusticyanin. Instead, the rusticyanin 
has a corresponding Ser86 which may responsible for its high potential. This 
residue is proposed to strengthen the interaction between two ligand-
containing loops and form different H-bond topology between the protein 
backbone and Cys thiolate.
304,309-310
 Another study done by Dennison and 
coworkers shows that F114Pin Az decreases the potential by 90 mV. The 




downward shift can be attributed to the deleted H-bond between Cys112 and 
Phe114, which increases the electron density on Cys112.
314
 A recent study by 
Marshall et al. has incorporated N47S and F114P individually into the 
combinative Az mutants. These multiple mutants surpass the low and high 
ends of potential from 90 ± 8 to 706 ± 3 mV.
305
 
4.6 Project Aims and Thesis Overview for Part II 
 From the reviews outlined above, it can be seen that T1 Az offers 
interesting redox property for potential bio-inspired devices. Also, the 
synthetic CuA Az is a close model of T1 Az which allows a direct comparison 
between the two classes of cupredoxins. Armed with the previous informative 
studies, it is thus desirable to expand our knowledge on these metalloproteins 
beyond what we have achieved so far.  
A close examination has uncovered that all T1 curepdoxins are actually 
employed an identical redox active center: a mononuclear copper ligated by 
one Cys and two His (Figure 4.2), despite their diverse redox potential. Hence, 
instead of tuning the potential of T1 Az by manipulating the interaction in 
primary coordination sphere, we should extend the investigation to the 
secondary coordination sphere.  
In Chapter 5.1, the engineering of the secondary interaction around His 
ligands in T1 Az and its electrochemical effect will be presented. As an 
extension, we will further combine these mutations with the previous work 
from our group in Chapter 5.2, in order to push the potential of Az to nearing 
1V. This high-potential mutant could be advantageously used for further 
application as viable redox agent. Further comparison with the CuA Az will be 




discussed in Chapter 5.3, to demonstrate if the effect observed in the 
mononuclear T1 Az can be regenerate in the binuclear CuA. 
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5.0 Preface  
 As mentioned in Chapter 4, little studies are conducted on the 
surrounding primary coordination sphere of redox protein, which may be 
insufficient to confer its function. This chapter is about the metalloprotein 
design of T1 azurin (Az) and synthetic CuA azurin (CuA Az), with greater 
emphasis on the role of secondary coordination sphere interaction on the redox 
property. It comprises of four parts. In Chapter 5.1, two new mutations, G9P 
and G116F together with the reported M13F and M44F are presented to 
investigate the secondary effect on the redox potential of T1 Az. Based on the 
results obtained; the high-potential M44F/G116F has been further combined 
with a reported N47S/F114N/M121L in Chapter 5.2. This is to construct a 
nearly 1V Az mutant. Chapter 5.3 will discuss the direct redox comparison 
between T1 and CuA cupredoxin. The N47S and E114P CuA Az, correspond to 
N47S and F114P in T1 Az are compared. All experimental works are 
combined in Chapter 5.4. 
 
 
Figure 5.1 Active sites of T1 Az (left; PDB 4AZU)
250
 and an engineered 
purple CuA Az (right, PDB ID: 1CC3).
280
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5.1 Effect of Altering the Secondary Coordination Sphere around the 
His Ligands in the Cupredoxin Azurin on the Copper Redox Potentials 
5.1.1 Introduction 
 Chapter 4 has addressed a few factors that affect the redox potential of 
redox protein. Nevertheless, such studies do not adequately account for the 
surrounding primary coordination sphere. Investigation of the secondary 
effects on redox potential is more challenging as the effects are more subtle. 
This is evident by a few studies on  T1 cupredoxins,
303,305





Here, the secondary effects on T1 Az will 
be highlighted.  
Rusticyanin is a T1 copper protein with its redox potential much higher 
than Az (680 mV vs. 320 mV). It has been well studied that its high potential 
maybe contributed to its different H-bond network of the ligand loop, as well 
as its relative preponderance hydrophobic residues around the metal center. In 
a recent work, Marshall has the redox potential of Az across the entire range 
of redox potentials seen in native T1 cupredoxins.
305 
This is achieved by 
manipulating the H-bonding with Cys112 to mimic the rusticyanin, in addition 
of increasing the hydrophobicity of Met121.  As an extension of this work, we 
reasoned that similar rearrangement of H-bonding around the His ligands 
would also affect the E˚ effectively. 
Crystal structure of wild type (WT) Az displays the surface-exposed 
‗northern histidine‘, His117 in a shallow depression in the middle of a 
hydrophobic patch (consists of Met13, Val43, Met44, Phe114 and Pro115), 
with its imidazole N
δ 
bonded to Cu, and opposite N
ε–H H-bonded to a water 




molecule from bulk solvent.
240,250 
Contrary to His117, His46 is buried deep 
inside the barrel of the protein and H-bonded to the backbone carbonyl of 
Asn10 (Figure 5.2). As mentioned, the perturbation of these H-bonds may 
preferentially stabilize Cu(I) and increase the redox potential.
307 
In this subchapter, several mutations were made to the secondary 
coordination around the two His ligands to the T1 copper in Az. Modeling 
using Visual Molecular Dynamic (VMD)
315
 and Not (just) Another Molecular 
Dynamic (NAMD)
316
 softwares were first employed to design the relevant 
mutations. The models were performed in an NVT (constant volume and 
temperature) ensemble, using 5,000 energy minimization steps and 20,000 
molecular dynamics steps of 1 fs each at 283 K. Zn(II) was chosen as an 
electrostatic and steric mimic of Cu(II). The selection of the mutations was 
based on structural comparison with rusticyanin. In this frame, Gly116, Met13 
and Met44 which were located spatially adjacent to His117
 
were mutated to 
Phe. This is to disrupt the H-bond of N
ε–H of His117 to the water molecules 
and affect the overall depolarization of the copper site. For His46, initial 
molecular dynamics simulations of G9P indicated that this mutation causes a 
kink in the β-barrel of Az that isolates His46 from solvent. This kink lengthens 
the H-bond between the backbone of Asn10 and the N
ε–H of His 46. To study 
the collective effect of these mutations, different combination of the 
aforementioned mutants were constructed. The redox potentials, spectroscopic 
features and crystals structures of several of these variants are discussed for a 
more detailed comparison. 





Figure 5.2 The mutation sites around the two His ligands in T1 Az (PDB 
4AZU).
250
 The adjacent residues to His117, namely Met13, Met44 and 
Gly116 were mutated to Phe to affect the depolarization of His117. His46 is 
buried inside and H-bonded to Asn10. Mutating Gly9 to Pro may induce a 
kink in the backbone, thus diminishing the H-bond. 
5.1.2 Results and Discussion 
5.1.2.1 Spectroscopic Characterization of Az Mutants 
All tabulated spectroscopy data for the Az variants are shown in Table 
5.1 and 5.2. ESI-MS shows the mass of all variants matches the calculated 
mass of respective variants within the experimental errors (± 5 Da).  
After screening the preliminary cyclic voltammetry (CV) results 
(Section 5.1.2.2), only those variants with interesting redox properties were 
chosen for further detailed characterization. Hence, variants containing M13F 
were omitted. In general, the variants containing Phe mutations around the 
His117 ligand (M44F, G116F and M44F/G116F) give nearly identical 
electronic spectra as WT Az, displaying a characteristically intense 
S(Cys112)3pπ–Cu(II)-3dx2-y2 ligand to metal charge transfer (LMCT) band 




around 600 nm (ε = 3000-4000 M-1cm-1) (Figure 5.3).238,242-245 The electron 
paramagnetic resonance (EPR) spectra of the Phe mutants are also 
characteristic of WT, exhibiting similar g and A║ values (Figure 5.4 and Table 
5.2). Taken together, these results indicate that these mutations have minimal 
structural perturbation at copper site.
247
  
Table 5.1 Mass spectroscopy results for Az variants. 
Variants Calculated Mass (Da) Experimental Mass 
(Da) 
WT Az 13945.8 13949.0 
G9P 13985.9 13991.0 
M13F 13961.8 13959.0 
M44F 13961.8 13960.0 
G116F 14035.9 14038.0 
M13F/G116F 14051.9 14047.0 
M44F/M13F 13977.8 13973.0 
M44F/G116F 14051.9 14048.0 
G9P/M44F/G116F 14092.0 14088.0 
 
Figure 5.3 UV-vis spectra of WT and Az variants. Spectra were obtained at 
25°C in buffer B (50 mM NH4OAc, pH 6.35). 




Table 5.2 Tabulated spectroscopic data for Az variants. 




) EPR g (A) 
WT Az 627 (4375) g1 = 2.2639 (54.4 G) 
g2 = 2.0311 (8.4 G) 
g3 = 2.0575 (8.3 G) 
G9P 620 (3978) Species 1: 
g1 = 2.2570 (52.8 G) 
g2 = 2.0291 (0.8 G) 
g3 = 2.0557 (28.3 G) 
Species 2: 
g1 = 2.2475 (38.2 G) 
g2 = 2.0230 (65.7 G) 
g3 = 2.0562 (18.0 G) 
M44F 626 (2928) g1 = 2.2689 (55.1 G) 
g2 = 2.0299 (8.7 G) 
g3 = 2.0555 (8.5 G) 
G116F 624 (3381) g1 = 2.2612 (55.2 G) 
g2 = 2.0305 (8.6 G) 
g3 = 2.0574 (8.5 G) 
M44F/G116F 624 (3345) g1 = 2.2672 (54.2 G) 
g2 = 2.0320 (7.7 G) 
g3 = 2.0560 (7.6 G) 
M44F/G116F/G9P 620 (3794) Species 1: 
g1 = 2.2528 (54.4 G) 
g2 = 2.0277 (5.3 G) 
g3 = 2.0557 (15.3 G) 
Species 2: 
g1 = 2.2483 (35.6 G) 
g2 = 2.0221 (59.1 G) 
g3 = 2.0557 (22.8 G) 
CuSO4  
(in buffer) 
- g1 = 2.2451 (58.3 G) 
g2 = 2.0032 (9.2 G) 














Figure 5.4 X-band EPR spectra of CuSO4 (—), WT Az (—), M44F/G116F (—
), M44F (—), G116F (—), G9P/M44F/G116F (—) and G9P (—). Spectra were 
measured in universal buffer pH 7.0 at frequency 9.04 GHz; power 0.2-2.0 
mW; modulation amplitude 4 G; temperature 60 K. 
 
In comparison with WT Az and Phe mutants, G9P and 
G9P/M44F/G116F give relatively higher absorbance at ~460 nm region, 
which have been ascribed to S(Cys112)3pσ–Cu(II)3dx2-y2 LMCT (Figure 
5.3).
238,242-245 
A correlation has been established between the relative ratio of 
the two absorbances and geometry of the T1 Cu center.
317
 The higher 
absorbance ratio suggests slight geometry perturbation of the T1 copper site in 
G9P. This conclusion is also supported by the EPR spectroscopic studies of 
G9P, which displayed two species: one similar to WT Az and another distinct 
rhombic signal (Table 5.2). These results suggest a deviation from more 
symmetrical trigonal geometry to less symmetrical distorted tetrahedral 
geometry. The H-bond between His46 and Asn10 may be important in 




maintaining proper positioning of His46 and overall site geometry. The G9P 
mutation likely affects the positioning and possibly the conformational 
freedom of His46 (Figure 5.2). 
Interestingly, when G9P was combined with M44F and G116F, the 
UV-vis and EPR spectra actually becomes more similar to those of WT Az 
than G9P alone.  Less intense 460 nm absorption and less rhombic character 
was observed in this triple mutant. The combination of these mutations must 
have some compensating effect for the stability and overall site geometry. 
5.1.2.2 Electrochemical Studies 
 The redox potentials of all Az variants at pH7.0 are shown in Table 
5.3. All samples exhibited reversible cyclic voltammograms, indicating no 
protein unfolding or loss of copper upon reduction of the protein. The 
observed potential result for WT Az (278 ± 3 mV vs. the normal hydrogen 




Table 5.3 Tabulated reduction potential of Az variants at pH 7.0. 
Variants Potential (mV vs. NHE) 
WT Az 278 ± 3 
M44F 325 ± 3 
G9P 301 ± 1 
G116F 282 ± 3 
M13F 256 ± 5 
M44F/G116F 342 ± 3 
M13F/M44F 303 ± 3 
M13F/G116F 242 ± 3 
G9P/M44F/G116F 319 ± 1 
 




Among the Phe mutants around the His117 ligand, M13F decreases the 
redox potential while M44F raises the potential relative to WT Az by 50 mV, 
consistent with the reported values for these variants.
303
 Since the goal of this 
study was to increase the potential, M13F was thus omitted for further 
investigation. Interestingly, even though the new mutant, G116F raises the 
reduction potential of Az by mere 5 mV, combining it with M44F resulted in a 
higher potential  (64 mV) that is ~10 mV more than the purely additive value.  
G9P variant around the His46 ligand is an interesting mutation that 
clearly has many effects on the structure and properties of Az. The mutation 
alone raises the redox potential of Az by 23 mV relative to WT at pH 7.0. 
However, G9P shows no additive effect upon combined with M44F and 
G116F. On the contrary, the redox potential of triple mutant, 
G9P/M44F/G116F actually went down relative to M44F/G116F double 
mutant.  
A plot of the pH-dependence of the redox potential is shown in Figure 
5.5. While WT Az and Phe mutants around the His117 ligand shows changes 
of ~135 mV from pH4 to 9, the G9P variants decrease by only ~115 mV over 
the same range. When combined with M44F and G116F, the change in redox 
potential of the triple mutant across the entire range was only 100 mV. This 
indicates the more pH-independent behavior of G9P mutants.  
 






Figure 5.5 pH-dependent study of WT Az and mutants. 
 
 
5.1.2.3  Description of Crystal Structures 
5.1.2.3.1   M44F/G116F 
The crystal of M44F/G116F double mutant has been determined at 
1.76 Å resolution. In agreement with the spectroscopic characteristics of the 
variant, the crystal structure of M44F/G116F shows little to no perturbation of 
the geometry of the copper site from that of WT. A relatively shorter Cu–
Gly45 (by 0.27 Å) was observed, which may be compensated with the longer 
Cu–Met121 (by 0.27 Å). Also, Cu–His117 bond in this mutant is 
approximately 0.17 Å longer than WT (Table 5.4). This weaker bond may 
responsible for the relatively higher potential of M44F containing mutants. 
The observed change in distances may be due to the net depolarization effect 




of the introduced Phe residues, which could, in turn, intensify intraprotein 
ionic interactions. However, despite the relatively high resolution of this 
structure, more study with other spectroscopic techniques is required to 
confirm these distances. 
Table 5.4 Selected bond distances of copper-ligands for the crystallized 
mutants. Parameters of WT Az (PDB code: 4AZU)
250 
are included for 
comparison. 
Mutant Atoms Distance (Å) 







 SMet121–Cu 3.15 
 OGly45–Cu 2.97 







 SMet121–Cu 3.42 
 OGly45–Cu 2.70 







 SMet121–Cu 3.24 
 OGly45–Cu 2.89 
 
Comparing Phe44 to Phe116, the two mutations have a very different 
amount of steric crowding around them (Figure 5.6a). Phe44 forms aromatic 
stacking with imidazole ring of His117 with centroid-centroid distances 
ranged from 4.18-4.23 Å. The phenylalanine side chain is likely blocked from 
rotating around by the adjacent Leu39 and Asp11. In contrast, the aromatic 
ring of G116F is actually oriented away from His117 and flipped out from the 
protein surface, giving rise to the overall trimeric packing (Figure 5.6b). This 




flipped-out orientation may be sterically facilitated by Phe114 and Pro115.The 
Cys112-His117 loop region is highly preserved as in WT Az, attributable to 














Figure 5.6 (a) The steric crowding around Phe44 (left) and Phe116 (right) in 
M44F/G116F. (b) The three Az molecules in the asymmetric unit of 
M44F/G116F form a three-member aromatic pair network via the mutated 
G116F residues. (c) The arrangement of three molecules in M44F/G116F, 
with two water molecules bridge His117 of one monomer to Ser118 of 
another monomer. 
 
The trimeric asymmetric unit is, to the best of our knowledge, a novel 
crystal form for Az. Each Phe116 from three molecules form hydrophobic 
interaction with centroid-centroid distances of 5.0-5.4 Å and interplane angles 
of 84˚, 68˚ and 85˚. These values agree well with similar aromatic-aromatic 
interactions found in other proteins, indicating a favorable edge-to-face 
interaction of the G116F side chains. Similar three-member aromatic pair 
network have been proposed by Petsko in the mutated phage λ repressor 
protein, in which Q33Y interacts with Tyr22 and Phe51. This favorable 








Instead of having two intercalating water molecules that bridge two 
His117 residues as in the WT dimers (Az1-His117H2OH2OHis117-Az2), 
the bridged water molecules in M44F/G116F interconnect His117 of one 
monomer to Ser118 of another monomer (Az1-His117H2OH2OSer118-
Az2) (Figure 5.6c). 
Due to the novelty of this packing form, the stability of this trimeric 
state in solution is further studied by native gel and syringe-pump ESI (Figure 
5.7 and 5.8).  
 
 
Figure 5. 7 Native-gel electrophoresis of WT Az and M44F/G116F. Lane 1-4: 
WT Az (100 µM, 90 µM, 80 µM and 70 µM). Lane 5-8: M44F/G116F (100 
µM, 90 µM, 80 µM and 70 µM). 
 





Figure 5.8 The dominant peak in ESI-MS spectrum of M44F/G116F 
indicates monomeric species.  
 
The major band in the native gel corresponds to the monomer observed 
for both samples. In the case of M44F/G116F Az, an oligomeric band was also 
observed, which is absent in WT. This indicates that the mutated protein likely 
exists in an oligomeric form at least some of the time. The non-covalent 
oligomeric protein was further investigated using syringe-pump ESI in non-
denaturing solvent of 50 mM NH4OAc pH 6.35. Only a monomeric peak was 
found as a dominant peak. Based on these data, it seems that the introduction 
of Phe residues on the surface of Az contributes to oligomerization of the 
protein, but that the interactions introduced by this mutation are too weak to 
survive in a mass spectrometer. 
5.1.2.3.2 M13F/M44F 
In contrast to M44F/G116F, this mutant crystallizes as a hexamer in 
the asymmetric unit, with each three monomers locate in close proximity. The 
Cu site in M13F/M44F is significantly altered with different Cu–ligand 
distances in comparison with WT Az (Table 5.4). However, the modest 




resolution (3 Å) of the crystal structure may be the cause of the altered 
distances. Notably, the imidazole ring of His117 in M13F/M44F is closer 
towards copper atom (Figure 5.9a and Table 5.4). Interestingly, the methyl 
group on Met121 in the M13F/M44F variant is also flipped relative to WT, 
which is clearly visible in the electron density map even at low resolution. The 
M13F mutation seems to affect the loop region that interacts with Met121 and 
allows it to rotate more freely.  
The conformation of Phe44 mutation is similar as in M44F/G116F. 
However, the M13F mutation which is spatially close to His117 has 
unexpectedly decreased the hydrophobicity encapsulation of His117 (Figure 
5.9b). Similar to G116F mutation in M44F/G116F, the aromatic ring of Phe13 
tends to flip-out of the protein surface but with no preferred intermolecular 
stacking observed. The side chain of Phe13 sterically interferes with Phe44, 
pushing Phe44 further away from His117, which could explain why 
combining M44F and M13F results in a lower redox potential than just M44F. 
Clearly the secondary effects of the M13F mutation negate any contribution to 
the depolarization of the copper binding site of Az. 








Figure 5.9 (a) The metal sites comparison of M13F/M44F (yellow) and 
M44F/G116F (green) with WT Az (blue). The imidazole ring of His117 in 
M13F/M44F orientates differently from that of WT. (b) The unexpected 
orientation of Phe13 side chain results in a more solvent-exposed His117. 
The overlaid protein surface of M13F/M44F and WT Az is shown in yellow 
and blue respectively. 




5.1.3 Summary & Conclusions 
In this subchapter, a series of Az variants has been prepared to study 
their effect on redox potential by perturbing the long-ranged interaction on His 
ligands. Combining G116F with a reported mutant, M44F around His117 
ligand has additively increased the potential by ~50 mV. G9P around His46 
ligand shows slight perturbation on the copper site and different pH profile. 
Two crystal structures of M44F/G116F and M13F/M44F show that simply 
introducing hydrophobicity near the copper binding site of Az is insufficient to 
have a predictable increase on redox potential. The exact positioning of these 
mutations is critical for avoiding secondary effects that negate any desolvation 
that should raise the redox potential. 










B)    Construction of 1V Azurin Mutant  




5.2 Part B 
5.2.1 Construction of 1V Azurin Mutant 
For decades, enzymes have gradually gained industrial interest 
(Section 4.4). Because the T1 copper centers are very useful as redox reagents 
and are exceptionally efficient in ET, they have been proposed to serve as 
electron carriers in bio-inspired devices like solar cells or fuel cells. In 
achieving this goal, Az offers a good candidate as it is smaller in size, 
genetically amenable, stable at physiological condition and more importantly, 
it allows manipulation of redox potential in a predictable manner across a wide 
range of ca. 700 mV.
305
 This indicates the feasibility of building Az mutant 
with E˚ ~1 V, which offer an ideal alternative for fuel cells application. 
It is well studied that altering the hydrophobicity of Met121 and H-
bonding in the secondary coordination sphere of Az can change the E˚ 
significantly. An Asn47→Ser mutation has successfully mimicked the H-bond 
network as in the high-potential Rusticyanin (Section 4.5.3) and resulted in 
130 mV upshift. In combination with F114N which designed to weaken the 
Cu–Gly45 bond, N47S/F114N further has up-tuned the E˚ by ca. 100 mV at 
pH7.0. This double mutant is further combined with M121L (Section 4.3.1) 
and has elevated the E˚ by as much as ~150 mV.305  
Given the observed secondary effects to His117 (Chapter 5.1), we 
hence combine M44F/G116F with the reported N47S/F114N/M121L to 
maximize the redox potential. Since M44F/G116F affects different aspects 
from N47S, F114N and M121L, the combined mutant may push the potential 
to a new high end of >700 mV. The desired mutation site is depicted in Figure 




5.10. This high-potential protein may offer a viable redox reagent for 
processes like oxygen reduction, water oxidation, or oxidation of organic 
substrates. 
 
Figure 5.10 The mutation site of the T1 Az site. The copper-binding ligands 
are depicted in stick model; the residues that involved in the site-directed 
mutagenesis are shown in lines (PDB ID: 4AZU).
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5.2.2 Results and Discussion 
5.2.2.1 Spectroscopic Characterization of 4Mut and 5Mut 
 The ESI-MS results show the correct mass for apo-proteins within ± 6 
Da (Table 5.5).  
After screening the preliminary CV results (Section 5.2.2.2), only 
5Mut (M44F/N47S/F114N/G116F/M121L) was chosen for further study since 
our goal is to construct high-potential Az mutants. Notably, 5Mut is visibly 
more greenish than WT and other Az mutants. This is also evidenced from its 




UV-vis spectrum (Figure 5.11). It is well studied that the dx2-y2 orbital lobes of 
copper in T1 cupredoxin bisects the p orbitals of S(Cys112), resulting in an 
intense π CT transition at ~600 nm (molar absorptivity, ε = 3000-6000 M-1cm-1) 






much lower than 
the normal range value of T1 cupredoxin.
238,242-245
 Furthermore, a more intense 
absorbance at 400 nm was observed, indicating the slight perturbation at 
copper active site. This transition is assignable as Sζ→Cu CT, which is 
commonly observed in type 2 (T2) and normal complexes.
238,242-245 
The 
spectrum corroborates the re-orientation of the T1 copper site in 5Mut to an 
extent closer to T2.  
The perturbation of the copper site in 5Mut is further supported by 
EPR data, which show the existence of various species. These species are pH-
dependent as depicted by the physical color change (Figure 5.13a) and the 
EPR spectra collected in different buffer (Figure 5.13b). The significant 
changes in the EPR result, especially of universal buffer (UB) pH 10 and 11, 
may due to the effective pH change when the samples were analyzed in the 
low temperature (30 K). This is in accordance with the study from Sieracki et 
al., which has demonstrated that the effective pH of phosphate buffer (KPi) is 
less sensitive to temperature as compared to UB.
319
   





M44F/N47S/F114N 13896.0 13902.0 
N47S/F114N/G116F 13970.0 13976.0 
M44F/N47S/F114N/G116F 13988.0 13992.0 
M44F/N47S/F114N/G116F/M121L 13970.0 13974.0 





Figure 5.11 UV-vis spectra of 5Mut. Spectrum was obtained at 25°C in 
buffer B (50 mM NH4OAc, pH 6.35). 
 
 
Figure 5.12 Different orientation of dx2-y2 orbital lobes of copper with cysteine 
thiolate ligand will affect the intensity of two different CT bands.
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Figure 5.13 (a) The EPR samples of 5Mut in different buffer. (b) The EPR 
spectra of 5Mut in different buffers. 




5.2.2.2 Electrochemical Studies 
In constructing the high-potential Az mutant, the E˚ of different 
combination using CV was first screened. The redox potentials of the mutants 
are summarized in Table 5.6. The incorporation of new mutation exerts 
additive effect on the redox potential as expected. For example, combining 
M44F and G116F into the reported N47S/F114N has up-tuned the potential by 
~60 and ~20 mV respectively. However, the potential of quadruple mutant, 
4Mut (M44F/N47S/F114N/G116F) shows only minor increment in relative to 
M44F/N47S/F114N. Further introduction of M121L into the 4Mut has 
significantly raised the E˚ to ~954 ± 5 mV. This quintuple mutant, 5Mut is 
somehow less stable. Its redox potential was measured in high salt 
concentration and lower pH to improve the protein binding to the unmodified 
electrode (Figure 5.14). Such unstability may contribute to the high potential 
values of 5mut. 
 
Table 5.6 Tabulated reduction potential of Az variants measured in 50 mM 
NH4OAc (pH 7.0), unless otherwise stated. 
Variants Potential (mV vs. NHE) 
M44F/G116F 342 ± 2  
N47S
305
  396 ± 25 
F114N
305
 398 ± 4 
N47S/ F114N
305
  494 ± 11 
N47S/F114N/M121L
305
 640 ± 1  
M44F/N47S/F114N 558 ± 6 
N47S/F114N/G116F 518 ± 6 
M44F/N47S/F114N/G116F (4Mut) 563 ± 8 
M44F/N47S/F114N/G116F/M121L (5Mut)
a
 954 ± 5 
a
In 50 mM NH4OAc buffer and 500 mM NaCl (pH 5.0)  
 





Figure 5.14 CV of 5Mut on glassy carbon electrode in 50 mM NH4OAc 
buffer and 500 mM NaCl (pH 5.0). 
 
5.2.2.3 Crystal Structure of 4Mut 
 4Mut crystallizes in P212121, with two molecules in an asymmetric unit 
related by a pseudo-twofold symmetry. There are two copper ions in each 
molecule (Figure 5.15a). The first copper is located at normal position, with a 
relatively weaker Cu–Gly45 bond at 3.38 Å compared to WT Az (Table 5.7). 
Another copper ion is ligated to His83, a residue that has been reported to bind 
to Zn(II), Ru(II), Re(I) and Os(II).
320-321
 Despite the presence of an additional 
copper ion, the overall crystal structure is very similar to WT Az.  
Structurally, 4Mut is a combination of N47S/F114N
305
 and 
M44F/G116F (Section 5.1.2.3.1), implies minimal to no structural 
perturbation upon quadruple mutations. The Asn47→Ser mutation alters the 
H-bond in the „zipper‟ region, particularly the parallel interaction with Thr113. 




The orientation of Asn114 allows the assignment of H-bond between 
carboxamide N and carbonyl Gly45 without ambiguity as in the reported 
crystal structure of N47S/F114N (Figure 5.15b).
2305
 This H-bond may weaken 
the axial interaction of Cu–Gly45, thus stabilize Cu(I) and raise the redox 
potential. Similarly, M44F and G116F cooperatively reduce the solvent 
accessibility of the copper site by introducing the bulky phenyalanine side 
chains. This structural data implies the additive effect played by each 
individual mutation sites in raising the redox potential, in agreement with the 
CV results. 
The attempt to crystallize 5Mut has failed. However, the 4Mut crystal 
structure (which is one mutation less than 5Mut) together with the reported 
N47S/M121L (PDB code: 3JT2),
305
 N47S/114N (PDB code: 3JTB)
305
 and WT 
Az (PDB code: 4AZU)
250
 may provide an informative picture into this. The 
spectroscopic results of 5Mut suggest that the copper active site is distorted 
upon quintuple mutations. In N47S/M121L, Leu121 pushes the copper atom 
~0.20 Å down the [NNS] trigonal plane due to steric effect. 4Mut crystal 
reveals that F114N, in conjunction with other mutation sites, has weakened the 
Cu–OGly45, pushing copper atom out-of-plane by ~0.19 Å in relative to WT 
and N47S/F114N. The simultaneous pushing effect in the opposite direction, 
in parallel with the other mutation effects on His117, may cause the 












Figure 5.15 Crystal structure of 4Mut contains two copper atoms in a 
molecule, with the special copper atom ligated to His83. (b) N47S and F114N 
rearrange the H-bonding in the active site (left). The hydrophobicity 
introduced by M44F and G116F weakens the H-bonding between His117 and 








Table 5.7  Selected bond distances of copper-ligands for 4Mut and WT Az 
(PDB code: 4AZU).
250 
Mutant Atoms Distance (Å) 







 SMet121–Cu 3.15 
 OGly45–Cu 2.97 







 SMet121–Cu 3.11 
 OGly45–Cu 3.38 
 
5.2.3 Summary and Conclusions 
 The study shows that the quintuple mutant, 5Mut has significantly 
extended the range of the redox potentials attainable by Az and other 
cupredoxins. The maximum potential observed was 954 ± 5mV at pH 5.5. 
Spectroscopic results show that this 5Mut is unstable. The crystal structures of 
its analogues, 4Mut and other available reported structures, imply that the 
introduction of M121L may cause opposing steric effects to the other four 
mutations, resulting in the rearrangement of the metal center. 








C)   Redox Studies on CuA Azurin by 
















5.3 Redox Studies on CuA Azurin by Manipulating the Secondary 
Coordination Sphere Interaction 
5.3.1 Introduction 
The redox study on T1 Az has been well conducted for decades. 
However, in the case of CuA, many conflicting studies have been published. 
For example, while mutating the axial Met160 in truncate CuA T. thermophilus 
oxidase changes the potential by ~200 mV,
322
 similar mutation of Met on CuA 
azurin results in just ~25 mV difference.
323
 This discrepancy is likely because 
the sites are in similar yet ultimately different protein scaffolds and 
environments. Being the closest synthetic model of native CuA, the CuA Az 
employs the identical Greek key β-barrel fold as blue T1 Az (Section 4.2.1.2). 
This provides the CuA Az a unique position for direct comparison between 
CuA and T1 Az.  
As discussed in Chapter 5.2, the N47S mutation in T1 Az has up-tuned 
the potential by ~130 mV. In contrast, a Phe114→Pro mutation has deleted the 
H-bond to ligand Cys112, eventually reduced the potential by 90 mV.
314
 These 
two mutations, correspond to N47S and E114P were made to the secondary 
coordination sphere of CuA Az to determine if similar electrochemical effect 
observed in T1 Az can be regenerate in CuA Az. Figure 5.16 shows the 
mutation sites, N47 and E114 in the CuA Az. 
 





Figure 5.16 The diamond core geometry of dinuclear copper site of CuA 





5.3.2 Results and Discussion 
5.3.2.1 Spectroscopic Studies of N47S and E114P  
The tabulated spectroscopy data for N47S and E114P is given in Table 
5.8. The ESI-MS result shows the correct apo mass for all variants (± 6 Da).  
The UV-vis spectra of both variants are similar to that of CuA Az. All samples 
show characteristic intense CT bands at 480 and 530 nm (Figure 5.17), 
corresponding to Scys(px)→Cuψ*(HOMO) and Scys(py)→Cuψ*(HOMO); and a 
weaker band at 760-780 nm region, assignable to Cu-Cu ψ→ψ* transition.263 
However, E114P displays a red shift in the ψ→ψ* transition region, indicating 
the possibility of a weaker axial ligand interaction
247
 and lengthened Cu–Cu 






This maybe attributable to the replacement of E114 by proline, which 
deletes the H-bond to C112 and results in a stronger Cu–Cys interaction as 
exemplified by F114P in blue T1 Az. Also, the CT region ~500nm of E114P is 
much deviated from that of CuA Az, showing the slight disruption of Cu2S2 
core plane. It is known that deleting this H-bond in the blue copper site causes 
some geometric distortion of the blue copper site.
311
  Therefore, it is not 
surprising that a similar result would be obtained for the CuA site. 
 
 








Table 5.8 Tabulated spectroscopic data for CuA Az variants. 
Variants λmax, nm  EPR g (A) Calculated 
Mass (Da) 
Experiment-
al Mass (Da) 
CuA Az 483, 530, 
760 
In 50 mM NH4OAc (pH 
5.1): 
gx = 2.018 (25.4 G) 
gy = 2.044 (12.2 G) 
gy = 2.058 (58.6 G) 
14173.0 14176.0 
In TIP7 (pH 7.0): 
gx = 2.021 (28.0 G) 
gy = 2.027 (12.1 G) 
gy = 2.173 (56.2 G) 
N47S 483, 530, 
753 
In 50 mM NH4OAc, pH 
5.1: 
gx = 2.016 (23.3 G) 
gy = 2.048 (12.2 G) 
gz = 2.170 (58.6 G) 
14140.0 14146.0 
In TIP7(pH 7.0): 
gx = 2.027 (24.3 G) 
gy = 2.027 (14.1 G) 
gy = 2.176 (55.8 G) 
E114P 473, 535, 
784 
In TIP7 (pH 7.0): 
gx = 2.017 (29.5 G) 
gy = 2.021 (10.9 G) 









EPR spectra of the CuA Az variants are shown in Figure 5.18. It is 
noteworthy that E114P in NH4OAc buffer is pH-sensitive at cryo-temperature, 
with apparent color change from light purple to brown. The EPR spectrum in 
this condition is ill-resolved, with g║ and g┴ region significantly differ from 
that of CuA Az and N47S. Hence, a previously developed temperature 
independent buffer (TIP7) was chosen for this study.
319
 In TIP7, all samples 
display a characteristic seven-line hyperfine, axial signal.
324-325
 Taken 
together, these results show that the alterations to the H-bonding network 
around Cys112 in CuA Az have a minimal effect on overall site geometry, and 
























Figure 5.18 X-band EPR spectrum of CuA Az, N47S and E114P mutants in 
(a) TIP7 buffer (pH7.0) and (b) 50 mM NH4OAc (pH5.1). 




5.3.2.2 Electrochemical Studies of N47S and E114P 
The redox potentials of CuA Az variants were determined using CV 
and redox titration (Table 5.9). Following the reported condition for CV 
measurement, the observed potential for CuA Az is 264 ± 4 mV vs. NHE, 
which is within error of the previously reported value (271 ± 7 mV vs. 
NHE).
326
 The measured Em of N47S is, however, only about ~70 mV higher 
than CuA Az, which is half the increase that was seen in blue copper Az. No 
decent CV was obtained for E114P under this condition despite numerous 
attempts. Thus, further measurement was attempted in different condition 
using 100 mM potassium phosphate (KPi) pH 7 as the higher pH increases the 
electrostatic attraction between the protein and the 
didodecyldimethylammonium bromide (DDAB) modified electrode. Under 
this condition we were able to observe signals for all three proteins with Em 
values of the Asn47Ser variant (307 ± 7 mV) being consistently higher than 
that of unmodified CuA Az (277 ± 21), while the Em of Glu114Pro variant is 
lower (235 ± 3 mV). 
Table 5.9 Comparison of Em (mV vs. NHE) of N47S and E114P in CuA Az 
with N47S and F114P in blue copper Az. For the mutated proteins, the 
difference in redox potential compared to non-mutated protein is shown in 
parenthesis. 
Purple CuA Blue Az 



















CuA Az 277 ± 21 264 ± 4 253 ± 1 WT Az 265 ± 19 
N47S 307 ± 7 
(+30) 
337 ± 4 
(+73) 
275 ± 14 (+22) N47S 396 ± 25 
(+131) 
E114P 235 ± 3 
(-42) 








To further confirm the potential trend seen on the polymer modified 
pyrolytic graphite edge (PGE) electrode, redox titration of the CuA Az variants 
was carried out with titrant [Ru(NH3)5Py](ClO4)2] (Figure 5.19). The obtained 
potential value of CuA Az agrees very well with the previously reported result 
(254 ± 4 mV).
326
 The E˚ values obtained from redox titration are consistently 
lower than that of CV results. The difference of the potential to CuA Az in both 
mutants is also less. However, an identical trend in redox potentials as in the 
CV was seen. Notably, to ensure the measurement condition remains 
internally consistent, the same titrant was used for all three variants. However, 
the redox potential of [Ru(NH3)5Py](ClO4)2] is 302 mV, which is below the E˚ 
of N47S and well removed from the E˚ of E114P, which can increase the error 
in the measurements.  
The consistency of the potential trend somehow reveals that the E˚ of 
the CuA Az site is clearly susceptible to the H-bonding network around the 
copper ligand Cys112, similar to the blue T1 copper site. Interestingly, the 
magnitude of the change in E˚ in CuA Az is only about half of that seen in the 
T1 Az. This may assignable to the effects of mutations are averaged over the 
two copper centers, similar as that observed in the changes of reorganization 


























Figure 5.19 Plots of redox titration for (a) CuA Az, (b) N47S and (c) E114P. 
 
5.3.3 Summary and Conclusions 
 To conclude, two CuA Az mutants, N47S and E114P were constructed 
to examine if similar secondary effect on the redox property observed in 
mononuclear T1 Az can be regenerate in CuA. The results give only half of the 
E˚ variation than that seen in T1 Az, implying the spread-out effect between 
the symmetrical bicopper centers in CuA. This work offers the direct 
secondary effect comparison between CuA and T1 for the first time, which 
provides a clearer picture on the difference between the two cupredoxins. 
 








D)    Experimental 
   
 
 





(Chapter 5.1 and 5.2) 
5.4.1 Design of Primers 
Primers for the mutation of pET9a WT azurin were ordered from 
Integrated DNA Technologies (IDT). They were generally 30-40 base-pairs 




5.4.2 Materials and Instrumentation 
Native Pfu polymerase and DpnI were purchased from Stratagen (San 
Diego, CA) and all the restriction enzymes were purchased from New England 
Biolabs (Ipswich, MA). dNTP‘s were purchased from Invitrogen (Carlsbad, 
CA). All media for cell growths was autoclaved before use.  
 PCR reaction was performed on a PTC-100 Programmable Thermal 
Controller (MJ Research Inc., San Francisco, CA). Apo-protein was purified 
using a Fast Flow SP Sepharose (Amersham Biosciences, Uppsala Sweden) 
cation-exchange beads on ÄKTA FPLC system (Amersham Bioscience). Mass 
Spectra was recorded on Macromass Quattro II Mass Spectrometer using non-
denaturing solvent (50 mM NH4OAc, pH 6.35) at 50˚C, cone voltage of 30V, 
capillary voltage of 2.4V. The obtained spectra were processed by Waters 
MassLynx data system. The obtained spectra were deconvoluted over the mass 
of 10,000-20,000 Da using the maximum entropy software, MaxEnt.
328
 UV-
visible absorption spectra were recorded on an Agilent HP8453 UV-visible 
array spectrophotometer at ambient temperature. Samples for EPR and ICP 




analysis were passed through a disposable pre-packed PD10-column 
(Amersham Biosciences, Uppsala Sweden) to remove excess free metal ions. 
The EPR samples were exchanged into UB buffer (50 mM NH4OAc, 40 mM 
in each MOPS, MES, Tris and CAPS, 100 mM NaCl and adjust to desired pH) 
and analyzed as a frozen glass in 50% glycerol at 60 K with a Varian E-line 
12‖ Century Series X-Band CW spectrometer. The instrument was equipped 
with an APD Helium cryostat and maintained by the Illinois EPR Research 
Center (IERC). Simulation of EPR spectra was performed using Simpow6 to 
determine g and A║ values.
329
 Extinction coefficient was calculated based on 
the elemental analyses of S and Cu in the proteins using inductively coupled 
plasma-mass spectrometer (ICP-MS) (performed at Microanalysis Laboratory 
at the University of Illinois at Urbana-Champaign). Based on the theoretical 
number of sulfur containing amino acids in the Az proteins, the ratio of S:Cu 
can then be converted to the ratio of protein:Cu. 
5.4.3 Electrochemical Measurement 
Cyclic voltammetry was performed on CH Instrument model 620A 
Electrochemical Analyzer (Austin, TX), using a series of universal buffer (50 
mM NH4OAc, 40 mM MOPS, 40 mM MES, 40 mM Tris, 40 mM CAPS and 
100 mM NaCl; ranged from pH 4 to 9) as electrolyte (unless otherwise stated 
in Chapter 5.3). All the buffer solution was degassed with nitrogen prior to 
measurement. The three electrodes consisted of pyrolytic graphite edge (PGE) 
working electrode (glassy carbon electrode was used for 5Mut), platinum wire 
auxiliary electrode and Ag/AgCl reference electrode (Bioanalytical Systems, 
West Lafayette, 1 N, 3 M NaCl) were set up according to literature 






 Ag/AgCl reference electrode was calibrated against a standard 
calomel electrode (SCE) (E = 0.253 V at 4°C). PGE electrode was polished on 
nylon polishing pad using alumina (0.05 μm), followed by sonication in 
deionized water for few minutes before measurement. 2μL of concentrated 
sample (2-4 mM) was applied to the graphite surface. After short incubation 
(<3 min at 4°C), the electrode was then immersed in the ice-cold electrolyte 
solution. Voltammograms were collected at scan rate 0.1 V/sec after 
equilibrate for about 2 min. No scan rate dependence of the peak potentials 
was observed for all samples. The electrodes were then transferred to another 
buffer solution of desired pH and new measurement was recorded. All 
reported readings were converted to corrected values vs. normal hydrogen 
electrode (NHE) potentials. 
5.4.4 Blue Native PAGE 
The blue native-polyacrylamide gel electrophoresis (BN-PAGE) was 
performed using Bio-Rad Tris-HCl gel 7.5% (v/v) at 145 V at 4 ˚C for 2 h. 10 
µL of protein mixed with equivolume of Coomassie Blue was loaded per well. 
To be definitive, WT and M44F/G116F with different concentrations were 
studied for comparison. 
5.4.5 PCR and Transformation 
The Az variants were constructed, expressed and purified in the apo 
form following the reported procedure.
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 The mutant DNAs were 
constructed on a recombinant Az gene from Pseudomonas Aeruginosa using a 
polymerase chain reaction (PCR) mutagenesis method. The PCR reaction was 




performed using STATAGEN program on the following mixture: 5 µL 
reaction buffer (10 x); 1 µL template DNA (100 ng/µL); 1 µL forward primer 
(100 ng/µL); 1 µL backward primer (100 ng/µL); 1 µL dNTP‘s (10 mM); 40 
µL H2O; 1 µL Pfu polymerase. The STATAGEN program consisted of 18 
temperature cycles of 95 ºC for 30 sec, 55 ºC for 1 min, and 68 ºC for 3 min. 
After 3.5 h cycle, the amplified DNA was digested with 1 µL of 10 U/µL 
DpnI restriction enzyme per reaction tube and incubated at 37 ºC for 1 h.  This 
exclusively cleaved the unreacted template DNA at methylated adenine 
residues. 
For DNA transformation, 2 µL of PCR DNA was added into a 
prechilled Falcon tube containing 40 µL of competent cell XL-10 Gold and 1 
µL 2-mercaptoethanol. After 30 min incubation on ice, the tubes were heat 
shocked in a 42 ºC water bath for 45 sec and rapidly chilled on ice again for 2 
min. 200 µL of SOC media was added to the tube and incubated in a 37 C 
water bath for 1 h. 100 µL of cells were then streaked onto LB plate with 
kanamycin and allowed to incubate at 37 ºC for 15-17 h. At least 3 single 
colonies were picked off from each LB plates for DNA sequencing. Each 
selected colony was inoculated with 5 mL of sterile LB broth containing 5 µL 
of 100 mg/mL kanamycin and allowed to grow in a 37 ºC water bath for 16-18 
h. Mini-prep was performed using Qiagen plasmid DNA purification kits 
(Valencia, CA) according to the protocol provided. Successful integrity of the 
entire azurin gene was tested by DNA sequencing performed at the 
Biotechnology Center at University of Illinois at Urbana-Champaign. 




5.4.6 Protein Expression and Purification 
1 µL successful PCR amplified plasmid DNA was expressed in 50 µL 
Escherichia coli BL21 (DE3) (Novagen) cell, incubated overnight, and 
inoculated in 5 mL of LB media similar as above mentioned but for shorter 
time of 8 hr.  
After the cells had begun to recover and grow, 1mL aliquot of the 5 
mL growth was then transferred to 2 L of 2xYT media (2 L purified water, 32 
g bacto-tryptone, 20 g yeast extract, 10 g NaCl). The culture was shaken in 
baffled Erlenmeyer flask at 25 ºC at 210 rpm for 15-16 h. Isopropyl-β-D-
thiogalactopyrano-side (IPTG) (150 mg/mL) was added to each flask to induce 
apoprotein production. After 3-4 h of cultivation, the cell supernatant was 
harvested by centrifugation for 10 min at 13,000 x g. The collected bacterial 
cell was resuspended in 20 % sucrose, 1 mM EDTA, 30 mM Tris base 
solution (pH 8.0) and shaken at ambient temperature for 40 min. The cell was 
again isolated by centrifugation for 10 min at 13,000 x g. The cell pellet was 
resuspended and lysed by shaking in cold osmotic shock solution (4 mM 
NaCl, 1 mM dithiothreitol-DTT) for 10 min at 4 °C. The cellular debris was 
then removed by centrifugation to recover the supernatant. The remaining 
solution was acidified with one-tenth volume of 0.5 M sodium acetate, pH 4.1, 
to precipitate the unwanted periplasmic proteins. Precipitates were removed by 
centrifugation and the clear supernatant was added to a slurry of pre-
equilibrated (50 mM NH4OAc, pH 4.1) Fast Flow SP Sepharose cation-
exchange beads and allowed to bind. After short incubation, the SP Sepharose 
beads were packed in a column and subjected to FPLC system for further 




purification. The protein was eluted against a gradient of 50 mM NH4OAc 
from pH 4.13 (buffer A) to pH 6.35 (buffer B) using Gradifrac system 
(Amersham Pharmacia Biotech). Fractions containing apo-protein were 
pooled, analyzed with ESI-MS and concentrated using an Amicon stirred-cell 
ultrafiltration system (Millipore, Billerica, MA) to an appropriate volume. The 
FPLC-purified protein was then applied to HiTrap Q Sepharose Fast-Flow 
(GE Healthcare) to remove the unwanted heme protein. 
5.4.7 Copper Titration 
Holo protein was obtained by stepwise titration of 5 mM CuSO4 (1 µL 
each) into apo protein and monitored by UV-visible spectroscopy. Titration 
was continued until ~A620 was constant with furthercopper addition. The holo 
protein was then concentrated in Milipore-centricon Centrigugal Filter Unit 
(10,000 MW cutoffs), washed with buffer B for 4-5 times and passed through 
a disposable pre-packed PD10-column to remove excess Cu
2+
. The 





. Finally, protein was flash frozen in liquid nitrogen and stored in -80 ºC 
freezer for further experiment. 
5.4.8 Crystallization of Az Variants 
 Az variants were crystallized using hanging drop vapor diffusion. 
Crystal of M44F/G116F was obtained by mixing the concentrated protein 
sample (2uL of 3mM protein; 50 mM NH4OAc at pH 6.35) with equal volume 
of reservoir solutions consisting of 80 mM NaOAc, 0.29 M CaCl2, 0.25 M 
LiNO3 (pH 6.0) and 20% polyethylene glycol (PEG, MW 10,000). Blue 




crystals suitable for X-ray diffraction studies were obtained after 1 week at 4 
˚C. Crystal of M13F/M44F and 4Mut crystals were obtained in a similar way, 
using different reservoir solution of 0.1 M TrisHCl, 20 mM CaCl2, 0.1 M 
LiNO3 mixed with 20% PEG MW 4,000 and 20% PEG MW 10,000 
respectively. M13F/M44F crystal was obtained after 6 months at r.t. whereas 
4Mut crystal was obtained after 1 week at 4 ˚C. 
(Chapter 5.3) 
5.4.9  Preparation of CuA Az Variants 
The N47S and E114P mutants were constructed, expressed and 
purified following the reported procedure
280,326,332
 using CuA Az as template 
DNA in PCR reaction. Other preparation step is similar as in Section 5.4.5 and 
5.4.6). However, CuA Az protein is more temperature sensitive than T1 Az. All 
the purification process was conducted in cold room and completed within the 
same day in order to obtain reasonable yield.  
For copper titration, the apo protein was exchanged into buffer 50 mM 
NH4OAc at pH 5.1. The holo protein was obtained by stepwise titration of 5 
mM CuSO4 (1 µL each) and monitored by UV-vis spectroscopy. Titration was 
continued until ~A485 was constant with further copper addition. The holo 
protein was then concentrated in Milipore-centricon Centrifugal Filter (10,000 
MW) and exchanged with buffer solution to remove excess Cu
2+
. 
5.4.10 Electrochemical Measurement for CuA Az Mutants 
Cyclic voltammetry was performed on CH Instrument model 620A 
Electrochemical Analyzer (Austin, TX), following the reported procedure for 






 Pyrolytic graphite edge (PGE) electrode was polished with alumina 
(0.3 and 0.05 µm), rinsed and coated using didodecyldimethylammonium 
bromide (DDAB) in chloroform (10 µL, 10 mM) as co-adsorbent. The DDAB-
film PGE electrode was kept in a closed tube for slow drying overnight. 
Platinum wire was used as auxiliary electrode and Ag/AgCl as reference 
electrode (Bioanalytical Systems, West Lafayette, 1N, 3M NaCl). The cyclic 
voltammetry was performed with the electrodes assembled following a 
previously published procedure.
318 
The protein sample was degassed with 
nitrogen prior to measurement. The assembled electrodes were immensed in 
the cold, degassed protein solution and measurement was conducted at 4 ˚C. 
All reported readings were converted to NHE potentials by adding 210 mV to 
the value obtained vs. the Ag/AgCl reference.  
5.4.11  Redox Titration 
0.1-0.2 mM of protein samples in degassed 50 mM NH4OAc buffer 
(pH 5.1) is titrated with appropriate aliquots of 2-6 mM [Ru(NH3)5Py](ClO4)2 
under a flow of argon.
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 The absorption change of Amax at ψ→ψ* transition 
region is monitored. The reduction potential of the protein can be calculated 
using equation  
 




E = ERu + 
RT 
nF       
ln K           (1) 





K  = equilibrium constant 
Amax  = maximum absorbance of CuA azurin at ψ→ψ* transition region 
A°max  = maximum absorbance of fully oxidized CuA azurin at ψ→ψ* 
transition region 
εmax     = extinction coefficient of Amax 




By extrapolating the plot of K vs. equivalent number of 
[Ru(NH3)5Py](ClO4)2 to zero, the intercept K value can be used for E˚ 
calculation. The reduced CuA Az mutants can be re-oxidized by titrating with 
ammonium cerium(IV) nitrate (EºCe4+/3+ = 1.72 V), indicating the reversibility 
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The overall objective of this project was to explore the crystal 
engineering of amino acid Schiff bases and metalloprotein design of 
cupredoxin.  
Firstly, supramolecular assemblies of different L-arginine Schiff bases 
with Cu(II) salts have been explored. This study is the first to investigate the 
arginine Schiff bases crystallographically. The findings suggest that such 
Schiff base promises a new valuable building block in supramolecular 
chemistry. Preliminary docking studies using these copper-arginine complexes 
with thrombin enzyme suggest that they may be potential inhibitors. Hence, 
future research on their inhibition constants and binding structures should 
attempt to further support these theoretical models. 
Secondly, construction of supramolecular architectures using aromatic 
amino acids has been conducted. The results showed that complexation of 
Cu(II) and Ni(II) with N-(2-hydroxyl-1-naphthalidene)-L-amino acid 
(tryptophan or tyrosine) can form lipid-bilayer resembling structures in a 
width controllable manner. The bilayer formation is governed by the stable 
stacking between naphthalene ring and aromatic side chains of the Schiff base, 
further fortified by H-bond of metal sites. In future study, it will be interesting 
to investigate the use of tetravalent metal (which may coordinate to two Schiff 
bases and increase the heteroatom sites) and synthetic amino acid to tune the 
hydrophilic and hydrophobic layers. The variable architectures of tryptophan, 
tyrosine and histidine Schiff bases were further developed, including metal 
aggregates, CP and MOF. A series of metal aggregates was obtained by using 
Chapter 6: Conclusions 
230 
 
vanilin-derived Schiff bases and their magnetic property was studied as well. 
An interesting Na-Fe heteronuclear CP was obtained using tyrosine Schiff 
base. The structure is somehow disordered and complicated. To address this 
problem, future study is needed to improve the crystallization condition. A 
novel calixarene-like tetramer was obtained as 
[Cu(YNap)(H2O)]·0.75H2O·0.25MeOH. Unfortunately, its framework was 
corrupted upon solvent removal by conventional heating. Supercritical carbon 
dioxide (SCD) treatment may offer an alternative with better validity as it 
causes less detrimental to the framework.
337
 Also, preparation of synthetic 
tyrosine analogues to study its effect on the host size, is another extension of 
this work.  
The second part of this study investigated the redox manipulation of 
T1 Az mutants. The findings have conceivably illustrated that secondary effect 
around the His ligands can play vital roles in tuning the potential. In this, 
M44F/G116F has successfully up-tuned the potential by ~60 mV. However, 
there is ambiguity to determine whether its trimeric crystal form is retained in 
the solution state. Further separation by size-exclusion chromatography 
(SEC)
338
 or sedimentation velocity analysis
339
 should be considered in future 
work. Driven by these results, we combined M44F/ G116F with the reported 
N47S/F114N/M121L;
250
 giving a quintuple mutant with ˚E ~1V. This 
indicates the potential applicability of Az as water-soluble biocatalyst. 
Nonetheless, such multiple mutation results in the low stability of the protein. 
More study is focused at improving its stability before it can be used for 
further application. Lastly, a direct comparison between T1 Az and CuA Az 
was discussed. A previous work from Lu group shows that N47S and F114P 
Chapter 6: Conclusions 
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mutants in T1 Az can significantly cause positive and negative changes by 
~100 mV. Herein, the findings demonstrate that the corresponding mutations 
in CuA Az, however, show only half of the changes. This is in accordance with 
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Table A1. Crystallographic data for Chapter 2. 
 2-a 2-1 2-2 2-3 2-4 









M 346.39 485.98 1014.68 495.63 1324.27 
Temperature 223(2) K 223(2) K 293(2) K 223(2) K 223(2) K 
Wavelength 0.71073 Å 0.71073 Å 0.71073 Å 0.71073 Å 0.71073 Å 
Crystal system Triclinic Orthorhombic Triclinic Triclinic Monoclinic 
Space group P1 P212121 P1 P-1 P21 
Unit cell 
dimensions 
a = 6.9339(5)Å  
b = 8.4735(6)Å    
c = 15.3249(10)Å              
α = 75.124(2)° 
β = 82.496(2)° 
γ = 80.882(2)° 
a = 11.7518(9)Å 
b = 16.3475(12)Å 
c = 23.4131(18)Å 
α = 90°      
β = 90°        
γ = 90° 
a = 8.2119(8)Å  
b = 8.7239(9)Å    
c = 14.2024(14)Å   
α = 90.923(2)° 
β = 96.679(2)° 
γ = 99.903(2)° 
a = 10.7047(7)Å 
b = 11.9728(7)Å 
c = 8.4354(5)Å 
α = 83.3020(10)° 
β = 85.4660(10)° 
γ = 71.2060(10)° 
a = 6.7963(6)Å 
b = 43.560(3)Å 
c = 10.1587(8)Å 
α = 90°      
β = 103.829(2)° 












































[R(int) = 0.0304] 
10372  
[R(int) = 0.0824] 
9021  
[R(int) = 0.0270] 
4629  
[R(int) = 0.0258] 
12031   
[R(int) = 0.0535] 
Goof 1.049 1.073 1.009 1.078 1.029 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0617 
wR2 = 0.1327 
R1 = 0.0782 
 wR2 = 0.1750 
R1 = 0.0382  
wR2 = 0.0831 
R1 = 0.0484 
wR2 = 0.1353 
R1 = 0.0693 








 2-5 2-6 
Formula C13H16ClCu N5O5 C16H22CuO5N4·  
5H2O 
M 421.30 504.00 
Temperature 223(2) K 223(2) K 
Wavelength 0.71073 Å 0.71073 Å 
Crystal system Monoclinic Orthorhombic 
Space group P21/c C2221 
Unit cell 
dimensions 
a = 13.772(3) Å 
b = 8.1323(16) Å 
c = 14.297(3) Å 
α = 90°      
β = 90.33(3)° 
γ = 90° 
a = 11.7263(10)Å 
b = 19.1424(10)Å 
c = 21.0208(14)Å 
α = 90°      
β = 90°        






Z 4 8 
















[R(int) = 0.0280] 
5400  
[R(int) = 0.0548] 
Goof 1.027 1.034 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0350,  
wR2 = 0.0895 
R1 = 0.0461 












Table A2. Crystallographic data for Chapter 3. 









M 912.91 501.17  487.14 307.31 1784.35 
Temperature 100(2) K 223(2) K 100(2) K 100(2) K 100(2) K 
Wavelength 0.71073 Å 0.71073 Å 0.71073 Å 0.71073 Å 0.71073 Å 
Crystal system Triclinic Monoclinic Monoclinic Orthorhombic Orthorhombic 
Space group P1 P21 P21 P212121 P212121 
Unit cell 
dimensions 
a = 6.0496(13)Å 
b = 8.1335(17)Å 
c = 19.475(4)Å 
α = 84.322(5)°      
β = 81.261(4)°        
γ = 89.675(5)° 
a = 7.0688(11)Å  
b = 7.4648(12)Å    
c =21.049(4)Å   
α = 90° 
β = 96.734(4)° 
γ = 90° 
a = 6.9571(5)Å 
b = 7.5601(5)Å 
c = 41.523(3)Å 
α = 90°      
β= 93.3490(10)° 
γ = 90° 
a = 13.772(3) Å 
b = 8.1323(16) Å 
c = 14.297(3) Å 
α = 90°      
β = 90° 
γ = 90° 
a = 14.3507(8)Å 
b = 22.9818(12)Å 
c = 24.6507(13)Å 
α = 90°      
β = 90° 












Z 1 2 4 4 4 





























[R(int) = 0.0273] 
3743 
[R (int) =0.436] 
7321  
[R (int) = 
0.0277] 
3675  
[R(int) = 0.0280] 
18652   
[R(int) = 0.0507] 
Goof 1.126 1.058 1.120 1.027 1.023 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0521 
wR2 = 0.1298 
R1 = 0.0472  
wR2 = 0.0992 
R1 = 0.0422 
wR2 = 0.0958 
R1 = 0.0350,  
wR2 = 0.0895 
R1 = 0.0504,  











 3-5 3-6 3-7 3-8 











M 986.84 2224.18 864.37 436.42 
Temperature 223(2) K 223(2) K 100(2) K 223(2) K 
Wavelength 0.71073 Å 0.71073 Å 0.71073 Å 0.71073 Å 
Crystal system Tetragonal Monoclinic Tetragonal Tetragonal 
Space group P43212 P21 P41212 I4 
Unit cell 
dimensions 
a = 17.1337(3)Å 
b = 17.1337(3)Å 
c = 14.0986(6)Å 
α = 90°           
β = 90°             
γ = 90°      
a = 14.1168(6) Å  
b = 23.1777(9) Å    
c = 16.6098(7) Å   
α = 90° 
β = 103.4580(10)° 
γ = 90° 
a = 14.1406(3)Å  
b = 14.1406(3)Å    
c = 37.4088(17)Å   
α = 90° 
β = 90 
γ = 90° 
a = 24.8447(7) Å 
b = 24.8447(7) Å 
c = 6.5038(4) Å 
α = 90°      
β = 90° 





  7480.1(4) Å
3
  4014.5(3) Å
3
 
Z 4 2 8 8 

























[R(int) = 0.0454] 
18070  
[R (int) =0.0504] 
8599 
[R (int) =0.0406] 
4555  
[R(int) = 0.0303] 
Goof 1.081 1.085 1.142 1.093 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0356 
wR2 = 0.0913 
R1 = 0.0778 
wR2 = 0.1743 
R1 = 0.0672  
wR2 = 0.1764 
R1 = 0.0422,  
wR2 = 0.1193 
 
  
Table A3. Crystallographic data for Chapter 5. 
 M44F/G116F M13F/M44F 4Mut 
Data collection    
Space Group P43212 P212121 P212121 
Cell dimension 
a, b, c (Å) 
α, β, γ (˚) 
 
58.68, 58.68, 219.67 
90.0, 90.0, 90.0 
 
53.90, 102.68, 149.94 
90.0, 90.0, 90.0 
 
50.52, 57.59, 98.63 
90.0, 90.0, 90.0 
Resolution (Å) 1.76 (1.82 – 1.76) 3.00 (3.11 – 3.00) 1.70(1.76– 1.700) 
Rmerge 0.0796 (0.376) 0.127 (0.485) 0.103(0.569) 
I/ σI 40.0 (9.1) 23.9 (6.6) 25.4(3.4) 
Redundancy 27.8 (27.9) 13.4 (13.4) 14.7(14.2) 
Completeness (%) 95.9 (100.0) 99.9 (100.0)   96.9(100.0) 
Refinement    
Resolution (Å) 10.0 – 1.76 8.0 – 3.0 10.0 – 1.70 
Rwork/Rfree 0.236/ 0.279 0.236/ 0.334 Rall/Rwork/Rfree 
0.2085/0.2073/ 
0.2566(4CU) 









Metal Ion  3 Cu 6Cu 4Cu 
Water  368 63 249 
Rms. deviations 
Bond lengths(Å)  





















































































































      Fig. S11 
1
















































































































































































































Appendix III (IR, TGA, UV-visible & ESI-MS) 
1) 2-a 
 
Fig. S1 IR of 2-a ligand. 
2) [Cu(RNap)(OAc)].2H2O, 2-1 
 
Fig. S2 IR of 2-1. 
  
 
Fig. S3 TGA of 2-1. 
 
 
Fig. S4 UV-visible spectrum of 2-1. 
  
 




Fig. S6 IR of 2-b ligand. 
  
4) [Cu(RNO2)Cl(H2O)].{[Cu(RNO2)(H2O)2](ClO4)}.3H2O, 2-2 
 
Fig. S7 IR of 2-2. 
 
 




Fig. S9 UV-visible spectrum of 2-2.  
  
                 













5) [Cu(RNO2)(0.5Cl)(1.5H2O)](0.5NO3).0.5MeOH.H2O, 2-3 
 
 
Fig. S11 IR of 2-3. 
 
Fig. S12 TGA of 2-3. 
  
 




Fig. S14 Positive mode ESI spectrum of 2-3 and its simulated isotopic spectrum. 
 
 
6) [Cu2(RNO2)2(Pyr)4](C8H8).4H2O, 2-4 
 
 
Fig. S15 IR of 2-4. 
  
 
Fig. S16 TGA of 2-4. 
 
Fig. S17 UV-visible spectrum of 2-4. 
  
 
7) [Cu(RNO2)Cl], 2-5 
 





Fig. S19 TGA of 2-5. 
8) 2-c 
 
Fig. S20 IR of 2-c ligand.  
 
  
9) [Cu(RMe)(OAc)].5H2O, 2-6 
 
Fig. S21 IR of 2-6. 
 
 
Fig. S22 UV-visible spectrum of 2-6. 
  
 
Fig. S23 Postitive mode ESI spectrum of 2-6 and its simulated isotopic spectrum. 
 
10)  3-a 
 





11) Cu2(WNap)2(H2O)2].2H2O, 3-1 
 








Fig. S27 Positive mode ESI spectrum of 3-1 and its simulated isotopic spectrum. 
 
12)  [Ni(WNap)(H2O)2(MeOH)].H2O, 3-2 
 
 















Fig. S31 IR of 3-b ligand. 
  
 
14)  [Ni(YNap)(H2O)2(MeOH)].1.5H2O, 3-3 
 
 

















Fig. S35 Postitive mode ESI spectrum of 3-3 and its simulated isotopic spectrum. 
 
 
15)  3-c 
 
Fig. S36 IR of 3-c. 
  
 
16)  Ni4(YVan)4].3H2O.MeOH, 3-4 
 
 





Fig. S38 TGA of 3-4. 
  
 







Fig. S40 Negative mode ESI spectrum of 3-4 and its simulated isotopic spectrum. 
  
 
17)  3-d 
 
Fig. S41 IR of 3-d ligand.  
 
 
18)  [Ni3(HVan)2(OAc)2 (H2O)2].H2O.0.5MeOH.0.5IPA, 3-5 
 








                 
Fig. S44 Positive mode ESI spectrum of 3-5 and its simulated isotopic spectrum. 
19) 3-e 
 





20)  [Ni4(WVan)4(DMSO)2(H2O)2].4DMSO.3EtOH, 3-6 
 
Fig. S46 IR of 3-6.  
 
 




Fig. S48 UV-visible spectrum of 3-6. 
 
21) {Na[Fe(YNO2)2].0.5H2O.0.5THF.CH2Cl2}n, 3-7 
 




Fig.S50 UV-visible spectrum of 3-7. 
 
22) [Cu(YNap)(H2O)].0.75H2O.0.25MeOH, 3-8 
 















Appendix IV (ESI-MS for Protein Mutants) 
1) WT Azurin 
 
 
2) G9P (Az) 
 
 




4) M44F (Az) 
 
 
5) G116F (Az) 
 




7) M13F/G116F (Az) 
 
8) M44F/G116F (Az) 
 
9) G9P/M44F/G116F (Az) 
 
  
10) M44F/N47S/F114N (Az)  
 
 
11) N47S/F114N/G116F (Az)  
 
12) M44F/N47S/F114N/G116F or 4Mut (Az)  
 
  
13) M44F/N47S/F114N/G116F/M121L or 5Mut (Az)  
 
 




15) N47S (CuA Az)  
 
16) E114P (CuA Az)  
 
